Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Aizawl East,1.1,Total number of pregnant women Registered for ANC,TOTAL,373.0,387.0,399.0,456.0,466.0,403.0,378.0,348.0,280.0,272.0,482.0,408.0,4652.0
Aizawl East,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,297.0,299.0,306.0,367.0,374.0,343.0,303.0,295.0,243.0,215.0,395.0,332.0,3769.0
Aizawl East,1.2,Number of Pregnant women registered under JSY,TOTAL,312.0,348.0,364.0,392.0,374.0,347.0,203.0,306.0,242.0,236.0,432.0,346.0,3902.0
Aizawl East,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,286.0,273.0,295.0,381.0,310.0,303.0,294.0,322.0,328.0,289.0,303.0,290.0,3674.0
Aizawl East,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,249.0,259.0,230.0,242.0,284.0,256.0,258.0,236.0,248.0,188.0,254.0,248.0,2952.0
Aizawl East,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,329.0,326.0,326.0,326.0,390.0,368.0,342.0,335.0,349.0,271.0,268.0,317.0,3947.0
Aizawl East,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,145.0,182.0,174.0,192.0,221.0,172.0,225.0,173.0,221.0,272.0,257.0,230.0,2464.0
Aizawl East,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,1.0,1.0,3.0,0.0,0.0,2.0,0.0,0.0,2.0,1.0,1.0,1.0,12.0
Aizawl East,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,197.0,205.0,204.0,292.0,271.0,196.0,151.0,222.0,194.0,191.0,226.0,216.0,2565.0
Aizawl East,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,1.8,Number of pregnancy test kits used at SC level,TOTAL,219.0,214.0,148.0,246.0,192.0,184.0,160.0,176.0,167.0,181.0,205.0,196.0,2288.0
Aizawl East,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,4.0,2.0,0.0,3.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,14.0
Aizawl East,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,2.0,0.0,1.0,0.0,5.0,1.0,1.0,1.0,0.0,3.0,0.0,14.0
Aizawl East,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,6.0,2.0,1.0,3.0,5.0,1.0,2.0,2.0,1.0,4.0,1.0,28.0
Aizawl East,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,3.0,0.0,1.0,1.0,2.0,1.0,2.0,2.0,1.0,1.0,1.0,15.0
Aizawl East,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,110.0,100.0,93.0,88.0,79.0,73.0,75.0,85.0,70.0,77.0,60.0,70.0,980.0
Aizawl East,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,80.0,68.0,68.0,47.0,44.0,55.0,45.0,64.0,51.0,40.0,44.0,40.0,646.0
Aizawl East,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,54.0,27.0,24.0,93.0,38.0,94.0,104.0,35.0,13.0,13.0,6.0,10.0,511.0
Aizawl East,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,71.0,10.0,10.0,71.0,42.0,82.0,101.0,64.0,9.0,5.0,3.0,6.0,474.0
Aizawl East,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,145.0,171.0,173.0,182.0,184.0,239.0,207.0,213.0,200.0,195.0,172.0,193.0,2274.0
Aizawl East,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,2.0,1.0,8.0
Aizawl East,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Aizawl East,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl East,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,42.0,46.0,69.0,67.0,67.0,74.0,65.0,68.0,49.0,59.0,57.0,56.0,719.0
Aizawl East,4.1.1.a,Number of male live births,TOTAL,131.0,136.0,137.0,147.0,135.0,148.0,155.0,158.0,138.0,147.0,114.0,128.0,1674.0
Aizawl East,4.1.1.b,Number of female live births,TOTAL,123.0,141.0,130.0,121.0,131.0,169.0,127.0,139.0,134.0,123.0,123.0,135.0,1596.0
Aizawl East,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,254.0,277.0,267.0,268.0,266.0,317.0,282.0,297.0,272.0,270.0,237.0,263.0,3270.0
Aizawl East,4.1.2,Number of still births,TOTAL,1.0,1.0,1.0,3.0,0.0,0.0,1.0,3.0,1.0,3.0,0.0,1.0,15.0
Aizawl East,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,9.0,9.0,5.0,14.0,15.0,11.0,5.0,7.0,12.0,3.0,5.0,4.0,99.0
Aizawl East,4.2.1,Number of Newborns weighed at birth,TOTAL,254.0,276.0,266.0,268.0,266.0,314.0,282.0,297.0,271.0,271.0,237.0,262.0,3264.0
Aizawl East,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,14.0,17.0,12.0,16.0,15.0,16.0,18.0,17.0,16.0,11.0,12.0,7.0,171.0
Aizawl East,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,252.0,273.0,267.0,267.0,265.0,314.0,278.0,295.0,270.0,269.0,237.0,263.0,3250.0
Aizawl East,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,3.0,2.0,1.0,0.0,0.0,1.0,2.0,1.0,1.0,1.0,13.0
Aizawl East,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Aizawl East,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl East,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,1.0,3.0,2.0,1.0,0.0,0.0,1.0,2.0,1.0,1.0,1.0,13.0
Aizawl East,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Aizawl East,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,2.0
Aizawl East,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,1.0,1.0,2.0,1.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,10.0
Aizawl East,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,101.0,104.0,131.0,245.0,257.0,309.0,280.0,292.0,96.0,99.0,221.0,263.0,2398.0
Aizawl East,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,351.0,332.0,273.0,455.0,365.0,411.0,379.0,322.0,339.0,317.0,432.0,314.0,4290.0
Aizawl East,6.3,PNC maternal complications attended,TOTAL,6.0,5.0,0.0,11.0,0.0,8.0,0.0,7.0,5.0,0.0,4.0,1.0,47.0
Aizawl East,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,1.0,0.0,1.0,2.0,6.0,1.0,3.0,0.0,2.0,2.0,0.0,18.0
Aizawl East,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,2.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,8.0
Aizawl East,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,3.0,0.0,1.0,2.0,7.0,2.0,4.0,1.0,3.0,3.0,0.0,26.0
Aizawl East,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,44.0,0.0,2.0,43.0,2.0,3.0,2.0,13.0,3.0,19.0,0.0,2.0,133.0
Aizawl East,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,14.0,3.0,18.0,29.0,14.0,14.0,15.0,23.0,4.0,22.0,2.0,7.0,165.0
Aizawl East,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,58.0,3.0,20.0,72.0,16.0,17.0,17.0,36.0,7.0,41.0,2.0,9.0,298.0
Aizawl East,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Aizawl East,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl East,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Aizawl East,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl East,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0
Aizawl East,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Aizawl East,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl East,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0
Aizawl East,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,3.0,3.0,1.0,2.0,17.0,2.0,1.0,0.0,0.0,0.0,2.0,0.0,31.0
Aizawl East,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Aizawl East,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl East,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3.0,3.0,1.0,2.0,17.0,2.0,1.0,0.0,0.0,0.0,2.0,0.0,31.0
Aizawl East,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,22.0,18.0,19.0,20.0,,,24.0,20.0,14.0,0.0,0.0,137.0
Aizawl East,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,18.0,20.0,20.0,21.0,41.0,15.0,20.0,15.0,19.0,12.0,16.0,14.0,231.0
Aizawl East,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,3.0,3.0,18.0,12.0,9.0,15.0,8.0,5.0,0.0,3.0,9.0,86.0
Aizawl East,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,2.0,,,,,,,,,,,2.0
Aizawl East,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl East,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,19.0,25.0,23.0,39.0,53.0,24.0,35.0,23.0,24.0,12.0,19.0,23.0,319.0
Aizawl East,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,2.0,7.0,0.0,4.0,0.0,0.0,0.0,0.0,1.0,0.0,7.0,0.0,21.0
Aizawl East,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,4.0,,8.0,,,9.0,2.0,4.0,9.0,5.0,3.0,4.0,48.0
Aizawl East,9.06,Number of IUCD removals,TOTAL,14.0,13.0,13.0,11.0,5.0,9.0,15.0,13.0,15.0,13.0,18.0,15.0,154.0
Aizawl East,9.07,Number of Oral Pills cycles distributed,TOTAL,895.0,845.0,1075.0,1022.0,738.0,1171.0,910.0,1058.0,1050.0,985.0,996.0,924.0,11669.0
Aizawl East,9.08,Number of Condom pieces distributed,TOTAL,2943.0,2644.0,2460.0,2367.0,1619.0,3105.0,2122.0,2323.0,2325.0,1961.0,2074.0,2297.0,28240.0
Aizawl East,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,40.0,28.0,6.0,18.0,18.0,17.0,27.0,5.0,12.0,5.0,14.0,22.0,212.0
Aizawl East,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,3.0,,,,1.0,,,,1.0,1.0,2.0,-1.0
Aizawl East,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,337.0,332.0,322.0,350.0,354.0,318.0,325.0,321.0,228.0,374.0,370.0,225.0,3856.0
Aizawl East,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,463.0,367.0,418.0,325.0,400.0,408.0,328.0,405.0,403.0,413.0,459.0,383.0,4772.0
Aizawl East,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,454.0,404.0,413.0,374.0,415.0,411.0,423.0,407.0,395.0,388.0,406.0,416.0,4906.0
Aizawl East,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,403.0,406.0,466.0,405.0,366.0,427.0,405.0,404.0,384.0,382.0,406.0,415.0,4869.0
Aizawl East,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,87.0,61.0,56.0,122.0,42.0,36.0,143.0,48.0,47.0,42.0,118.0,131.0,933.0
Aizawl East,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,465.0,359.0,418.0,328.0,103.0,426.0,78.0,448.0,408.0,297.0,459.0,376.0,4165.0
Aizawl East,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,461.0,405.0,413.0,368.0,100.0,419.0,176.0,437.0,405.0,415.0,406.0,411.0,4416.0
Aizawl East,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,405.0,405.0,466.0,409.0,86.0,417.0,161.0,441.0,403.0,386.0,409.0,416.0,4404.0
Aizawl East,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,39.0,50.0,29.0,122.0,48.0,30.0,109.0,43.0,44.0,132.0,117.0,121.0,884.0
Aizawl East,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,386.0,369.0,484.0,496.0,417.0,474.0,450.0,393.0,471.0,397.0,419.0,448.0,5204.0
Aizawl East,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,452.0,361.0,417.0,527.0,507.0,424.0,387.0,419.0,398.0,333.0,336.0,387.0,4948.0
Aizawl East,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,191.0,194.0,236.0,245.0,209.0,230.0,244.0,204.0,266.0,187.0,202.0,219.0,2627.0
Aizawl East,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,192.0,170.0,199.0,249.0,208.0,243.0,204.0,189.0,197.0,201.0,217.0,212.0,2481.0
Aizawl East,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,383.0,364.0,435.0,494.0,417.0,473.0,448.0,393.0,463.0,388.0,419.0,431.0,5108.0
Aizawl East,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,447.0,356.0,349.0,463.0,432.0,428.0,404.0,439.0,408.0,319.0,308.0,375.0,4728.0
Aizawl East,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,447.0,355.0,349.0,463.0,235.0,457.0,318.0,486.0,410.0,319.0,308.0,379.0,4526.0
Aizawl East,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2.0,6.0,0.0,1.0,0.0,3.0,0.0,3.0,0.0,2.0,5.0,3.0,25.0
Aizawl East,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,2.0,2.0,0.0,0.0,6.0,0.0,12.0
Aizawl East,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2.0,6.0,0.0,1.0,0.0,5.0,2.0,5.0,0.0,2.0,11.0,3.0,37.0
Aizawl East,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,110.0,132.0,141.0,389.0,403.0,551.0,160.0,399.0,160.0,25.0,285.0,195.0,2950.0
Aizawl East,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,85.0,100.0,293.0,467.0,462.0,347.0,332.0,318.0,305.0,65.0,241.0,107.0,3122.0
Aizawl East,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,56.0,98.0,357.0,459.0,336.0,419.0,244.0,225.0,116.0,35.0,236.0,99.0,2680.0
Aizawl East,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,6.0,4.0,7.0,8.0,4.0,9.0,5.0,3.0,4.0,3.0,4.0,60.0
Aizawl East,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,109.0,106.0,108.0,112.0,109.0,103.0,113.0,108.0,108.0,113.0,112.0,110.0,1311.0
Aizawl East,10.4.2,Number of Immunisation sessions held during the month,TOTAL,109.0,104.0,108.0,112.0,109.0,103.0,113.0,108.0,108.0,109.0,113.0,110.0,1306.0
Aizawl East,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,89.0,93.0,95.0,92.0,98.0,90.0,94.0,98.0,94.0,94.0,95.0,74.0,1106.0
Aizawl East,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,385.0,365.0,482.0,468.0,411.0,473.0,447.0,287.0,460.0,386.0,419.0,440.0,5023.0
Aizawl East,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,204.0,213.0,219.0,234.0,229.0,224.0,183.0,253.0,303.0,227.0,339.0,269.0,2897.0
Aizawl East,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,206.0,187.0,218.0,290.0,338.0,270.0,244.0,315.0,270.0,228.0,216.0,319.0,3101.0
Aizawl East,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,3.0
Aizawl East,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,17.0,25.0,32.0,15.0,28.0,18.0,11.0,8.0,34.0,20.0,15.0,24.0,247.0
Aizawl East,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,8.0,18.0,16.0,15.0,24.0,6.0,5.0,7.0,4.0,5.0,12.0,12.0,132.0
Aizawl East,13.1,Number of Patients operated for cataract,TOTAL,4.0,7.0,10.0,12.0,7.0,14.0,0.0,8.0,6.0,17.0,13.0,19.0,117.0
Aizawl East,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1.0,1.0,1.0,2.0,2.0,0.0,2.0,4.0,1.0,1.0,1.0,5.0,21.0
Aizawl East,13.3,Number of School children detected with Refractive errors,TOTAL,13.0,24.0,12.0,50.0,14.0,29.0,68.0,72.0,46.0,33.0,43.0,150.0,554.0
Aizawl East,13.4,Number of children provided free glasses,TOTAL,8.0,8.0,5.0,0.0,6.0,6.0,6.0,8.0,8.0,10.0,6.0,13.0,84.0
Aizawl East,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Aizawl East,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,6.0,5.0,5.0,4.0,5.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Aizawl East,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,67.0,67.0,78.0,82.0,85.0,82.0,86.0,75.0,85.0,78.0,84.0,84.0,-1.0
Aizawl East,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Aizawl East,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,2.0,1.0,1.0,9.0
Aizawl East,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,6.0,6.0,7.0,5.0,5.0,6.0,7.0,8.0,7.0,7.0,8.0,-1.0
Aizawl East,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,16.0,19.0,8.0,4.0,10.0,0.0,0.0,12.0,9.0,11.0,13.0,16.0,118.0
Aizawl East,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Aizawl East,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Aizawl East,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Aizawl East,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Aizawl East,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Aizawl East,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,340.0,362.0,379.0,481.0,403.0,312.0,335.0,330.0,322.0,350.0,323.0,383.0,4320.0
Aizawl East,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,686.0,617.0,842.0,781.0,695.0,842.0,846.0,845.0,724.0,744.0,736.0,823.0,9181.0
Aizawl East,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,260.0,306.0,320.0,351.0,331.0,319.0,278.0,274.0,266.0,282.0,304.0,313.0,3604.0
Aizawl East,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,874.0,804.0,883.0,917.0,867.0,996.0,1037.0,982.0,842.0,811.0,838.0,838.0,10689.0
Aizawl East,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,600.0,668.0,699.0,832.0,734.0,631.0,613.0,604.0,588.0,632.0,627.0,696.0,7924.0
Aizawl East,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1560.0,1421.0,1725.0,1698.0,1562.0,1838.0,1883.0,1827.0,1566.0,1555.0,1574.0,1661.0,19870.0
Aizawl East,14.10.2.a,Number of death cases of Inpatient males,TOTAL,34.0,39.0,48.0,47.0,28.0,44.0,41.0,37.0,40.0,48.0,41.0,59.0,506.0
Aizawl East,14.10.2.b,Number of death cases of Inpatient females,TOTAL,17.0,19.0,18.0,31.0,12.0,21.0,13.0,16.0,16.0,17.0,24.0,22.0,226.0
Aizawl East,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,51.0,58.0,66.0,78.0,40.0,65.0,54.0,53.0,56.0,65.0,65.0,81.0,732.0
Aizawl East,14.11,In-Patient Head Count at midnight,TOTAL,1176.0,1182.0,1201.0,1201.0,10360.0,10345.0,1199.0,1067.0,1037.0,750.0,1282.0,1014.0,31814.0
Aizawl East,14.12.1,OPD attendance (All),TOTAL,18304.0,18797.0,18890.0,21189.0,20723.0,19875.0,20520.0,19599.0,16684.0,12182.0,18149.0,16320.0,221232.0
Aizawl East,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,244.0,336.0,264.0,401.0,362.0,438.0,429.0,367.0,312.0,362.0,369.0,460.0,4344.0
Aizawl East,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,8.0,0.0,0.0,71.0,73.0,19.0,17.0,16.0,5.0,60.0,11.0,0.0,280.0
Aizawl East,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Aizawl East,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,529.0,543.0,244.0,392.0,370.0,403.0,413.0,361.0,350.0,304.0,425.0,383.0,4717.0
Aizawl East,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Aizawl East,14.14.a,Number of patients given AYUSH treatment,TOTAL,336.0,159.0,379.0,259.0,250.0,122.0,102.0,301.0,267.0,152.0,258.0,219.0,2804.0
Aizawl East,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,395.0,386.0,350.0,265.0,286.0,292.0,285.0,226.0,183.0,225.0,169.0,270.0,3332.0
Aizawl East,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Aizawl East,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1462.0,3230.0,1492.0,1440.0,3745.0,3624.0,3565.0,3540.0,3299.0,3122.0,3240.0,3747.0,35506.0
Aizawl East,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,23.0,57.0,21.0,50.0,90.0,83.0,68.0,81.0,75.0,83.0,66.0,70.0,767.0
Aizawl East,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,142.0,394.0,165.0,112.0,431.0,341.0,267.0,310.0,401.0,350.0,384.0,422.0,3719.0
Aizawl East,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,22.0,9.0,4.0,23.0,11.0,24.0,7.0,16.0,9.0,17.0,25.0,172.0
Aizawl East,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,111.0,236.0,171.0,133.0,305.0,183.0,302.0,232.0,264.0,240.0,263.0,275.0,2715.0
Aizawl East,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,6.0,9.0,5.0,12.0,8.0,11.0,10.0,5.0,6.0,8.0,10.0,91.0
Aizawl East,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,136.0,349.0,230.0,145.0,525.0,459.0,336.0,399.0,389.0,361.0,482.0,418.0,4229.0
Aizawl East,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,3.0,7.0,2.0,5.0,0.0,11.0,1.0,2.0,3.0,2.0,2.0,38.0
Aizawl East,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,389.0,979.0,566.0,390.0,1261.0,983.0,905.0,941.0,1054.0,951.0,1129.0,1115.0,10663.0
Aizawl East,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,31.0,25.0,11.0,40.0,19.0,46.0,18.0,23.0,18.0,27.0,37.0,301.0
Aizawl East,15.2,Number of Widal tests conducted,Number tested,289.0,374.0,326.0,275.0,412.0,473.0,693.0,713.0,244.0,339.0,445.0,350.0,4933.0
Aizawl East,15.3.a,Number of VDRL tests conducted on males,Number tested,1.0,48.0,29.0,5.0,46.0,47.0,55.0,50.0,61.0,67.0,61.0,57.0,527.0
Aizawl East,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,19.0,67.0,48.0,24.0,81.0,127.0,56.0,57.0,48.0,68.0,51.0,46.0,692.0
Aizawl East,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,32.0,203.0,82.0,67.0,276.0,271.0,291.0,183.0,173.0,231.0,232.0,78.0,2119.0
Aizawl East,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,52.0,318.0,159.0,96.0,403.0,445.0,402.0,290.0,282.0,366.0,344.0,181.0,3338.0
Aizawl East,15.4.1,Number of blood smears examined for Malaria,TOTAL,365.0,1199.0,501.0,445.0,1562.0,1371.0,1422.0,1315.0,1005.0,889.0,2953.0,1043.0,14070.0
Aizawl East,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,5.0,4.0,4.0,2.0,1.0,1.0,2.0,0.0,2.0,1.0,4.0,28.0
Aizawl East,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,8.0,3.0,3.0,2.0,2.0,3.0,4.0,0.0,0.0,0.0,3.0,30.0
Aizawl East,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Aizawl East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Aizawl East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Aizawl East,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl East,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Aizawl East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,,1.0,1.0,,1.0,,,,1.0,5.0
Aizawl East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,,1.0,,,,,,2.0
Aizawl East,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,,,1.0,1.0,1.0,1.0,,,,1.0,7.0
Aizawl East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,,1.0,,,1.0,,,,1.0,,4.0
Aizawl East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aizawl East,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,1.0,,,1.0,,,,1.0,,4.0
Aizawl East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,2.0,3.0,,1.0,,1.0,,,1.0,1.0,10.0
Aizawl East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Aizawl East,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,2.0,3.0,,1.0,,2.0,,,1.0,1.0,11.0
Aizawl East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,,,,,,2.0,,,,3.0
Aizawl East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aizawl East,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,,,,,,2.0,,,,3.0
Aizawl East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,1.0,1.0,1.0,,2.0,1.0,1.0,,7.0
Aizawl East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,2.0,,2.0
Aizawl East,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,1.0,1.0,1.0,,2.0,1.0,3.0,,9.0
Aizawl East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aizawl East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aizawl East,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Aizawl East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aizawl East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aizawl East,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Aizawl East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aizawl East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aizawl East,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Aizawl East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,13.0
Aizawl East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,1.0,,,,1.0,,2.0
Aizawl East,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,,2.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,2.0,15.0
Aizawl East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Aizawl East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,1.0,2.0
Aizawl East,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,,1.0,1.0,3.0
Aizawl East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,,,,2.0,2.0,,,2.0,4.0,1.0,4.0,17.0
Aizawl East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,1.0,,,,,,1.0,3.0
Aizawl East,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,,,1.0,2.0,3.0,,,2.0,4.0,1.0,5.0,20.0
Aizawl East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,2.0,3.0,4.0,1.0,6.0,4.0,1.0,1.0,1.0,,2.0,27.0
Aizawl East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,1.0,2.0,3.0,4.0,2.0,5.0,6.0,7.0,3.0,2.0,3.0,39.0
Aizawl East,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,3.0,5.0,7.0,5.0,8.0,9.0,7.0,8.0,4.0,2.0,5.0,66.0
Aizawl East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,3.0,,,,1.0,,,,,,5.0
Aizawl East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,3.0,,,,1.0,,,,,,5.0
Aizawl East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,2.0,1.0,2.0,,,,5.0
Aizawl East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,2.0,4.0,2.0,2.0,2.0,2.0,2.0,5.0,3.0,3.0,3.0,32.0
Aizawl East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,,,1.0,2.0,1.0,1.0,1.0,2.0,,2.0,,13.0
Aizawl East,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,2.0,4.0,3.0,4.0,3.0,5.0,4.0,9.0,3.0,5.0,3.0,50.0
Aizawl East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Aizawl East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,7.0,9.0,4.0,11.0,11.0,8.0,5.0,9.0,4.0,12.0,7.0,11.0,98.0
Aizawl East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,1.0,,1.0,,1.0,1.0,1.0,,1.0,,2.0,9.0
Aizawl East,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,8.0,10.0,5.0,12.0,11.0,9.0,6.0,10.0,4.0,13.0,7.0,13.0,108.0
Aizawl East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,4.0,3.0,,5.0,3.0,4.0,2.0,4.0,4.0,2.0,4.0,38.0
Aizawl East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,1.0,6.0,4.0,1.0,6.0,5.0,6.0,6.0,6.0,2.0,1.0,47.0
Aizawl East,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,5.0,9.0,4.0,6.0,9.0,9.0,8.0,10.0,10.0,4.0,5.0,85.0
Aizawl East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,2.0,1.0,1.0,,1.0,,,2.0,1.0,1.0,1.0,11.0
Aizawl East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,2.0,2.0,3.0,2.0,1.0,3.0,,2.0,6.0,5.0,1.0,30.0
Aizawl East,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,4.0,3.0,4.0,2.0,2.0,3.0,,4.0,7.0,6.0,2.0,41.0
Aizawl East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Aizawl East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Aizawl East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Aizawl East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Aizawl East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Aizawl East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,1.0,,,1.0,,,,,2.0
Aizawl East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,1.0,,,1.0,,,,,2.0
Aizawl East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,,,3.0,,,1.0,,2.0,7.0
Aizawl East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,4.0,4.0,2.0,2.0,2.0,2.0,6.0,2.0,6.0,2.0,5.0,44.0
Aizawl East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,2.0,,1.0,,2.0,3.0,1.0,1.0,,1.0,12.0
Aizawl East,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,8.0,4.0,7.0,2.0,3.0,2.0,7.0,9.0,3.0,8.0,2.0,8.0,63.0
Aizawl East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Aizawl East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,3.0,,1.0,3.0,3.0,,2.0,2.0,1.0,3.0,2.0,23.0
Aizawl East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,2.0,,,,,,2.0
Aizawl East,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,3.0,,1.0,3.0,4.0,2.0,2.0,2.0,1.0,3.0,2.0,26.0
Aizawl East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Aizawl East,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Aizawl East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,6.0,9.0,2.0,6.0,3.0,6.0,4.0,3.0,8.0,2.0,7.0,59.0
Aizawl East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,4.0,3.0,7.0,,5.0,4.0,7.0,3.0,6.0,8.0,2.0,50.0
Aizawl East,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,10.0,12.0,9.0,6.0,8.0,10.0,11.0,6.0,14.0,10.0,9.0,109.0
Aizawl East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,,,1.0,,1.0,3.0
Aizawl East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,12.0,16.0,21.0,22.0,15.0,36.0,22.0,13.0,16.0,14.0,23.0,28.0,238.0
Aizawl East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,24.0,17.0,25.0,30.0,29.0,25.0,14.0,28.0,24.0,29.0,34.0,28.0,307.0
Aizawl East,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,36.0,33.0,46.0,52.0,44.0,61.0,37.0,41.0,40.0,44.0,57.0,57.0,548.0
Aizawl East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Aizawl East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,2.0,5.0,5.0,4.0,7.0,9.0,6.0,1.0,6.0,5.0,2.0,55.0
Aizawl East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,4.0,5.0,3.0,2.0,2.0,4.0,5.0,8.0,9.0,8.0,7.0,3.0,60.0
Aizawl East,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,7.0,7.0,8.0,7.0,6.0,11.0,14.0,14.0,10.0,14.0,12.0,6.0,116.0
Aizawl West,1.1,Total number of pregnant women Registered for ANC,TOTAL,391.0,332.0,361.0,261.0,276.0,268.0,255.0,252.0,260.0,253.0,286.0,303.0,3498.0
Aizawl West,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,276.0,236.0,266.0,206.0,203.0,210.0,185.0,195.0,206.0,192.0,207.0,239.0,2621.0
Aizawl West,1.2,Number of Pregnant women registered under JSY,TOTAL,337.0,331.0,319.0,261.0,276.0,268.0,254.0,251.0,260.0,253.0,286.0,303.0,3399.0
Aizawl West,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,230.0,183.0,234.0,209.0,218.0,223.0,197.0,189.0,222.0,193.0,175.0,167.0,2440.0
Aizawl West,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,236.0,199.0,202.0,160.0,200.0,155.0,168.0,144.0,165.0,177.0,183.0,214.0,2203.0
Aizawl West,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,247.0,280.0,283.0,259.0,238.0,275.0,240.0,235.0,218.0,198.0,237.0,233.0,2943.0
Aizawl West,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,166.0,149.0,165.0,188.0,173.0,169.0,162.0,86.0,68.0,62.0,47.0,44.0,1479.0
Aizawl West,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,1.0,0.0,0.0,2.0,1.0,0.0,8.0
Aizawl West,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,192.0,83.0,82.0,89.0,135.0,141.0,237.0,138.0,115.0,128.0,141.0,77.0,1558.0
Aizawl West,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,3.0,2.0,1.0,4.0,0.0,2.0,3.0,1.0,16.0
Aizawl West,1.8,Number of pregnancy test kits used at SC level,TOTAL,136.0,128.0,178.0,167.0,157.0,160.0,167.0,123.0,122.0,113.0,103.0,138.0,1692.0
Aizawl West,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,5.0
Aizawl West,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Aizawl West,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,0.0,1.0,2.0,1.0,0.0,0.0,1.0,2.0,0.0,0.0,1.0,9.0
Aizawl West,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,0.0,1.0,2.0,1.0,0.0,0.0,1.0,2.0,0.0,0.0,1.0,9.0
Aizawl West,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,447.0,441.0,431.0,427.0,437.0,493.0,457.0,494.0,501.0,480.0,487.0,422.0,5517.0
Aizawl West,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,359.0,366.0,337.0,325.0,380.0,382.0,279.0,325.0,311.0,305.0,311.0,260.0,3940.0
Aizawl West,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,20.0,26.0,31.0,41.0,32.0,31.0,34.0,31.0,36.0,35.0,24.0,32.0,373.0
Aizawl West,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,10.0,24.0,27.0,16.0,25.0,14.0,20.0,18.0,29.0,28.0,17.0,18.0,246.0
Aizawl West,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,30.0,15.0,40.0,29.0,26.0,30.0,37.0,23.0,32.0,22.0,46.0,45.0,375.0
Aizawl West,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,7.0,6.0,13.0,16.0,14.0,15.0,8.0,6.0,13.0,8.0,5.0,8.0,119.0
Aizawl West,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Aizawl West,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,0.0,0.0
Aizawl West,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,31.0,42.0,25.0,28.0,21.0,29.0,30.0,28.0,40.0,36.0,33.0,29.0,372.0
Aizawl West,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,95.0,62.0,71.0,67.0,92.0,84.0,70.0,83.0,77.0,88.0,84.0,83.0,956.0
Aizawl West,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl West,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,126.0,104.0,96.0,95.0,113.0,113.0,100.0,111.0,117.0,124.0,117.0,112.0,1328.0
Aizawl West,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,15.0,7.0,17.0,14.0,11.0,14.0,14.0,9.0,10.0,10.0,21.0,17.0,159.0
Aizawl West,4.1.1.a,Number of male live births,TOTAL,241.0,224.0,239.0,251.0,239.0,264.0,239.0,259.0,250.0,238.0,256.0,244.0,2944.0
Aizawl West,4.1.1.b,Number of female live births,TOTAL,231.0,231.0,229.0,202.0,215.0,253.0,249.0,256.0,276.0,257.0,270.0,217.0,2886.0
Aizawl West,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,472.0,455.0,468.0,453.0,454.0,517.0,488.0,515.0,526.0,495.0,526.0,461.0,5830.0
Aizawl West,4.1.2,Number of still births,TOTAL,6.0,1.0,4.0,5.0,10.0,6.0,6.0,3.0,9.0,7.0,7.0,7.0,71.0
Aizawl West,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,18.0,13.0,11.0,20.0,25.0,21.0,7.0,30.0,25.0,29.0,30.0,21.0,250.0
Aizawl West,4.2.1,Number of Newborns weighed at birth,TOTAL,470.0,455.0,468.0,453.0,454.0,517.0,488.0,515.0,526.0,495.0,526.0,461.0,5828.0
Aizawl West,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,28.0,29.0,30.0,27.0,27.0,26.0,26.0,42.0,27.0,38.0,11.0,14.0,325.0
Aizawl West,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,472.0,455.0,465.0,453.0,453.0,515.0,488.0,514.0,525.0,494.0,525.0,458.0,5817.0
Aizawl West,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,31.0,42.0,25.0,28.0,21.0,29.0,30.0,28.0,40.0,36.0,33.0,29.0,372.0
Aizawl West,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,95.0,62.0,71.0,67.0,92.0,84.0,71.0,83.0,77.0,88.0,84.0,83.0,957.0
Aizawl West,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl West,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,126.0,104.0,96.0,95.0,113.0,113.0,101.0,111.0,117.0,124.0,117.0,112.0,1329.0
Aizawl West,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,15.0,7.0,17.0,14.0,11.0,14.0,14.0,9.0,10.0,10.0,21.0,17.0,159.0
Aizawl West,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,139.0,111.0,107.0,104.0,124.0,124.0,112.0,120.0,124.0,130.0,136.0,129.0,1460.0
Aizawl West,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Aizawl West,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,18.0,0.0,25.0,6.0,0.0,116.0,3.0,1.0,3.0,4.0,3.0,0.0,179.0
Aizawl West,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,5.0,5.0,35.0,10.0,5.0,6.0,22.0,1.0,0.0,0.0,0.0,1.0,90.0
Aizawl West,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,473.0,456.0,461.0,457.0,464.0,522.0,492.0,518.0,535.0,502.0,533.0,468.0,5881.0
Aizawl West,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,359.0,361.0,311.0,360.0,257.0,444.0,335.0,289.0,319.0,360.0,316.0,339.0,4050.0
Aizawl West,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Aizawl West,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Aizawl West,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Aizawl West,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,6.0,0.0,8.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Aizawl West,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,9.0,8.0,16.0,17.0,4.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,56.0
Aizawl West,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,15.0,8.0,24.0,23.0,4.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,76.0
Aizawl West,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Aizawl West,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Aizawl West,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl West,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Aizawl West,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Aizawl West,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Aizawl West,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,1.0,1.0,5.0,4.0,1.0,7.0,1.0,1.0,2.0,3.0,27.0
Aizawl West,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl West,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,1.0,0.0,1.0,1.0,5.0,4.0,1.0,7.0,1.0,1.0,2.0,3.0,27.0
Aizawl West,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,0.0,0.0,0.0
Aizawl West,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,33.0,22.0,28.0,22.0,25.0,32.0,28.0,24.0,25.0,27.0,32.0,19.0,317.0
Aizawl West,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl West,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,33.0,22.0,28.0,22.0,25.0,32.0,28.0,24.0,25.0,27.0,32.0,19.0,317.0
Aizawl West,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,2.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,4.0,5.0,0.0,16.0
Aizawl West,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,1.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Aizawl West,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,19.0,18.0,16.0,16.0,35.0,24.0,16.0,17.0,19.0,27.0,17.0,22.0,246.0
Aizawl West,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl West,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,19.0,18.0,17.0,20.0,35.0,24.0,16.0,17.0,19.0,27.0,17.0,22.0,251.0
Aizawl West,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,1.0,3.0,7.0,0.0,1.0,6.0,6.0,3.0,4.0,0.0,0.0,8.0,39.0
Aizawl West,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,3.0,7.0,3.0,6.0,4.0,3.0,3.0,2.0,3.0,5.0,5.0,3.0,47.0
Aizawl West,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,1.0,1.0,2.0,4.0,0.0,1.0,1.0,2.0,1.0,1.0,1.0,16.0
Aizawl West,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,32.0,32.0,43.0,40.0,24.0,33.0,43.0,30.0,28.0,23.0,39.0,41.0,408.0
Aizawl West,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Aizawl West,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,36.0,40.0,47.0,48.0,32.0,36.0,47.0,33.0,33.0,29.0,45.0,45.0,471.0
Aizawl West,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Aizawl West,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,3.0,17.0,14.0,15.0,12.0,11.0,15.0,9.0,7.0,10.0,10.0,12.0,135.0
Aizawl West,9.06,Number of IUCD removals,TOTAL,22.0,67.0,51.0,46.0,41.0,53.0,48.0,35.0,42.0,45.0,45.0,49.0,544.0
Aizawl West,9.07,Number of Oral Pills cycles distributed,TOTAL,968.0,1134.0,960.0,990.0,988.0,1117.0,885.0,918.0,819.0,746.0,814.0,867.0,11206.0
Aizawl West,9.08,Number of Condom pieces distributed,TOTAL,1668.0,1863.0,1408.0,1070.0,1114.0,1320.0,1639.0,1463.0,1216.0,949.0,1067.0,1582.0,16359.0
Aizawl West,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,49.0,36.0,35.0,61.0,39.0,42.0,31.0,5.0,13.0,25.0,29.0,26.0,391.0
Aizawl West,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Aizawl West,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,4.0
Aizawl West,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Aizawl West,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,381.0,381.0,411.0,354.0,362.0,410.0,441.0,389.0,431.0,223.0,309.0,330.0,4422.0
Aizawl West,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,254.0,206.0,244.0,231.0,250.0,221.0,222.0,236.0,270.0,253.0,261.0,231.0,2879.0
Aizawl West,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,211.0,249.0,232.0,248.0,220.0,249.0,242.0,232.0,217.0,248.0,256.0,279.0,2883.0
Aizawl West,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,240.0,214.0,235.0,223.0,254.0,220.0,244.0,238.0,241.0,190.0,235.0,265.0,2799.0
Aizawl West,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,222.0,199.0,226.0,188.0,187.0,254.0,293.0,208.0,227.0,66.0,159.0,182.0,2411.0
Aizawl West,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,254.0,206.0,244.0,231.0,250.0,221.0,222.0,236.0,270.0,253.0,261.0,231.0,2879.0
Aizawl West,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,211.0,249.0,232.0,248.0,220.0,249.0,242.0,232.0,217.0,248.0,256.0,279.0,2883.0
Aizawl West,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,240.0,214.0,235.0,223.0,254.0,220.0,241.0,238.0,241.0,190.0,235.0,265.0,2796.0
Aizawl West,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,222.0,199.0,226.0,188.0,187.0,254.0,293.0,213.0,225.0,66.0,159.0,180.0,2412.0
Aizawl West,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,223.0,181.0,207.0,217.0,242.0,237.0,233.0,249.0,233.0,225.0,245.0,216.0,2708.0
Aizawl West,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,263.0,216.0,233.0,197.0,242.0,218.0,196.0,193.0,180.0,186.0,218.0,172.0,2514.0
Aizawl West,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,118.0,103.0,115.0,111.0,113.0,114.0,122.0,132.0,108.0,113.0,117.0,112.0,1378.0
Aizawl West,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,104.0,78.0,92.0,106.0,129.0,123.0,111.0,117.0,125.0,112.0,128.0,104.0,1329.0
Aizawl West,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,222.0,181.0,207.0,217.0,242.0,237.0,233.0,249.0,233.0,225.0,245.0,216.0,2707.0
Aizawl West,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,263.0,216.0,230.0,197.0,242.0,218.0,196.0,193.0,180.0,186.0,218.0,172.0,2511.0
Aizawl West,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,263.0,216.0,230.0,197.0,242.0,218.0,196.0,193.0,180.0,186.0,218.0,172.0,2511.0
Aizawl West,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Aizawl West,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,23.0,74.0,309.0,470.0,126.0,48.0,210.0,485.0,239.0,60.0,192.0,174.0,2410.0
Aizawl West,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,4.0,222.0,343.0,436.0,84.0,100.0,148.0,267.0,204.0,58.0,227.0,146.0,2239.0
Aizawl West,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,7.0,193.0,154.0,1126.0,188.0,240.0,94.0,110.0,207.0,32.0,83.0,198.0,2632.0
Aizawl West,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Aizawl West,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Aizawl West,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,76.0,76.0,76.0,77.0,74.0,73.0,76.0,74.0,75.0,76.0,74.0,75.0,902.0
Aizawl West,10.4.2,Number of Immunisation sessions held during the month,TOTAL,76.0,75.0,75.0,77.0,74.0,73.0,76.0,74.0,75.0,76.0,74.0,75.0,900.0
Aizawl West,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,74.0,74.0,75.0,77.0,73.0,71.0,76.0,74.0,74.0,76.0,73.0,75.0,892.0
Aizawl West,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,214.0,186.0,189.0,201.0,230.0,230.0,230.0,235.0,231.0,218.0,239.0,215.0,2618.0
Aizawl West,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,81.0,59.0,74.0,69.0,81.0,112.0,131.0,109.0,119.0,112.0,107.0,94.0,1148.0
Aizawl West,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,53.0,48.0,54.0,51.0,84.0,89.0,109.0,135.0,140.0,141.0,130.0,103.0,1137.0
Aizawl West,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,2.0,1.0,1.0,1.0,0.0,0.0,0.0,2.0,7.0,2.0,3.0,22.0
Aizawl West,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,46.0,49.0,41.0,38.0,28.0,27.0,46.0,34.0,30.0,31.0,66.0,175.0,611.0
Aizawl West,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,3.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,7.0
Aizawl West,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,116.0,76.0,68.0,60.0,92.0,70.0,38.0,40.0,31.0,38.0,47.0,56.0,732.0
Aizawl West,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,1.0,5.0
Aizawl West,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Aizawl West,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Aizawl West,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,63.0,60.0,58.0,66.0,75.0,61.0,62.0,64.0,60.0,54.0,66.0,56.0,-1.0
Aizawl West,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Aizawl West,14.05,Number of RKS meetings held during the month,TOTAL,2.0,2.0,3.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,10.0
Aizawl West,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,8.0,9.0,9.0,9.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,-1.0
Aizawl West,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,55.0,68.0,60.0,75.0,64.0,89.0,106.0,74.0,46.0,39.0,51.0,69.0,796.0
Aizawl West,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,2.0,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Aizawl West,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Aizawl West,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Aizawl West,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Aizawl West,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Aizawl West,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,266.0,243.0,322.0,366.0,370.0,336.0,350.0,269.0,307.0,244.0,314.0,343.0,3730.0
Aizawl West,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,684.0,565.0,809.0,737.0,638.0,723.0,648.0,669.0,666.0,641.0,659.0,642.0,8081.0
Aizawl West,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,227.0,198.0,276.0,261.0,275.0,304.0,380.0,274.0,258.0,206.0,281.0,276.0,3216.0
Aizawl West,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1035.0,936.0,1106.0,1055.0,1002.0,1184.0,1007.0,1106.0,1108.0,931.0,1013.0,889.0,12372.0
Aizawl West,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,493.0,441.0,598.0,627.0,645.0,640.0,730.0,543.0,565.0,450.0,595.0,619.0,6946.0
Aizawl West,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1719.0,1501.0,1915.0,1792.0,1640.0,1907.0,1655.0,1775.0,1774.0,1572.0,1672.0,1531.0,20453.0
Aizawl West,14.10.2.a,Number of death cases of Inpatient males,TOTAL,61.0,37.0,50.0,42.0,47.0,61.0,7.0,58.0,55.0,55.0,20.0,52.0,545.0
Aizawl West,14.10.2.b,Number of death cases of Inpatient females,TOTAL,27.0,21.0,27.0,18.0,30.0,26.0,3.0,30.0,25.0,29.0,44.0,34.0,314.0
Aizawl West,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,88.0,58.0,77.0,60.0,77.0,87.0,10.0,88.0,80.0,84.0,64.0,86.0,859.0
Aizawl West,14.11,In-Patient Head Count at midnight,TOTAL,2212.0,1942.0,2377.0,3168.0,5887.0,17014.0,13514.0,10078.0,11106.0,9805.0,9288.0,24017.0,110408.0
Aizawl West,14.12.1,OPD attendance (All),TOTAL,47923.0,44060.0,50133.0,50598.0,48628.0,54393.0,62383.0,46075.0,45053.0,35807.0,42476.0,41092.0,568621.0
Aizawl West,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,830.0,728.0,817.0,724.0,725.0,898.0,812.0,709.0,788.0,582.0,611.0,760.0,8984.0
Aizawl West,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,10.0,0.0,6.0,2.0,1.0,3.0,3.0,5.0,1.0,2.0,5.0,17.0,55.0
Aizawl West,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Aizawl West,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1207.0,1140.0,1258.0,1231.0,1510.0,1512.0,1853.0,1550.0,1330.0,1179.0,1309.0,1276.0,16355.0
Aizawl West,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Aizawl West,14.14.a,Number of patients given AYUSH treatment,TOTAL,673.0,569.0,772.0,702.0,692.0,845.0,896.0,1129.0,1071.0,639.0,655.0,702.0,9345.0
Aizawl West,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2849.0,2106.0,2418.0,2130.0,2079.0,2477.0,2537.0,2180.0,2033.0,1478.0,2381.0,1696.0,26364.0
Aizawl West,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Aizawl West,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3437.0,2888.0,3723.0,3535.0,3360.0,3763.0,3575.0,3360.0,3388.0,2613.0,3338.0,3093.0,40073.0
Aizawl West,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,33.0,14.0,22.0,26.0,25.0,11.0,1.0,35.0,24.0,18.0,7.0,0.0,216.0
Aizawl West,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,485.0,388.0,455.0,439.0,445.0,517.0,579.0,451.0,396.0,434.0,456.0,453.0,5498.0
Aizawl West,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,36.0,28.0,41.0,28.0,46.0,53.0,5.0,49.0,33.0,34.0,38.0,25.0,416.0
Aizawl West,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,330.0,327.0,455.0,417.0,374.0,492.0,213.0,493.0,329.0,304.0,347.0,396.0,4477.0
Aizawl West,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,17.0,14.0,25.0,14.0,25.0,31.0,3.0,28.0,21.0,18.0,26.0,16.0,238.0
Aizawl West,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,480.0,537.0,653.0,559.0,645.0,659.0,569.0,612.0,472.0,418.0,533.0,493.0,6630.0
Aizawl West,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,5.0,8.0,10.0,5.0,6.0,3.0,8.0,9.0,5.0,7.0,5.0,75.0
Aizawl West,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1295.0,1252.0,1563.0,1415.0,1464.0,1668.0,1361.0,1556.0,1197.0,1156.0,1336.0,1342.0,16605.0
Aizawl West,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,57.0,47.0,74.0,52.0,76.0,90.0,11.0,85.0,63.0,57.0,71.0,46.0,729.0
Aizawl West,15.2,Number of Widal tests conducted,Number tested,186.0,195.0,234.0,174.0,297.0,470.0,434.0,301.0,248.0,193.0,231.0,244.0,3207.0
Aizawl West,15.3.a,Number of VDRL tests conducted on males,Number tested,107.0,69.0,87.0,105.0,93.0,107.0,131.0,85.0,106.0,68.0,88.0,80.0,1126.0
Aizawl West,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,37.0,21.0,32.0,70.0,27.0,30.0,86.0,71.0,22.0,31.0,35.0,45.0,507.0
Aizawl West,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,266.0,413.0,473.0,399.0,506.0,568.0,510.0,517.0,399.0,220.0,468.0,404.0,5143.0
Aizawl West,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,410.0,503.0,592.0,574.0,626.0,705.0,727.0,673.0,527.0,319.0,591.0,529.0,6776.0
Aizawl West,15.4.1,Number of blood smears examined for Malaria,TOTAL,403.0,492.0,728.0,1383.0,1017.0,787.0,851.0,614.0,589.0,211.0,418.0,243.0,7736.0
Aizawl West,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,9.0,7.0,4.0,8.0,1.0,3.0,4.0,7.0,1.0,0.0,0.0,45.0
Aizawl West,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,3.0,8.0,9.0,1.0,5.0,1.0,1.0,0.0,0.0,0.0,1.0,31.0
Aizawl West,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1250.0,990.0,80.0,80.0,80.0,40.0,60.0,50.0,30.0,90.0,3480.0,480.0,6710.0
Aizawl West,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,,136.0,140.0,100.0,120.0,0.0,310.0,200.0,3890.0,1500.0,0.0,6396.0
Aizawl West,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,480.0,3480.0
Aizawl West,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,260.0,910.0,136.0,140.0,140.0,100.0,10.0,330.0,140.0,500.0,1500.0,,4166.0
Aizawl West,16.1.1,Stock position of DPT vaccines,5. Total Stock,990.0,80.0,80.0,80.0,40.0,60.0,50.0,30.0,90.0,3480.0,480.0,0.0,5460.0
Aizawl West,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2110.0,1520.0,530.0,530.0,620.0,310.0,370.0,70.0,70.0,120.0,1000.0,910.0,8160.0
Aizawl West,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,380.0,390.0,0.0,370.0,0.0,300.0,380.0,1280.0,1000.0,480.0,4580.0
Aizawl West,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,590.0,990.0,380.0,300.0,310.0,310.0,300.0,300.0,330.0,400.0,1090.0,610.0,5910.0
Aizawl West,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1520.0,530.0,530.0,620.0,310.0,370.0,70.0,70.0,120.0,1000.0,910.0,780.0,6830.0
Aizawl West,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3000.0,1100.0,80.0,40.0,40.0,20.0,0.0,0.0,20.0,40.0,0.0,1460.0,5800.0
Aizawl West,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,,440.0,500.0,460.0,540.0,500.0,480.0,600.0,600.0,3000.0,25080.0,32200.0
Aizawl West,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1900.0,1020.0,480.0,500.0,480.0,560.0,500.0,460.0,580.0,640.0,1540.0,24320.0,32980.0
Aizawl West,16.1.2,Stock position of OPV vaccines,5. Total Stock,1100.0,80.0,40.0,40.0,20.0,0.0,0.0,20.0,40.0,0.0,1460.0,2220.0,5020.0
Aizawl West,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4420.0,4080.0,130.0,90.0,0.0,10.0,10.0,0.0,50.0,280.0,1810.0,390.0,11270.0
Aizawl West,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,,250.0,220.0,230.0,230.0,150.0,500.0,600.0,1850.0,1500.0,2500.0,8030.0
Aizawl West,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.1.3,Stock position of TT vaccines,4. Stock Distributed,340.0,3950.0,290.0,310.0,220.0,230.0,160.0,450.0,370.0,320.0,2920.0,530.0,10090.0
Aizawl West,16.1.3,Stock position of TT vaccines,5. Total Stock,4080.0,130.0,90.0,0.0,10.0,10.0,0.0,50.0,280.0,1810.0,390.0,2360.0,9210.0
Aizawl West,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2170.0,1990.0,30.0,30.0,30.0,0.0,20.0,20.0,10.0,70.0,590.0,870.0,5830.0
Aizawl West,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,,210.0,220.0,170.0,220.0,200.0,22.0,300.0,740.0,1000.0,930.0,4012.0
Aizawl West,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,180.0,1960.0,210.0,220.0,200.0,200.0,200.0,32.0,240.0,220.0,720.0,450.0,4832.0
Aizawl West,16.1.5,Stock position of BCG vaccines,5. Total Stock,1990.0,30.0,30.0,30.0,0.0,20.0,20.0,10.0,70.0,590.0,870.0,1350.0,5010.0
Aizawl West,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3965.0,3820.0,450.0,255.0,25.0,45.0,65.0,150.0,55.0,105.0,50.0,825.0,9810.0
Aizawl West,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,,,0.0,240.0,250.0,250.0,110.0,255.0,145.0,1500.0,0.0,2750.0
Aizawl West,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,145.0,3370.0,195.0,230.0,220.0,230.0,165.0,205.0,205.0,200.0,725.0,380.0,6270.0
Aizawl West,16.1.6,Stock position of Measles vaccines,5. Total Stock,3820.0,450.0,255.0,25.0,45.0,65.0,150.0,55.0,105.0,50.0,825.0,445.0,6290.0
Aizawl West,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2590.0,2590.0,90.0,80.0,80.0,80.0,80.0,80.0,80.0,80.0,1900.0,1550.0,9280.0
Aizawl West,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,1820.0,,240.0,2060.0
Aizawl West,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Aizawl West,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,2500.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,350.0,10.0,2870.0
Aizawl West,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2590.0,90.0,80.0,80.0,80.0,80.0,80.0,80.0,80.0,1900.0,1550.0,1780.0,8470.0
Aizawl West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,50.0,30.0,6.0,0.0,3.0,21.0,30.0,16.0,7.0,,,,163.0
Aizawl West,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,6.0,5.0,30.0,20.0,0.0,0.0,100.0,,,,161.0
Aizawl West,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Aizawl West,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,20.0,24.0,12.0,2.0,12.0,11.0,14.0,9.0,10.0,,,,114.0
Aizawl West,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,30.0,6.0,0.0,3.0,21.0,30.0,16.0,7.0,97.0,0.0,0.0,0.0,210.0
Aizawl West,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Aizawl West,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Aizawl West,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Aizawl West,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Aizawl West,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,810.0,250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,120.0,0.0,391.0,1571.0
Aizawl West,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,,73.0,75.0,74.0,84.0,90.0,93.0,114.0,0.0,1000.0,600.0,2203.0
Aizawl West,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,560.0,250.0,73.0,75.0,74.0,84.0,90.0,93.0,114.0,120.0,609.0,122.0,2264.0
Aizawl West,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,391.0,869.0,1510.0
Aizawl West,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3800.0,4200.0,8000.0
Aizawl West,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,992.0,1217.0,1068.0,967.0,900.0,1071.0,1020.0,4000.0,2000.0,5400.0,18635.0
Aizawl West,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,992.0,1217.0,1068.0,967.0,900.0,1071.0,1020.0,200.0,1600.0,1651.0,10686.0
Aizawl West,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3800.0,4200.0,7949.0,15949.0
Aizawl West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,300.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1900.0,2300.0
Aizawl West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,,85.0,74.0,75.0,82.0,82.0,82.0,100.0,150.0,2206.0,0.0,2936.0
Aizawl West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0
Aizawl West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200.0,100.0,85.0,74.0,75.0,82.0,82.0,82.0,100.0,150.0,306.0,7.0,1343.0
Aizawl West,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1900.0,1893.0,3893.0
Aizawl West,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,1.0,,,,,,1.0
Aizawl West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,,1.0,2.0,2.0,,,1.0,2.0,3.0,1.0,2.0,16.0
Aizawl West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,1.0,2.0
Aizawl West,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,3.0,,1.0,2.0,2.0,,,1.0,2.0,3.0,1.0,3.0,18.0
Aizawl West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,1.0,,4.0,1.0,,3.0,,3.0,2.0,3.0,19.0
Aizawl West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Aizawl West,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,1.0,,4.0,1.0,,3.0,,3.0,2.0,3.0,19.0
Aizawl West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,2.0,2.0,2.0,1.0,,9.0,3.0,3.0,4.0,5.0,31.0
Aizawl West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Aizawl West,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,2.0,2.0,2.0,1.0,,10.0,3.0,3.0,4.0,5.0,32.0
Aizawl West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,1.0,2.0,2.0,,2.0,2.0,4.0,2.0,2.0,2.0,5.0,26.0
Aizawl West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,,,1.0,1.0,,,,3.0
Aizawl West,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,1.0,3.0,2.0,,2.0,2.0,5.0,3.0,2.0,2.0,5.0,29.0
Aizawl West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,1.0,,,,1.0,1.0,1.0,,,1.0,6.0
Aizawl West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,,1.0,,,,,2.0
Aizawl West,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,1.0,,,1.0,1.0,2.0,1.0,,,1.0,8.0
Aizawl West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Aizawl West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aizawl West,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,1.0,1.0
Aizawl West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,1.0,,,,,1.0
Aizawl West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aizawl West,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,1.0,,,,,1.0
Aizawl West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Aizawl West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Aizawl West,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Aizawl West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,3.0,3.0,,1.0,4.0,1.0,4.0,6.0,3.0,3.0,5.0,36.0
Aizawl West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,1.0,,,1.0,,,,,2.0
Aizawl West,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,3.0,3.0,,2.0,4.0,1.0,5.0,6.0,3.0,3.0,5.0,38.0
Aizawl West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,1.0,,1.0,3.0
Aizawl West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,1.0,,,,,1.0,,,3.0
Aizawl West,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,,,1.0,,,,,2.0,,1.0,6.0
Aizawl West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,2.0,3.0,1.0,1.0,1.0,,,4.0,1.0,14.0
Aizawl West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,1.0,,,1.0,1.0,,,3.0
Aizawl West,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,2.0,3.0,2.0,1.0,1.0,1.0,1.0,4.0,1.0,17.0
Aizawl West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,,2.0,4.0,4.0,3.0,2.0,1.0,7.0,8.0,10.0,6.0,52.0
Aizawl West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,14.0,3.0,4.0,4.0,5.0,5.0,1.0,4.0,4.0,6.0,4.0,3.0,57.0
Aizawl West,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,19.0,3.0,6.0,8.0,9.0,8.0,3.0,5.0,11.0,14.0,14.0,9.0,109.0
Aizawl West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,3.0,1.0,,,,,,1.0,,,5.0
Aizawl West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,3.0,1.0,,,,,,1.0,,,5.0
Aizawl West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,1.0,7.0,4.0,3.0,9.0,4.0,4.0,2.0,1.0,,,38.0
Aizawl West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,3.0,3.0,3.0,6.0,5.0,3.0,3.0,1.0,2.0,3.0,33.0
Aizawl West,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,1.0,10.0,7.0,6.0,15.0,9.0,7.0,5.0,2.0,2.0,3.0,71.0
Aizawl West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,5.0,2.0,4.0,3.0,2.0,1.0,,,1.0,2.0,,,20.0
Aizawl West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,5.0,2.0,4.0,3.0,2.0,1.0,,,1.0,2.0,,,20.0
Aizawl West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,2.0,,,,,,,,,,2.0
Aizawl West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,5.0,5.0,7.0,2.0,2.0,,11.0,3.0,8.0,5.0,5.0,60.0
Aizawl West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,10.0,11.0,6.0,9.0,6.0,6.0,4.0,8.0,3.0,5.0,7.0,9.0,84.0
Aizawl West,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,17.0,16.0,13.0,16.0,8.0,8.0,4.0,19.0,6.0,13.0,12.0,14.0,146.0
Aizawl West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Aizawl West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,1.0,,1.0,1.0,1.0,2.0,,2.0,1.0,4.0,3.0,17.0
Aizawl West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,,1.0,3.0,,4.0,2.0,2.0,4.0,4.0,21.0
Aizawl West,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,1.0,1.0,2.0,4.0,2.0,4.0,4.0,3.0,9.0,7.0,39.0
Aizawl West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,1.0,,1.0,,,,,2.0
Aizawl West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,1.0,,1.0,,,,,2.0
Aizawl West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Aizawl West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,1.0,,,,1.0
Aizawl West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Aizawl West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Aizawl West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Aizawl West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Aizawl West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,1.0,,,,1.0
Aizawl West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,,,,,,,,2.0,4.0
Aizawl West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,8.0,6.0,11.0,8.0,8.0,7.0,3.0,3.0,5.0,6.0,6.0,7.0,78.0
Aizawl West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,4.0,3.0,1.0,2.0,1.0,2.0,,1.0,2.0,1.0,1.0,20.0
Aizawl West,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,10.0,11.0,15.0,9.0,10.0,8.0,5.0,3.0,6.0,8.0,7.0,10.0,102.0
Aizawl West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,,2.0,1.0,5.0,1.0,2.0,,1.0,1.0,1.0,1.0,18.0
Aizawl West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,,2.0,1.0,5.0,1.0,2.0,,1.0,1.0,1.0,1.0,18.0
Aizawl West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Aizawl West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,,,,,2.0,1.0,,,,4.0
Aizawl West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,,,,,2.0,1.0,,,1.0,5.0
Aizawl West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,1.0,,,1.0,,,,2.0
Aizawl West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,12.0,11.0,10.0,9.0,14.0,19.0,6.0,7.0,11.0,12.0,14.0,3.0,128.0
Aizawl West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,5.0,6.0,5.0,4.0,10.0,2.0,12.0,7.0,9.0,11.0,7.0,82.0
Aizawl West,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,16.0,16.0,16.0,14.0,18.0,30.0,8.0,19.0,19.0,21.0,25.0,10.0,212.0
Aizawl West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,1.0,,,,,1.0,1.0,,4.0
Aizawl West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,18.0,19.0,21.0,18.0,21.0,26.0,9.0,20.0,17.0,21.0,13.0,22.0,225.0
Aizawl West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,14.0,22.0,14.0,9.0,18.0,15.0,10.0,11.0,16.0,16.0,18.0,23.0,186.0
Aizawl West,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,33.0,41.0,35.0,27.0,40.0,41.0,19.0,31.0,33.0,38.0,32.0,45.0,415.0
Aizawl West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Aizawl West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Aizawl West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Aizawl West,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,1.0,,,,,,,1.0
Champhai,1.1,Total number of pregnant women Registered for ANC,TOTAL,264.0,229.0,229.0,261.0,233.0,221.0,203.0,197.0,198.0,180.0,267.0,214.0,2696.0
Champhai,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,185.0,181.0,181.0,189.0,195.0,183.0,168.0,165.0,162.0,128.0,215.0,177.0,2129.0
Champhai,1.2,Number of Pregnant women registered under JSY,TOTAL,208.0,209.0,209.0,202.0,213.0,191.0,186.0,181.0,179.0,142.0,236.0,189.0,2345.0
Champhai,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,131.0,167.0,152.0,185.0,163.0,166.0,166.0,179.0,165.0,158.0,189.0,174.0,1995.0
Champhai,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,158.0,128.0,119.0,131.0,118.0,101.0,136.0,138.0,118.0,99.0,151.0,121.0,1518.0
Champhai,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,218.0,211.0,204.0,194.0,220.0,198.0,176.0,234.0,202.0,158.0,204.0,210.0,2429.0
Champhai,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,142.0,168.0,171.0,198.0,158.0,160.0,155.0,169.0,154.0,155.0,196.0,178.0,2004.0
Champhai,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,2.0,0.0,10.0,11.0,17.0,17.0,12.0,4.0,4.0,3.0,0.0,19.0,99.0
Champhai,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,143.0,167.0,142.0,157.0,156.0,165.0,133.0,134.0,146.0,113.0,123.0,129.0,1708.0
Champhai,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Champhai,1.8,Number of pregnancy test kits used at SC level,TOTAL,127.0,138.0,142.0,120.0,152.0,158.0,138.0,146.0,143.0,81.0,139.0,79.0,1563.0
Champhai,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,4.0,2.0,0.0,2.0,3.0,2.0,0.0,1.0,0.0,1.0,3.0,19.0
Champhai,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,14.0,6.0,11.0,6.0,8.0,3.0,4.0,5.0,0.0,5.0,4.0,5.0,71.0
Champhai,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,15.0,10.0,13.0,6.0,10.0,6.0,6.0,5.0,1.0,5.0,5.0,8.0,90.0
Champhai,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,9.0,3.0,7.0,0.0,3.0,4.0,5.0,2.0,0.0,4.0,3.0,7.0,47.0
Champhai,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,158.0,138.0,148.0,132.0,158.0,175.0,140.0,131.0,117.0,150.0,133.0,164.0,1744.0
Champhai,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,138.0,119.0,137.0,123.0,73.0,78.0,72.0,64.0,50.0,83.0,86.0,79.0,1102.0
Champhai,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,78.0,68.0,67.0,64.0,93.0,119.0,87.0,83.0,69.0,533.0,71.0,80.0,1412.0
Champhai,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,78.0,68.0,66.0,62.0,92.0,117.0,85.0,80.0,68.0,73.0,65.0,75.0,929.0
Champhai,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Champhai,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Champhai,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Champhai,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Champhai,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Champhai,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,9.0,7.0,1.0,0.0,0.0,0.0,4.0,6.0,5.0,8.0,2.0,7.0,49.0
Champhai,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champhai,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,9.0,7.0,1.0,0.0,0.0,0.0,4.0,6.0,5.0,8.0,2.0,7.0,49.0
Champhai,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Champhai,4.1.1.a,Number of male live births,TOTAL,88.0,77.0,84.0,68.0,76.0,97.0,74.0,80.0,59.0,71.0,79.0,88.0,941.0
Champhai,4.1.1.b,Number of female live births,TOTAL,85.0,70.0,76.0,70.0,90.0,84.0,72.0,56.0,59.0,83.0,58.0,82.0,885.0
Champhai,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,173.0,147.0,160.0,138.0,166.0,181.0,146.0,136.0,118.0,154.0,137.0,170.0,1826.0
Champhai,4.1.2,Number of still births,TOTAL,0.0,1.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0,8.0
Champhai,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,21.0,21.0,15.0,18.0,15.0,20.0,18.0,17.0,13.0,15.0,11.0,24.0,208.0
Champhai,4.2.1,Number of Newborns weighed at birth,TOTAL,169.0,142.0,155.0,137.0,150.0,181.0,146.0,136.0,118.0,150.0,137.0,170.0,1791.0
Champhai,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,6.0,7.0,9.0,7.0,9.0,10.0,8.0,10.0,12.0,10.0,6.0,13.0,107.0
Champhai,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,170.0,142.0,155.0,125.0,151.0,179.0,145.0,136.0,116.0,149.0,135.0,169.0,1772.0
Champhai,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,4.0
Champhai,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champhai,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,4.0
Champhai,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Champhai,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Champhai,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Champhai,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,147.0,135.0,128.0,116.0,134.0,155.0,115.0,122.0,105.0,117.0,119.0,155.0,1548.0
Champhai,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,109.0,147.0,146.0,123.0,120.0,160.0,141.0,101.0,103.0,132.0,117.0,117.0,1516.0
Champhai,6.3,PNC maternal complications attended,TOTAL,1.0,3.0,3.0,0.0,0.0,4.0,2.0,0.0,0.0,0.0,0.0,0.0,13.0
Champhai,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,5.0,2.0,5.0,3.0,4.0,2.0,6.0,0.0,4.0,2.0,3.0,45.0
Champhai,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,3.0,3.0,1.0,0.0,0.0,3.0,1.0,1.0,2.0,0.0,5.0,19.0
Champhai,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,9.0,8.0,5.0,6.0,3.0,4.0,5.0,7.0,1.0,6.0,2.0,8.0,64.0
Champhai,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1.0,1.0,4.0,1.0,4.0,6.0,64.0,8.0,0.0,0.0,0.0,0.0,89.0
Champhai,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,19.0,19.0,19.0,15.0,18.0,11.0,158.0,16.0,3.0,4.0,14.0,9.0,305.0
Champhai,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,20.0,20.0,23.0,16.0,22.0,17.0,222.0,24.0,3.0,4.0,14.0,9.0,394.0
Champhai,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champhai,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champhai,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champhai,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champhai,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,2.0,2.0,0.0,0.0,0.0,0.0,3.0,2.0,6.0,6.0,2.0,23.0
Champhai,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champhai,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,2.0,2.0,0.0,0.0,0.0,0.0,3.0,2.0,6.0,6.0,2.0,23.0
Champhai,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champhai,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,5.0,4.0,2.0,0.0,5.0,5.0,6.0,2.0,6.0,4.0,2.0,1.0,42.0
Champhai,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champhai,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,5.0,4.0,2.0,0.0,5.0,5.0,6.0,2.0,6.0,4.0,2.0,1.0,42.0
Champhai,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champhai,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,18.0,14.0,17.0,18.0,20.0,19.0,18.0,11.0,17.0,9.0,11.0,14.0,186.0
Champhai,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,4.0,8.0,6.0,0.0,0.0,1.0,2.0,8.0,2.0,9.0,6.0,47.0
Champhai,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,15.0,10.0,5.0,5.0,5.0,12.0,15.0,13.0,9.0,18.0,7.0,14.0,128.0
Champhai,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Champhai,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,34.0,28.0,30.0,29.0,25.0,31.0,34.0,26.0,34.0,29.0,27.0,34.0,361.0
Champhai,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,9.0,8.0,4.0,4.0,6.0,4.0,9.0,8.0,5.0,7.0,7.0,8.0,79.0
Champhai,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Champhai,9.06,Number of IUCD removals,TOTAL,12.0,13.0,13.0,21.0,17.0,48.0,24.0,19.0,35.0,11.0,22.0,11.0,246.0
Champhai,9.07,Number of Oral Pills cycles distributed,TOTAL,1303.0,1454.0,1550.0,1481.0,1634.0,1483.0,1491.0,1458.0,1469.0,1307.0,1380.0,1379.0,17389.0
Champhai,9.08,Number of Condom pieces distributed,TOTAL,2198.0,2550.0,2214.0,2136.0,2217.0,1798.0,1717.0,1321.0,1231.0,1283.0,1295.0,1351.0,21311.0
Champhai,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,11.0,24.0,7.0,6.0,9.0,7.0,14.0,8.0,5.0,6.0,17.0,20.0,134.0
Champhai,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Champhai,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,212.0,212.0,173.0,189.0,175.0,179.0,180.0,159.0,139.0,156.0,138.0,166.0,2078.0
Champhai,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,5.0,0.0,0.0,0.0,6.0
Champhai,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Champhai,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,4.0
Champhai,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,213.0,227.0,183.0,217.0,161.0,163.0,176.0,227.0,183.0,153.0,192.0,189.0,2284.0
Champhai,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,203.0,189.0,224.0,190.0,190.0,181.0,139.0,186.0,217.0,141.0,174.0,208.0,2242.0
Champhai,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,193.0,181.0,195.0,232.0,169.0,206.0,165.0,155.0,180.0,180.0,180.0,166.0,2202.0
Champhai,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,83.0,70.0,65.0,74.0,101.0,126.0,90.0,79.0,90.0,91.0,89.0,111.0,1069.0
Champhai,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,213.0,224.0,87.0,194.0,160.0,156.0,146.0,229.0,191.0,137.0,187.0,189.0,2113.0
Champhai,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,202.0,188.0,108.0,167.0,193.0,179.0,121.0,192.0,220.0,138.0,169.0,194.0,2071.0
Champhai,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,187.0,181.0,92.0,201.0,170.0,210.0,150.0,155.0,187.0,157.0,175.0,167.0,2032.0
Champhai,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,83.0,73.0,70.0,74.0,89.0,130.0,84.0,77.0,90.0,86.0,72.0,106.0,1034.0
Champhai,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,4.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Champhai,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,154.0,201.0,175.0,190.0,190.0,215.0,132.0,228.0,175.0,156.0,213.0,175.0,2204.0
Champhai,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,201.0,168.0,179.0,152.0,162.0,163.0,98.0,208.0,148.0,116.0,175.0,155.0,1925.0
Champhai,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,80.0,85.0,91.0,111.0,96.0,107.0,71.0,122.0,86.0,78.0,110.0,86.0,1123.0
Champhai,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,69.0,104.0,88.0,84.0,86.0,102.0,60.0,97.0,87.0,73.0,93.0,81.0,1024.0
Champhai,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,149.0,189.0,179.0,195.0,182.0,209.0,131.0,219.0,173.0,151.0,203.0,167.0,2147.0
Champhai,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,206.0,164.0,152.0,172.0,174.0,202.0,156.0,221.0,173.0,138.0,159.0,172.0,2089.0
Champhai,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,206.0,158.0,93.0,168.0,168.0,202.0,142.0,223.0,173.0,133.0,160.0,172.0,1998.0
Champhai,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,13.0,11.0,3.0,6.0,7.0,8.0,7.0,10.0,4.0,6.0,6.0,1.0,82.0
Champhai,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,16.0,13.0,5.0,2.0,3.0,6.0,11.0,4.0,6.0,4.0,4.0,5.0,79.0
Champhai,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,29.0,24.0,8.0,8.0,10.0,14.0,18.0,14.0,10.0,10.0,10.0,6.0,161.0
Champhai,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,163.0,104.0,142.0,135.0,84.0,115.0,94.0,228.0,160.0,35.0,46.0,96.0,1402.0
Champhai,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,148.0,187.0,140.0,135.0,79.0,78.0,86.0,182.0,119.0,58.0,50.0,72.0,1334.0
Champhai,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,64.0,125.0,73.0,176.0,61.0,69.0,38.0,138.0,79.0,42.0,40.0,52.0,957.0
Champhai,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Champhai,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,107.0,105.0,106.0,103.0,105.0,103.0,102.0,108.0,96.0,89.0,105.0,102.0,1231.0
Champhai,10.4.2,Number of Immunisation sessions held during the month,TOTAL,104.0,102.0,104.0,101.0,104.0,98.0,96.0,106.0,95.0,88.0,103.0,101.0,1202.0
Champhai,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,90.0,99.0,96.0,91.0,95.0,89.0,91.0,97.0,91.0,78.0,98.0,98.0,1113.0
Champhai,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,166.0,386.0,169.0,177.0,164.0,193.0,131.0,126.0,74.0,29.0,16.0,29.0,1660.0
Champhai,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,193.0,177.0,116.0,132.0,125.0,117.0,108.0,67.0,38.0,37.0,11.0,17.0,1138.0
Champhai,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,81.0,104.0,117.0,114.0,103.0,98.0,82.0,63.0,50.0,24.0,3.0,13.0,852.0
Champhai,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,8.0,3.0,1.0,1.0,0.0,0.0,1.0,6.0,0.0,2.0,2.0,4.0,28.0
Champhai,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,119.0,117.0,107.0,102.0,108.0,102.0,90.0,78.0,47.0,104.0,206.0,140.0,1320.0
Champhai,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,10.0
Champhai,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,30.0,32.0,29.0,68.0,48.0,75.0,53.0,30.0,25.0,32.0,18.0,20.0,460.0
Champhai,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,13.0
Champhai,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,13.0
Champhai,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,7.0,6.0,4.0,5.0,18.0,13.0,15.0,13.0,31.0,22.0,10.0,144.0
Champhai,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,7.0,7.0,8.0,0.0,0.0,0.0,0.0,22.0
Champhai,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,226.0,0.0,242.0,0.0,210.0,0.0,0.0,678.0
Champhai,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Champhai,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,9.0,-1.0
Champhai,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,78.0,89.0,76.0,89.0,86.0,88.0,86.0,95.0,87.0,87.0,96.0,87.0,-1.0
Champhai,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Champhai,14.05,Number of RKS meetings held during the month,TOTAL,3.0,3.0,2.0,2.0,2.0,3.0,3.0,3.0,4.0,2.0,2.0,4.0,33.0
Champhai,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,-1.0
Champhai,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,6.0,8.0,5.0,4.0,10.0,6.0,8.0,1.0,7.0,13.0,14.0,8.0,90.0
Champhai,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Champhai,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Champhai,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Champhai,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Champhai,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Champhai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,154.0,91.0,143.0,145.0,165.0,177.0,139.0,123.0,102.0,139.0,172.0,156.0,1706.0
Champhai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,157.0,193.0,164.0,190.0,193.0,172.0,184.0,178.0,122.0,159.0,152.0,146.0,2010.0
Champhai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,152.0,76.0,86.0,122.0,129.0,185.0,123.0,108.0,101.0,109.0,106.0,129.0,1426.0
Champhai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,305.0,371.0,297.0,274.0,342.0,339.0,317.0,284.0,229.0,269.0,237.0,299.0,3563.0
Champhai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,306.0,167.0,229.0,267.0,294.0,362.0,262.0,231.0,203.0,248.0,278.0,285.0,3132.0
Champhai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,462.0,564.0,461.0,464.0,535.0,511.0,501.0,462.0,351.0,428.0,389.0,445.0,5573.0
Champhai,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10.0,9.0,4.0,4.0,11.0,8.0,16.0,6.0,7.0,8.0,11.0,6.0,100.0
Champhai,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,5.0,9.0,1.0,2.0,2.0,3.0,6.0,3.0,2.0,3.0,2.0,40.0
Champhai,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,14.0,13.0,5.0,13.0,10.0,19.0,12.0,10.0,10.0,14.0,8.0,140.0
Champhai,14.11,In-Patient Head Count at midnight,TOTAL,485.0,471.0,479.0,963.0,1277.0,2085.0,1813.0,1646.0,1322.0,1608.0,1538.0,1603.0,15290.0
Champhai,14.12.1,OPD attendance (All),TOTAL,7476.0,7742.0,8097.0,8620.0,9735.0,9224.0,9849.0,7946.0,6672.0,6229.0,7500.0,7395.0,96485.0
Champhai,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,21.0,3.0,6.0,1.0,2.0,6.0,17.0,13.0,17.0,17.0,8.0,15.0,126.0
Champhai,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,12.0,2.0,5.0,0.0,0.0,4.0,12.0,18.0,12.0,17.0,7.0,9.0,98.0
Champhai,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Champhai,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,92.0,78.0,122.0,108.0,86.0,81.0,115.0,78.0,255.0,71.0,79.0,75.0,1240.0
Champhai,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Champhai,14.14.a,Number of patients given AYUSH treatment,TOTAL,252.0,511.0,194.0,502.0,575.0,668.0,834.0,478.0,515.0,464.0,429.0,352.0,5774.0
Champhai,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,101.0,157.0,111.0,142.0,180.0,129.0,592.0,465.0,276.0,370.0,451.0,335.0,3309.0
Champhai,14.14.c,Number of Adolescents counselled,TOTAL,12.0,0.0,0.0,0.0,0.0,0.0,8.0,9.0,5.0,3.0,2.0,4.0,43.0
Champhai,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Champhai,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,676.0,624.0,821.0,926.0,1060.0,763.0,691.0,676.0,538.0,533.0,542.0,598.0,8448.0
Champhai,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,19.0,10.0,6.0,36.0,16.0,16.0,14.0,14.0,11.0,10.0,38.0,17.0,207.0
Champhai,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,133.0,124.0,178.0,121.0,171.0,132.0,149.0,144.0,126.0,97.0,112.0,188.0,1675.0
Champhai,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,5.0,5.0,5.0,7.0,11.0,5.0,5.0,2.0,3.0,5.0,8.0,66.0
Champhai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,80.0,68.0,68.0,57.0,64.0,53.0,104.0,83.0,48.0,44.0,38.0,50.0,757.0
Champhai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,1.0,1.0,3.0,4.0,1.0,6.0,3.0,1.0,1.0,1.0,2.0,26.0
Champhai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,228.0,207.0,195.0,220.0,241.0,180.0,170.0,174.0,139.0,164.0,181.0,192.0,2291.0
Champhai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,3.0,1.0,0.0,3.0,3.0,1.0,0.0,1.0,0.0,0.0,2.0,14.0
Champhai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,441.0,399.0,441.0,398.0,476.0,365.0,423.0,401.0,313.0,305.0,331.0,430.0,4723.0
Champhai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,7.0,9.0,7.0,8.0,14.0,15.0,12.0,8.0,4.0,4.0,6.0,12.0,106.0
Champhai,15.2,Number of Widal tests conducted,Number tested,116.0,97.0,148.0,107.0,137.0,359.0,839.0,359.0,252.0,123.0,94.0,77.0,2708.0
Champhai,15.3.a,Number of VDRL tests conducted on males,Number tested,88.0,1.0,104.0,0.0,2.0,110.0,71.0,55.0,0.0,50.0,92.0,0.0,573.0
Champhai,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,38.0,0.0,34.0,4.0,30.0,26.0,105.0,122.0,19.0,20.0,21.0,0.0,419.0
Champhai,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,33.0,16.0,117.0,30.0,31.0,97.0,86.0,136.0,39.0,135.0,183.0,52.0,955.0
Champhai,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,159.0,17.0,255.0,34.0,63.0,233.0,262.0,313.0,58.0,205.0,296.0,52.0,1947.0
Champhai,15.4.1,Number of blood smears examined for Malaria,TOTAL,290.0,449.0,550.0,637.0,641.0,700.0,769.0,440.0,301.0,254.0,307.0,170.0,5508.0
Champhai,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,2.0,5.0,4.0,0.0,4.0,1.0,0.0,0.0,0.0,0.0,0.0,16.0
Champhai,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,2.0,5.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Champhai,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1110.0,1110.0,300.0,490.0,0.0,990.0,,,,,,,4000.0
Champhai,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,300.0,500.0,500.0,1000.0,0.0,,,,,,,2300.0
Champhai,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,790.0,1110.0,310.0,990.0,10.0,590.0,,,,,,,3800.0
Champhai,16.1.1,Stock position of DPT vaccines,5. Total Stock,320.0,300.0,490.0,0.0,990.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,2500.0
Champhai,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Champhai,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Champhai,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Champhai,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1360.0,1360.0,0.0,3080.0,1520.0,2360.0,,,,,,,9680.0
Champhai,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,2000.0,3500.0,3500.0,2500.0,0.0,,,,,,,13500.0
Champhai,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1960.0,3360.0,420.0,5060.0,1660.0,1540.0,,,,,,,14000.0
Champhai,16.1.2,Stock position of OPV vaccines,5. Total Stock,1400.0,0.0,3080.0,1520.0,2360.0,820.0,0.0,0.0,0.0,0.0,0.0,0.0,9180.0
Champhai,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2400.0,2400.0,2740.0,1800.0,1100.0,1620.0,,,,,,,12060.0
Champhai,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,2000.0,300.0,300.0,1500.0,0.0,,,,,,,4100.0
Champhai,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.3,Stock position of TT vaccines,4. Stock Distributed,950.0,1660.0,1240.0,1000.0,980.0,630.0,,,,,,,6460.0
Champhai,16.1.3,Stock position of TT vaccines,5. Total Stock,1450.0,2740.0,1800.0,1100.0,1620.0,990.0,0.0,0.0,0.0,0.0,0.0,0.0,9700.0
Champhai,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,,,,,,,,,,,,0.0
Champhai,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,,,,,,,,,,,0.0
Champhai,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,,,,,,,,,,,,0.0
Champhai,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2120.0,2120.0,670.0,850.0,130.0,360.0,,,,,,,6250.0
Champhai,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,1000.0,1200.0,1000.0,1000.0,,,,,,,4200.0
Champhai,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,750.0,1450.0,820.0,1920.0,770.0,760.0,,,,,,,6470.0
Champhai,16.1.5,Stock position of BCG vaccines,5. Total Stock,1370.0,670.0,850.0,130.0,360.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,3980.0
Champhai,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1065.0,1065.0,835.0,910.0,560.0,620.0,,,,,,,5055.0
Champhai,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,1000.0,500.0,500.0,500.0,0.0,,,,,,,3500.0
Champhai,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,600.0,1230.0,425.0,850.0,440.0,545.0,,,,,,,4090.0
Champhai,16.1.6,Stock position of Measles vaccines,5. Total Stock,1465.0,835.0,910.0,560.0,620.0,75.0,0.0,0.0,0.0,0.0,0.0,0.0,4465.0
Champhai,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1000.0,1000.0,620.0,440.0,340.0,240.0,,,,,,,3640.0
Champhai,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,200.0,,,,,,,200.0
Champhai,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,180.0,380.0,180.0,100.0,100.0,80.0,,,,,,,1020.0
Champhai,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,820.0,620.0,440.0,340.0,240.0,360.0,0.0,0.0,0.0,0.0,0.0,0.0,2820.0
Champhai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,80.0,80.0,40.0,40.0,40.0,40.0,,,,,,,320.0
Champhai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,40.0,40.0,0.0,0.0,0.0,20.0,,,,,,,100.0
Champhai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,40.0,40.0,40.0,40.0,40.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,220.0
Champhai,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,840.0,840.0,500.0,500.0,400.0,100.0,,,,,,,3180.0
Champhai,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,40.0,340.0,0.0,100.0,300.0,100.0,,,,,,,880.0
Champhai,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,800.0,500.0,500.0,400.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2300.0
Champhai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1200.0,1200.0,1200.0,1200.0,1200.0,1200.0,,,,,,,7200.0
Champhai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,400.0,,,,,,,400.0
Champhai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1200.0,1200.0,1200.0,1200.0,1200.0,800.0,0.0,0.0,0.0,0.0,0.0,0.0,6800.0
Champhai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,25.0,25.0,25.0,25.0,25.0,25.0,,,,,,,150.0
Champhai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,25.0,25.0,25.0,25.0,25.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0
Champhai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Champhai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Champhai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Champhai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Champhai,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Champhai,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Champhai,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Champhai,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Champhai,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Champhai,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Champhai,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Champhai,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Champhai,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Champhai,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Champhai,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Champhai,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Champhai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Champhai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Champhai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,4800.0,4800.0,0.0,0.0,0.0,55200.0,,,,,,,64800.0
Champhai,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,4800.0,0.0,0.0,0.0,45000.0,,,,,,,49800.0
Champhai,16.3.07,Stock Position of IFA Tablets,5. Total Stock,4800.0,0.0,0.0,0.0,0.0,10200.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0
Champhai,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,9.0,9.0,7.0,1.0,0.0,0.0,,,,,,,26.0
Champhai,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,2.0,2.0,6.0,1.0,0.0,0.0,,,,,,,11.0
Champhai,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,7.0,7.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Champhai,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Champhai,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Champhai,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,400.0,,,,,,,400.0
Champhai,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,160.0,0.0,400.0,0.0,,,,,,,560.0
Champhai,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,160.0,0.0,0.0,240.0,,,,,,,400.0
Champhai,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,400.0,160.0,0.0,0.0,0.0,0.0,0.0,0.0,560.0
Champhai,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,3000.0,,,,,,,3000.0
Champhai,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,1610.0,0.0,3000.0,0.0,,,,,,,4610.0
Champhai,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,1610.0,0.0,0.0,1800.0,,,,,,,3410.0
Champhai,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,3000.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,4200.0
Champhai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,200.0,,,,,,,200.0
Champhai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,115.0,0.0,200.0,0.0,,,,,,,315.0
Champhai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Champhai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,115.0,0.0,0.0,160.0,,,,,,,275.0
Champhai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,200.0,40.0,0.0,0.0,0.0,0.0,0.0,0.0,240.0
Champhai,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,1.0,1.0
Champhai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,,1.0
Champhai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Champhai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,1.0,,1.0
Champhai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,,,1.0
Champhai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Champhai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,1.0,,,,1.0
Champhai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Champhai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Champhai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Champhai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,1.0,,,,1.0,,,,,,3.0
Champhai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,1.0,,,,1.0,,,,,,3.0
Champhai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,1.0,2.0,,,,2.0,,,,,,6.0
Champhai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,2.0,1.0,,,1.0,,1.0,,,,,6.0
Champhai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,1.0,,,,,,,,2.0
Champhai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,3.0,1.0,,1.0,1.0,,1.0,,,,,8.0
Champhai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,3.0,,1.0,,,,1.0,,,,2.0,,7.0
Champhai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Champhai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,3.0,,1.0,,,,1.0,,,,2.0,,7.0
Champhai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,1.0,,1.0,,,,2.0
Champhai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,2.0,,,,,,,,,,2.0
Champhai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,,,,1.0,,1.0,,,,4.0
Champhai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Champhai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Champhai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Champhai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,1.0,1.0,,2.0,,,,,,,5.0
Champhai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,1.0,,2.0,1.0,1.0,1.0,,1.0,,,8.0
Champhai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,,2.0,1.0,2.0,3.0,1.0,1.0,,1.0,,,13.0
Champhai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Champhai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Champhai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Champhai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,,,1.0,,2.0,1.0,1.0,1.0,,7.0
Champhai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,2.0,,,,,,,3.0
Champhai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,1.0,,,3.0,,2.0,1.0,1.0,1.0,,10.0
Champhai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Champhai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,1.0,,1.0,,1.0,,1.0,,,1.0,6.0
Champhai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,3.0,3.0,1.0,3.0,4.0,1.0,,1.0,2.0,2.0,2.0,1.0,23.0
Champhai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,4.0,3.0,2.0,3.0,5.0,1.0,1.0,2.0,3.0,2.0,2.0,2.0,30.0
Champhai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Champhai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Champhai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,,,,1.0
Champhai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Champhai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,2.0,,,1.0,,1.0,1.0,,1.0,1.0,8.0
Champhai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,2.0,3.0,1.0,1.0,,1.0,,,1.0,10.0
Champhai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,3.0,2.0,3.0,3.0,1.0,1.0,2.0,,1.0,2.0,19.0
Champhai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,2.0,2.0,1.0,1.0,,1.0,1.0,,,,1.0,11.0
Champhai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Champhai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,2.0,2.0,1.0,1.0,,1.0,1.0,,,,1.0,11.0
Champhai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,4.0,,3.0,1.0,2.0,3.0,,3.0,4.0,5.0,1.0,27.0
Champhai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,2.0,1.0,3.0,5.0,5.0,2.0,3.0,4.0,3.0,3.0,5.0,38.0
Champhai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,6.0,1.0,6.0,6.0,7.0,5.0,3.0,7.0,7.0,8.0,6.0,65.0
Champhai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,1.0,2.0,1.0,,,,5.0
Champhai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,,,1.0,,1.0,,1.0,1.0,,,1.0,6.0
Champhai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,,,1.0,1.0,1.0,1.0,3.0,2.0,,,1.0,11.0
Champhai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Champhai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Champhai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Champhai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Champhai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Champhai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Champhai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Champhai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Champhai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Champhai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Champhai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Champhai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,,,,,,,,1.0
Champhai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Champhai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Champhai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Champhai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Champhai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Champhai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Champhai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,3.0,,,,,,,,,,4.0
Champhai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,1.0,2.0,4.0,2.0,2.0,1.0,1.0,3.0,1.0,2.0,1.0,22.0
Champhai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,2.0,,,,,,,,1.0,,,6.0
Champhai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,4.0,5.0,4.0,2.0,2.0,1.0,1.0,3.0,2.0,2.0,1.0,32.0
Champhai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,,2.0,2.0,,15.0
Champhai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Champhai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,,3.0,2.0,,17.0
Champhai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Champhai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Champhai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Champhai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,1.0,,,1.0
Champhai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,1.0,,,,1.0,2.0,5.0
Champhai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,2.0,3.0,1.0,1.0,5.0,4.0,7.0,2.0,4.0,1.0,3.0,35.0
Champhai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,6.0,2.0,3.0,2.0,2.0,,3.0,1.0,1.0,2.0,3.0,5.0,30.0
Champhai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,4.0,7.0,3.0,3.0,5.0,8.0,8.0,3.0,6.0,5.0,10.0,70.0
Champhai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Champhai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,9.0,7.0,11.0,4.0,9.0,5.0,6.0,11.0,7.0,7.0,12.0,3.0,91.0
Champhai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,19.0,5.0,8.0,10.0,20.0,16.0,15.0,23.0,12.0,15.0,17.0,15.0,175.0
Champhai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,28.0,12.0,19.0,14.0,29.0,21.0,21.0,34.0,19.0,22.0,29.0,19.0,267.0
Champhai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Champhai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,3.0,,1.0,3.0,2.0,1.0,2.0,,1.0,4.0,2.0,20.0
Champhai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,5.0,4.0,4.0,6.0,5.0,5.0,4.0,2.0,2.0,4.0,8.0,52.0
Champhai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,4.0,8.0,4.0,5.0,9.0,7.0,6.0,7.0,2.0,3.0,8.0,10.0,73.0
Kolasib,1.1,Total number of pregnant women Registered for ANC,TOTAL,179.0,189.0,144.0,153.0,175.0,138.0,122.0,133.0,98.0,111.0,196.0,167.0,1805.0
Kolasib,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,128.0,151.0,109.0,120.0,138.0,109.0,94.0,101.0,73.0,88.0,149.0,125.0,1385.0
Kolasib,1.2,Number of Pregnant women registered under JSY,TOTAL,150.0,156.0,120.0,125.0,146.0,117.0,97.0,107.0,76.0,92.0,149.0,141.0,1476.0
Kolasib,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,110.0,120.0,116.0,107.0,139.0,89.0,119.0,109.0,108.0,127.0,130.0,90.0,1364.0
Kolasib,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,110.0,112.0,107.0,101.0,119.0,94.0,62.0,82.0,70.0,70.0,110.0,94.0,1131.0
Kolasib,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,158.0,148.0,137.0,151.0,157.0,133.0,135.0,107.0,120.0,101.0,139.0,150.0,1636.0
Kolasib,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,87.0,124.0,114.0,88.0,106.0,87.0,102.0,94.0,105.0,105.0,105.0,84.0,1201.0
Kolasib,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,3.0
Kolasib,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,39.0,46.0,55.0,41.0,46.0,59.0,50.0,41.0,31.0,25.0,44.0,31.0,508.0
Kolasib,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,1.8,Number of pregnancy test kits used at SC level,TOTAL,19.0,25.0,33.0,48.0,31.0,40.0,25.0,34.0,28.0,30.0,31.0,40.0,384.0
Kolasib,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,3.0,5.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,3.0,0.0,29.0
Kolasib,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,3.0,1.0,2.0,5.0,3.0,2.0,3.0,5.0,10.0,3.0,8.0,3.0,48.0
Kolasib,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,11.0,4.0,7.0,7.0,6.0,3.0,4.0,6.0,11.0,4.0,11.0,3.0,77.0
Kolasib,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,10.0,4.0,4.0,4.0,6.0,2.0,3.0,2.0,11.0,4.0,6.0,2.0,58.0
Kolasib,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,94.0,95.0,94.0,84.0,79.0,113.0,116.0,86.0,98.0,72.0,99.0,91.0,1121.0
Kolasib,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,94.0,95.0,85.0,72.0,79.0,113.0,109.0,69.0,80.0,63.0,93.0,73.0,1025.0
Kolasib,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,36.0,11.0,78.0,4.0,76.0,210.0,33.0,11.0,0.0,5.0,3.0,467.0
Kolasib,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,61.0,8.0,112.0,4.0,105.0,308.0,23.0,11.0,0.0,5.0,0.0,637.0
Kolasib,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Kolasib,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Kolasib,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kolasib,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kolasib,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Kolasib,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,6.0,6.0,7.0,2.0,1.0,1.0,5.0,1.0,0.0,0.0,4.0,5.0,38.0
Kolasib,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolasib,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,6.0,6.0,7.0,2.0,1.0,1.0,5.0,1.0,0.0,0.0,4.0,5.0,38.0
Kolasib,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Kolasib,4.1.1.a,Number of male live births,TOTAL,57.0,47.0,54.0,49.0,48.0,51.0,61.0,47.0,41.0,37.0,48.0,56.0,596.0
Kolasib,4.1.1.b,Number of female live births,TOTAL,58.0,51.0,47.0,41.0,37.0,65.0,58.0,43.0,67.0,35.0,60.0,37.0,599.0
Kolasib,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,115.0,98.0,101.0,90.0,85.0,116.0,119.0,90.0,108.0,72.0,108.0,93.0,1195.0
Kolasib,4.1.2,Number of still births,TOTAL,1.0,1.0,0.0,1.0,0.0,0.0,1.0,2.0,1.0,4.0,2.0,2.0,15.0
Kolasib,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,17.0,10.0,9.0,14.0,19.0,10.0,21.0,1.0,18.0,1.0,14.0,12.0,146.0
Kolasib,4.2.1,Number of Newborns weighed at birth,TOTAL,104.0,98.0,101.0,90.0,85.0,116.0,119.0,90.0,107.0,73.0,105.0,92.0,1180.0
Kolasib,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,3.0,3.0,4.0,9.0,5.0,4.0,3.0,2.0,1.0,3.0,8.0,8.0,53.0
Kolasib,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,103.0,93.0,101.0,89.0,85.0,116.0,113.0,90.0,108.0,72.0,103.0,92.0,1165.0
Kolasib,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kolasib,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolasib,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kolasib,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Kolasib,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kolasib,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,103.0,98.0,97.0,91.0,84.0,116.0,119.0,90.0,108.0,72.0,108.0,92.0,1178.0
Kolasib,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,96.0,117.0,112.0,91.0,86.0,92.0,110.0,111.0,90.0,95.0,115.0,89.0,1204.0
Kolasib,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,2.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,5.0
Kolasib,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,6.0,8.0,12.0,17.0,7.0,8.0,19.0,18.0,6.0,2.0,2.0,1.0,106.0
Kolasib,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,6.0,8.0,14.0,18.0,7.0,9.0,19.0,18.0,7.0,2.0,2.0,1.0,111.0
Kolasib,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolasib,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kolasib,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolasib,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kolasib,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Kolasib,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolasib,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Kolasib,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kolasib,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,5.0
Kolasib,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,10.0,0.0,4.0,0.0,6.0,6.0,7.0,6.0,0.0,3.0,0.0,42.0
Kolasib,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolasib,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,10.0,0.0,6.0,0.0,6.0,6.0,8.0,7.0,1.0,3.0,0.0,47.0
Kolasib,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kolasib,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,2.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,7.0
Kolasib,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,8.0,9.0,12.0,8.0,10.0,0.0,0.0,6.0,0.0,2.0,12.0,5.0,72.0
Kolasib,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolasib,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,10.0,10.0,13.0,8.0,10.0,0.0,0.0,7.0,0.0,2.0,14.0,5.0,79.0
Kolasib,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kolasib,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kolasib,9.06,Number of IUCD removals,TOTAL,15.0,8.0,16.0,5.0,5.0,0.0,3.0,12.0,13.0,8.0,6.0,8.0,99.0
Kolasib,9.07,Number of Oral Pills cycles distributed,TOTAL,142.0,158.0,178.0,185.0,182.0,142.0,264.0,268.0,211.0,245.0,260.0,311.0,2546.0
Kolasib,9.08,Number of Condom pieces distributed,TOTAL,492.0,518.0,574.0,522.0,748.0,456.0,522.0,908.0,765.0,612.0,613.0,617.0,7347.0
Kolasib,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,2.0,1.0,0.0,6.0,1.0,3.0,0.0,0.0,0.0,5.0,0.0,2.0,20.0
Kolasib,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Kolasib,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,125.0,124.0,131.0,93.0,93.0,101.0,140.0,94.0,112.0,63.0,113.0,85.0,1274.0
Kolasib,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,133.0,143.0,142.0,117.0,121.0,106.0,110.0,162.0,145.0,125.0,148.0,121.0,1573.0
Kolasib,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,151.0,120.0,131.0,136.0,127.0,119.0,103.0,166.0,133.0,118.0,151.0,121.0,1576.0
Kolasib,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,115.0,125.0,124.0,125.0,134.0,118.0,114.0,119.0,117.0,125.0,114.0,114.0,1444.0
Kolasib,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,30.0,25.0,28.0,25.0,24.0,35.0,22.0,29.0,28.0,26.0,34.0,24.0,330.0
Kolasib,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,133.0,143.0,86.0,120.0,121.0,60.0,63.0,150.0,141.0,125.0,146.0,121.0,1409.0
Kolasib,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,152.0,120.0,84.0,134.0,131.0,55.0,63.0,113.0,135.0,119.0,150.0,121.0,1377.0
Kolasib,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,115.0,125.0,60.0,128.0,134.0,71.0,65.0,130.0,117.0,126.0,114.0,114.0,1299.0
Kolasib,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,84.0,85.0,87.0,71.0,69.0,96.0,101.0,77.0,89.0,63.0,90.0,84.0,996.0
Kolasib,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,120.0,116.0,98.0,132.0,138.0,121.0,121.0,131.0,133.0,103.0,122.0,92.0,1427.0
Kolasib,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,111.0,125.0,110.0,108.0,108.0,103.0,95.0,156.0,95.0,83.0,123.0,77.0,1294.0
Kolasib,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,56.0,54.0,41.0,67.0,59.0,63.0,47.0,77.0,71.0,45.0,56.0,48.0,684.0
Kolasib,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,54.0,61.0,52.0,63.0,66.0,58.0,66.0,54.0,61.0,51.0,69.0,43.0,698.0
Kolasib,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,110.0,115.0,93.0,130.0,125.0,121.0,113.0,131.0,132.0,96.0,125.0,91.0,1382.0
Kolasib,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,117.0,131.0,116.0,117.0,117.0,115.0,87.0,127.0,98.0,86.0,130.0,80.0,1321.0
Kolasib,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,117.0,118.0,67.0,120.0,118.0,68.0,73.0,131.0,104.0,86.0,130.0,80.0,1212.0
Kolasib,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,2.0,4.0,1.0,2.0,1.0,2.0,1.0,0.0,0.0,0.0,9.0,0.0,22.0
Kolasib,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4.0,6.0,2.0,1.0,2.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,19.0
Kolasib,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2.0,8.0,4.0,2.0,1.0,1.0,2.0,1.0,0.0,0.0,0.0,1.0,22.0
Kolasib,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,6.0,14.0,6.0,3.0,3.0,3.0,4.0,1.0,0.0,0.0,0.0,1.0,41.0
Kolasib,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,3.0,31.0,60.0,172.0,117.0,0.0,9.0,155.0,245.0,99.0,225.0,30.0,1146.0
Kolasib,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,0.0,6.0,29.0,181.0,85.0,52.0,17.0,215.0,286.0,110.0,357.0,24.0,1362.0
Kolasib,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,0.0,0.0,4.0,116.0,71.0,110.0,5.0,140.0,71.0,23.0,131.0,4.0,675.0
Kolasib,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,4.0,2.0,1.0,0.0,0.0,7.0,2.0,0.0,1.0,2.0,0.0,19.0
Kolasib,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,46.0,45.0,46.0,48.0,47.0,47.0,42.0,42.0,42.0,41.0,43.0,40.0,529.0
Kolasib,10.4.2,Number of Immunisation sessions held during the month,TOTAL,46.0,45.0,46.0,48.0,46.0,47.0,44.0,41.0,40.0,40.0,42.0,40.0,525.0
Kolasib,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,40.0,46.0,45.0,45.0,45.0,43.0,42.0,40.0,39.0,38.0,41.0,40.0,504.0
Kolasib,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,103.0,113.0,98.0,132.0,137.0,117.0,120.0,94.0,121.0,95.0,114.0,78.0,1322.0
Kolasib,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,53.0,82.0,92.0,80.0,52.0,85.0,59.0,59.0,71.0,45.0,47.0,46.0,771.0
Kolasib,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,37.0,88.0,128.0,66.0,59.0,54.0,47.0,31.0,89.0,45.0,88.0,86.0,818.0
Kolasib,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,3.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,7.0
Kolasib,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,114.0,89.0,64.0,46.0,79.0,76.0,58.0,83.0,69.0,43.0,80.0,80.0,881.0
Kolasib,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,0.0,3.0,3.0,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Kolasib,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,11.0,7.0,17.0,10.0,33.0,4.0,8.0,10.0,4.0,4.0,6.0,5.0,119.0
Kolasib,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,3.0,0.0,6.0,30.0,12.0,60.0,35.0,49.0,0.0,0.0,0.0,195.0
Kolasib,13.4,Number of children provided free glasses,TOTAL,0.0,3.0,0.0,1.0,4.0,3.0,32.0,20.0,49.0,0.0,0.0,0.0,112.0
Kolasib,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Kolasib,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Kolasib,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,41.0,35.0,31.0,37.0,36.0,37.0,40.0,38.0,37.0,35.0,37.0,35.0,-1.0
Kolasib,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Kolasib,14.05,Number of RKS meetings held during the month,TOTAL,2.0,2.0,1.0,1.0,1.0,0.0,0.0,0.0,2.0,1.0,1.0,3.0,14.0
Kolasib,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,5.0,6.0,6.0,-1.0
Kolasib,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,15.0,18.0,21.0,28.0,14.0,26.0,18.0,20.0,16.0,9.0,16.0,13.0,214.0
Kolasib,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Kolasib,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Kolasib,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Kolasib,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Kolasib,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Kolasib,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,88.0,94.0,148.0,145.0,115.0,98.0,123.0,89.0,93.0,94.0,140.0,124.0,1351.0
Kolasib,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,128.0,161.0,152.0,140.0,179.0,134.0,118.0,105.0,138.0,140.0,144.0,124.0,1663.0
Kolasib,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,89.0,109.0,98.0,103.0,99.0,96.0,110.0,88.0,102.0,76.0,146.0,76.0,1192.0
Kolasib,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,148.0,212.0,225.0,200.0,240.0,240.0,342.0,200.0,212.0,163.0,199.0,184.0,2565.0
Kolasib,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,177.0,203.0,246.0,248.0,214.0,194.0,233.0,177.0,195.0,170.0,286.0,200.0,2543.0
Kolasib,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,276.0,373.0,377.0,340.0,419.0,374.0,460.0,305.0,350.0,303.0,343.0,308.0,4228.0
Kolasib,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,7.0,7.0,6.0,9.0,9.0,5.0,7.0,9.0,11.0,6.0,10.0,92.0
Kolasib,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,2.0,7.0,2.0,4.0,5.0,5.0,3.0,3.0,7.0,2.0,1.0,41.0
Kolasib,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,9.0,14.0,8.0,13.0,14.0,10.0,10.0,12.0,18.0,8.0,11.0,133.0
Kolasib,14.11,In-Patient Head Count at midnight,TOTAL,453.0,576.0,623.0,685.0,623.0,580.0,623.0,472.0,677.0,483.0,629.0,507.0,6931.0
Kolasib,14.12.1,OPD attendance (All),TOTAL,5042.0,5579.0,7302.0,6504.0,6731.0,6547.0,6298.0,6502.0,4852.0,5630.0,5878.0,4472.0,71337.0
Kolasib,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,17.0,27.0,22.0,20.0,20.0,17.0,11.0,5.0,16.0,3.0,32.0,34.0,224.0
Kolasib,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,5.0
Kolasib,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Kolasib,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,324.0,394.0,533.0,172.0,433.0,486.0,443.0,381.0,345.0,300.0,364.0,425.0,4600.0
Kolasib,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Kolasib,14.14.a,Number of patients given AYUSH treatment,TOTAL,325.0,336.0,598.0,390.0,451.0,529.0,437.0,426.0,434.0,399.0,499.0,414.0,5238.0
Kolasib,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,397.0,589.0,639.0,522.0,424.0,515.0,423.0,531.0,424.0,357.0,445.0,359.0,5625.0
Kolasib,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0,34.0
Kolasib,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Kolasib,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,200.0,316.0,412.0,613.0,436.0,470.0,823.0,544.0,361.0,228.0,499.0,407.0,5309.0
Kolasib,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,3.0,9.0,11.0,9.0,5.0,9.0,20.0,10.0,6.0,1.0,10.0,14.0,107.0
Kolasib,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,44.0,59.0,59.0,55.0,49.0,55.0,59.0,60.0,85.0,35.0,57.0,120.0,737.0
Kolasib,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,1.0,0.0,1.0,3.0,3.0,5.0,3.0,1.0,0.0,2.0,3.0,24.0
Kolasib,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,22.0,31.0,35.0,20.0,55.0,43.0,38.0,55.0,30.0,12.0,27.0,30.0,398.0
Kolasib,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,2.0,0.0,2.0,2.0,1.0,1.0,0.0,0.0,0.0,1.0,9.0
Kolasib,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,87.0,95.0,93.0,163.0,132.0,102.0,129.0,119.0,93.0,78.0,136.0,139.0,1366.0
Kolasib,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,1.0,6.0,1.0,13.0
Kolasib,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,153.0,185.0,187.0,238.0,236.0,200.0,226.0,234.0,208.0,125.0,220.0,289.0,2501.0
Kolasib,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,1.0,2.0,3.0,6.0,6.0,6.0,4.0,1.0,1.0,8.0,5.0,46.0
Kolasib,15.2,Number of Widal tests conducted,Number tested,49.0,131.0,157.0,161.0,159.0,142.0,246.0,223.0,112.0,78.0,131.0,124.0,1713.0
Kolasib,15.3.a,Number of VDRL tests conducted on males,Number tested,6.0,1.0,25.0,27.0,26.0,15.0,25.0,42.0,42.0,15.0,34.0,84.0,342.0
Kolasib,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,6.0,9.0,7.0,7.0,5.0,4.0,16.0,6.0,6.0,2.0,9.0,9.0,86.0
Kolasib,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,66.0,38.0,26.0,67.0,74.0,40.0,75.0,77.0,38.0,57.0,86.0,71.0,715.0
Kolasib,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,78.0,48.0,58.0,101.0,105.0,59.0,116.0,125.0,86.0,74.0,129.0,164.0,1143.0
Kolasib,15.4.1,Number of blood smears examined for Malaria,TOTAL,118.0,223.0,353.0,324.0,300.0,213.0,337.0,251.0,120.0,112.0,142.0,108.0,2601.0
Kolasib,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
Kolasib,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,0.0,0.0,1.0,1.0,2.0,0.0,1.0,0.0,0.0,0.0,7.0
Kolasib,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Kolasib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Kolasib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Kolasib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Kolasib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolasib,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Kolasib,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Kolasib,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Kolasib,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,1.0,,,1.0,,,2.0
Kolasib,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kolasib,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kolasib,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Kolasib,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kolasib,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kolasib,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Kolasib,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,,,1.0
Kolasib,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Kolasib,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,1.0,,,,1.0,,,,,2.0
Kolasib,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,2.0,2.0,1.0,3.0,1.0,,,9.0
Kolasib,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kolasib,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,2.0,2.0,1.0,3.0,1.0,,,9.0
Kolasib,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kolasib,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kolasib,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kolasib,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,2.0,,,,,,3.0
Kolasib,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kolasib,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,2.0,,,,,,3.0
Kolasib,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Kolasib,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kolasib,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,1.0,,,,1.0
Kolasib,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,2.0,,3.0,,1.0,1.0,,7.0
Kolasib,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Kolasib,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,2.0,,3.0,,1.0,1.0,,7.0
Kolasib,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kolasib,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kolasib,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Kolasib,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,2.0,,,,,,,,1.0,1.0,,4.0
Kolasib,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,,1.0,,,,2.0
Kolasib,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,2.0,,,,,,,1.0,1.0,1.0,,6.0
Kolasib,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,,,,,,1.0,,1.0,1.0,,5.0
Kolasib,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,1.0,1.0,4.0,1.0,,,,,3.0,2.0,13.0
Kolasib,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,2.0,1.0,1.0,4.0,1.0,,1.0,,1.0,4.0,2.0,18.0
Kolasib,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kolasib,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kolasib,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kolasib,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Kolasib,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,2.0,,,,,,,,1.0,4.0
Kolasib,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kolasib,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,2.0,,,,1.0,,,,1.0,5.0
Kolasib,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Kolasib,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kolasib,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,1.0,,,,,,,1.0
Kolasib,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,1.0,4.0,1.0,,1.0,1.0,2.0,1.0,,12.0
Kolasib,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,2.0,1.0,,,3.0,1.0,2.0,3.0,2.0,5.0,,20.0
Kolasib,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,2.0,2.0,1.0,4.0,4.0,1.0,3.0,4.0,4.0,6.0,,32.0
Kolasib,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,1.0,,,,,,1.0,,1.0,,,4.0
Kolasib,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,1.0,1.0,,,,,1.0,,2.0,,6.0
Kolasib,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,2.0,1.0,1.0,,,,1.0,1.0,1.0,2.0,,10.0
Kolasib,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kolasib,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kolasib,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kolasib,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kolasib,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Kolasib,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kolasib,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Kolasib,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kolasib,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Kolasib,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Kolasib,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kolasib,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,1.0,,,,1.0
Kolasib,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Kolasib,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kolasib,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Kolasib,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Kolasib,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,,2.0,1.0,1.0,2.0,1.0,1.0,,4.0,2.0,,19.0
Kolasib,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Kolasib,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,,2.0,1.0,1.0,3.0,2.0,1.0,,4.0,2.0,,22.0
Kolasib,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kolasib,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,4.0,1.0,2.0,1.0,,3.0,1.0,1.0,14.0
Kolasib,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Kolasib,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,1.0,4.0,1.0,2.0,1.0,,3.0,1.0,1.0,15.0
Kolasib,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Kolasib,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Kolasib,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kolasib,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,,,1.0,1.0,,,,,,3.0
Kolasib,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Kolasib,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,3.0,4.0,2.0,5.0,1.0,4.0,4.0,9.0,10.0,3.0,8.0,55.0
Kolasib,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,3.0,4.0,5.0,4.0,2.0,1.0,2.0,1.0,3.0,3.0,2.0,31.0
Kolasib,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,6.0,9.0,7.0,9.0,3.0,5.0,6.0,10.0,13.0,6.0,10.0,87.0
Kolasib,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Kolasib,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,1.0,1.0,5.0,1.0,4.0,7.0,5.0,2.0,4.0,4.0,5.0,40.0
Kolasib,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,9.0,9.0,8.0,4.0,5.0,5.0,4.0,5.0,15.0,5.0,10.0,81.0
Kolasib,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,10.0,11.0,14.0,5.0,9.0,12.0,9.0,7.0,19.0,9.0,15.0,123.0
Kolasib,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Kolasib,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,3.0,4.0,,,2.0,,3.0,,3.0,2.0,4.0,22.0
Kolasib,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,1.0,2.0,3.0,3.0,2.0,2.0,3.0,2.0,1.0,4.0,4.0,,27.0
Kolasib,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,5.0,7.0,3.0,2.0,4.0,3.0,5.0,1.0,8.0,6.0,4.0,50.0
Lawngtlai,1.1,Total number of pregnant women Registered for ANC,TOTAL,196.0,198.0,213.0,179.0,223.0,200.0,173.0,153.0,208.0,174.0,297.0,254.0,2468.0
Lawngtlai,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,150.0,163.0,167.0,147.0,174.0,163.0,146.0,135.0,110.0,121.0,179.0,169.0,1824.0
Lawngtlai,1.2,Number of Pregnant women registered under JSY,TOTAL,100.0,114.0,114.0,109.0,151.0,147.0,106.0,106.0,101.0,77.0,151.0,134.0,1410.0
Lawngtlai,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,112.0,101.0,94.0,126.0,147.0,139.0,135.0,110.0,119.0,105.0,112.0,85.0,1385.0
Lawngtlai,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,116.0,138.0,135.0,128.0,130.0,115.0,112.0,93.0,135.0,66.0,214.0,216.0,1598.0
Lawngtlai,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,190.0,178.0,186.0,159.0,181.0,215.0,156.0,183.0,187.0,140.0,157.0,232.0,2164.0
Lawngtlai,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,119.0,144.0,145.0,170.0,157.0,136.0,96.0,100.0,176.0,101.0,127.0,128.0,1599.0
Lawngtlai,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,4.0,0.0,0.0,,5.0,4.0,4.0,4.0,4.0,,6.0,1.0,32.0
Lawngtlai,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,0.0,0.0,,1.0,,,1.0,,,,,2.0
Lawngtlai,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,69.0,68.0,77.0,159.0,129.0,137.0,72.0,72.0,47.0,55.0,97.0,72.0,1054.0
Lawngtlai,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,0.0,0.0,7.0,1.0,2.0,,,,,,,10.0
Lawngtlai,1.8,Number of pregnancy test kits used at SC level,TOTAL,20.0,36.0,51.0,75.0,98.0,98.0,82.0,81.0,76.0,71.0,39.0,63.0,790.0
Lawngtlai,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,12.0,6.0,8.0,10.0,7.0,8.0,4.0,2.0,1.0,9.0,5.0,80.0
Lawngtlai,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,69.0,54.0,55.0,31.0,29.0,35.0,26.0,41.0,41.0,41.0,71.0,62.0,555.0
Lawngtlai,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,77.0,66.0,61.0,39.0,39.0,42.0,34.0,45.0,43.0,42.0,80.0,67.0,635.0
Lawngtlai,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,22.0,20.0,9.0,20.0,16.0,17.0,9.0,14.0,21.0,8.0,16.0,24.0,196.0
Lawngtlai,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Lawngtlai,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,79.0,59.0,66.0,59.0,72.0,61.0,90.0,78.0,63.0,76.0,75.0,76.0,854.0
Lawngtlai,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,75.0,53.0,57.0,55.0,72.0,61.0,89.0,78.0,61.0,75.0,74.0,75.0,825.0
Lawngtlai,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,23.0,45.0,25.0,32.0,38.0,169.0,117.0,13.0,11.0,11.0,17.0,10.0,511.0
Lawngtlai,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,19.0,23.0,24.0,17.0,17.0,84.0,58.0,13.0,7.0,11.0,17.0,10.0,300.0
Lawngtlai,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,3.0,,,,3.0
Lawngtlai,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,10.0,14.0,10.0,12.0,19.0,18.0,16.0,21.0,18.0,10.0,13.0,10.0,171.0
Lawngtlai,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,0.0,,,29.0,39.0,20.0,,,,,88.0
Lawngtlai,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,0.0,0.0,,,22.0,10.0,10.0,1.0,,,,43.0
Lawngtlai,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,0.0,0.0,,,,,,,,,,0.0
Lawngtlai,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Lawngtlai,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Lawngtlai,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,1.0,,1.0,1.0,,,,,,,,3.0
Lawngtlai,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lawngtlai,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,1.0,,1.0,1.0,,,,,,,,3.0
Lawngtlai,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1.0,3.0,1.0,3.0,4.0,4.0,4.0,5.0,5.0,,5.0,3.0,38.0
Lawngtlai,4.1.1.a,Number of male live births,TOTAL,85.0,62.0,67.0,48.0,53.0,59.0,65.0,68.0,62.0,64.0,89.0,71.0,793.0
Lawngtlai,4.1.1.b,Number of female live births,TOTAL,79.0,75.0,69.0,59.0,75.0,61.0,77.0,75.0,62.0,61.0,77.0,81.0,851.0
Lawngtlai,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,164.0,137.0,136.0,107.0,128.0,120.0,142.0,143.0,124.0,125.0,166.0,152.0,1644.0
Lawngtlai,4.1.2,Number of still births,TOTAL,2.0,2.0,1.0,3.0,2.0,1.0,,1.0,0.0,3.0,2.0,1.0,18.0
Lawngtlai,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,9.0,4.0,7.0,11.0,10.0,5.0,5.0,8.0,10.0,3.0,7.0,11.0,90.0
Lawngtlai,4.2.1,Number of Newborns weighed at birth,TOTAL,118.0,102.0,100.0,94.0,112.0,102.0,119.0,126.0,105.0,106.0,116.0,103.0,1303.0
Lawngtlai,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,2.0,0.0,4.0,3.0,5.0,6.0,4.0,3.0,4.0,4.0,7.0,7.0,49.0
Lawngtlai,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,117.0,97.0,98.0,91.0,113.0,100.0,117.0,124.0,109.0,106.0,114.0,117.0,1303.0
Lawngtlai,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,4.0,,,,,,,,4.0
Lawngtlai,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Lawngtlai,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,2.0,2.0,2.0,,,,,,,,,,6.0
Lawngtlai,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lawngtlai,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,2.0,2.0,2.0,,4.0,,,,,,,,10.0
Lawngtlai,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,2.0,2.0,0.0,2.0,6.0,5.0,7.0,8.0,7.0,2.0,2.0,,43.0
Lawngtlai,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,0.0,,,,,,0.0,,,,1.0
Lawngtlai,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,12.0,0.0,0.0,1.0,4.0,3.0,4.0,5.0,0.0,2.0,2.0,2.0,35.0
Lawngtlai,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,0.0,0.0,,6.0,4.0,2.0,2.0,0.0,,5.0,2.0,21.0
Lawngtlai,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,73.0,31.0,35.0,56.0,99.0,40.0,80.0,68.0,64.0,54.0,70.0,74.0,744.0
Lawngtlai,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,37.0,39.0,32.0,29.0,30.0,31.0,35.0,34.0,34.0,26.0,42.0,36.0,405.0
Lawngtlai,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,0.0,,,,,,0.0,,,,1.0
Lawngtlai,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,6.0,7.0,16.0,9.0,15.0,16.0,12.0,2.0,5.0,8.0,13.0,9.0,118.0
Lawngtlai,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Lawngtlai,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,6.0,7.0,16.0,9.0,15.0,16.0,12.0,2.0,5.0,8.0,13.0,9.0,118.0
Lawngtlai,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1.0,5.0,6.0,5.0,,8.0,18.0,,15.0,1.0,21.0,7.0,87.0
Lawngtlai,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1.0,11.0,21.0,11.0,5.0,3.0,14.0,,24.0,4.0,13.0,17.0,124.0
Lawngtlai,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2.0,16.0,27.0,16.0,5.0,11.0,32.0,,39.0,5.0,34.0,24.0,211.0
Lawngtlai,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Lawngtlai,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Lawngtlai,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,6.0,3.0,,,8.0,,,,,17.0
Lawngtlai,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,2.0,1.0,5.0,,,,1.0,8.0,,17.0
Lawngtlai,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,8.0,4.0,5.0,,8.0,,1.0,8.0,,34.0
Lawngtlai,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,1.0,,,,2.0,,,,,,3.0
Lawngtlai,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,2.0,,1.0,1.0,,,,,1.0,,,5.0
Lawngtlai,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,2.0,1.0,1.0,1.0,,2.0,,,1.0,,,8.0
Lawngtlai,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,1.0,1.0,7.0,5.0,3.0,1.0,5.0,4.0,1.0,3.0,6.0,37.0
Lawngtlai,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,5.0,2.0,4.0,1.0,4.0,2.0,1.0,,1.0,,20.0
Lawngtlai,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,1.0,,,,,1.0,,,,1.0,,6.0,9.0
Lawngtlai,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lawngtlai,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1.0,1.0,6.0,9.0,9.0,5.0,5.0,7.0,5.0,2.0,4.0,12.0,66.0
Lawngtlai,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1.0,3.0,4.0,10.0,,,6.0,4.0,6.0,2.0,2.0,,38.0
Lawngtlai,9.06,Number of IUCD removals,TOTAL,2.0,3.0,3.0,17.0,4.0,9.0,7.0,15.0,5.0,2.0,10.0,15.0,92.0
Lawngtlai,9.07,Number of Oral Pills cycles distributed,TOTAL,241.0,282.0,391.0,453.0,636.0,394.0,352.0,311.0,385.0,412.0,384.0,429.0,4670.0
Lawngtlai,9.08,Number of Condom pieces distributed,TOTAL,151.0,138.0,425.0,491.0,930.0,647.0,588.0,638.0,637.0,389.0,518.0,601.0,6153.0
Lawngtlai,9.09,Number of Centchroman (weekly) pills given,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,4.0,3.0,9.0,6.0,11.0,11.0,11.0,9.0,13.0,8.0,5.0,3.0,93.0
Lawngtlai,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.11.2.a,Number of failures following male sterilization,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.11.2.b,Number of failures following female sterilization,TOTAL,,0.0,0.0,,,1.0,,,0.0,,,,1.0
Lawngtlai,9.11.3.a,Number of deaths following male sterilization,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.11.3.b,Number of deaths following female sterilization,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Lawngtlai,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,188.0,208.0,169.0,140.0,97.0,150.0,131.0,141.0,217.0,79.0,216.0,306.0,2042.0
Lawngtlai,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4.0,9.0,29.0,6.0,2.0,2.0,4.0,,4.0,,,,60.0
Lawngtlai,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,39.0,71.0,20.0,1.0,6.0,3.0,3.0,,3.0,,,,146.0
Lawngtlai,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,45.0,22.0,29.0,11.0,10.0,7.0,5.0,,0.0,,,,129.0
Lawngtlai,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,192.0,210.0,160.0,133.0,134.0,117.0,113.0,131.0,236.0,112.0,350.0,203.0,2091.0
Lawngtlai,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,129.0,192.0,147.0,134.0,124.0,152.0,104.0,122.0,162.0,141.0,185.0,348.0,1940.0
Lawngtlai,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,98.0,98.0,182.0,149.0,135.0,129.0,104.0,125.0,149.0,139.0,176.0,210.0,1694.0
Lawngtlai,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,91.0,24.0,53.0,34.0,46.0,54.0,62.0,60.0,76.0,45.0,114.0,70.0,729.0
Lawngtlai,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,181.0,192.0,171.0,138.0,136.0,121.0,104.0,119.0,236.0,112.0,310.0,197.0,2017.0
Lawngtlai,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,149.0,254.0,149.0,130.0,129.0,158.0,96.0,115.0,162.0,176.0,161.0,328.0,2007.0
Lawngtlai,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,123.0,96.0,182.0,158.0,126.0,138.0,99.0,113.0,170.0,102.0,176.0,208.0,1691.0
Lawngtlai,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,18.0,18.0,21.0,34.0,33.0,59.0,62.0,55.0,43.0,36.0,40.0,64.0,483.0
Lawngtlai,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,36.0,2.0,26.0,7.0,15.0,,3.0,,10.0,,,,99.0
Lawngtlai,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,39.0,63.0,12.0,2.0,6.0,5.0,1.0,,2.0,,,,130.0
Lawngtlai,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,43.0,18.0,32.0,9.0,9.0,10.0,,,6.0,,,,127.0
Lawngtlai,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,135.0,179.0,128.0,120.0,118.0,142.0,104.0,160.0,164.0,96.0,209.0,139.0,1694.0
Lawngtlai,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,125.0,115.0,97.0,117.0,110.0,106.0,85.0,94.0,103.0,81.0,117.0,110.0,1260.0
Lawngtlai,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,65.0,83.0,66.0,57.0,48.0,71.0,53.0,73.0,85.0,42.0,82.0,56.0,781.0
Lawngtlai,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,65.0,71.0,63.0,61.0,45.0,67.0,45.0,88.0,57.0,41.0,75.0,37.0,715.0
Lawngtlai,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,130.0,154.0,129.0,118.0,93.0,138.0,98.0,161.0,142.0,83.0,157.0,93.0,1496.0
Lawngtlai,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,137.0,107.0,108.0,106.0,76.0,127.0,81.0,110.0,76.0,78.0,99.0,155.0,1260.0
Lawngtlai,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,127.0,102.0,102.0,125.0,107.0,114.0,77.0,100.0,80.0,81.0,101.0,158.0,1274.0
Lawngtlai,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,24.0,3.0,0.0,8.0,,,2.0,,7.0,4.0,,,48.0
Lawngtlai,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,31.0,36.0,37.0,43.0,42.0,61.0,28.0,44.0,34.0,30.0,35.0,58.0,479.0
Lawngtlai,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,30.0,48.0,37.0,31.0,43.0,43.0,34.0,38.0,40.0,50.0,42.0,48.0,484.0
Lawngtlai,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,61.0,84.0,74.0,74.0,85.0,104.0,62.0,82.0,74.0,80.0,77.0,106.0,963.0
Lawngtlai,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,50.0,80.0,50.0,49.0,51.0,129.0,68.0,54.0,67.0,43.0,104.0,101.0,846.0
Lawngtlai,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,36.0,54.0,40.0,42.0,30.0,107.0,47.0,40.0,29.0,50.0,65.0,65.0,605.0
Lawngtlai,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,23.0,32.0,35.0,19.0,31.0,40.0,25.0,21.0,19.0,38.0,9.0,21.0,313.0
Lawngtlai,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,6.0,7.0,6.0,3.0,4.0,2.0,11.0,,,2.0,43.0
Lawngtlai,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,53.0,56.0,57.0,56.0,55.0,56.0,53.0,57.0,62.0,54.0,63.0,63.0,685.0
Lawngtlai,10.4.2,Number of Immunisation sessions held during the month,TOTAL,51.0,54.0,54.0,54.0,52.0,54.0,51.0,55.0,58.0,43.0,59.0,61.0,646.0
Lawngtlai,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,46.0,44.0,43.0,47.0,43.0,46.0,45.0,48.0,47.0,37.0,53.0,46.0,545.0
Lawngtlai,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,91.0,145.0,118.0,107.0,92.0,104.0,85.0,84.0,84.0,62.0,158.0,70.0,1200.0
Lawngtlai,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,51.0,72.0,47.0,64.0,32.0,57.0,47.0,42.0,44.0,36.0,80.0,55.0,627.0
Lawngtlai,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,33.0,44.0,22.0,24.0,37.0,37.0,33.0,29.0,60.0,21.0,84.0,36.0,460.0
Lawngtlai,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,10.0,5.0,7.0,6.0,5.0,7.0,3.0,4.0,5.0,,9.0,11.0,72.0
Lawngtlai,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,43.0,60.0,46.0,52.0,54.0,37.0,27.0,24.0,38.0,28.0,87.0,137.0,633.0
Lawngtlai,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,30.0,30.0,55.0,35.0,18.0,33.0,18.0,12.0,14.0,2.0,8.0,9.0,264.0
Lawngtlai,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,38.0,62.0,28.0,31.0,73.0,35.0,21.0,24.0,12.0,11.0,19.0,15.0,369.0
Lawngtlai,13.1,Number of Patients operated for cataract,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,13.3,Number of School children detected with Refractive errors,TOTAL,,0.0,0.0,9.0,,,108.0,10.0,2.0,,5.0,25.0,159.0
Lawngtlai,13.4,Number of children provided free glasses,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,13.5,Number of eyes collected through eye donation,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,13.6,Number of eyes utilised for corneal transplant,TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Lawngtlai,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,1.0,2.0,1.0,1.0,2.0,1.0,2.0,-1.0
Lawngtlai,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,16.0,15.0,17.0,18.0,20.0,21.0,26.0,26.0,22.0,19.0,17.0,21.0,-1.0
Lawngtlai,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,-1.0
Lawngtlai,14.05,Number of RKS meetings held during the month,TOTAL,,,,2.0,0.0,0.0,,,,,,,2.0
Lawngtlai,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,1.0,2.0,1.0,2.0,1.0,1.0,2.0,1.0,3.0,-1.0
Lawngtlai,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,4.0,2.0,2.0,2.0,4.0,5.0,4.0,4.0,3.0,2.0,8.0,8.0,48.0
Lawngtlai,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Lawngtlai,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,0.0,,,,,,,,-1.0
Lawngtlai,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Lawngtlai,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Lawngtlai,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Lawngtlai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,130.0,110.0,140.0,126.0,128.0,107.0,113.0,108.0,85.0,73.0,91.0,110.0,1321.0
Lawngtlai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,121.0,181.0,200.0,136.0,143.0,160.0,148.0,165.0,109.0,109.0,146.0,122.0,1740.0
Lawngtlai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,92.0,88.0,94.0,100.0,115.0,81.0,81.0,103.0,88.0,53.0,79.0,98.0,1072.0
Lawngtlai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,159.0,209.0,196.0,215.0,226.0,184.0,226.0,202.0,174.0,162.0,179.0,175.0,2307.0
Lawngtlai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,222.0,198.0,234.0,226.0,243.0,188.0,194.0,211.0,173.0,126.0,170.0,208.0,2393.0
Lawngtlai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,280.0,390.0,396.0,351.0,369.0,344.0,374.0,367.0,283.0,271.0,325.0,297.0,4047.0
Lawngtlai,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,9.0,8.0,9.0,7.0,15.0,7.0,8.0,10.0,10.0,5.0,6.0,101.0
Lawngtlai,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,6.0,11.0,6.0,3.0,8.0,6.0,10.0,4.0,4.0,4.0,5.0,73.0
Lawngtlai,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13.0,15.0,19.0,15.0,10.0,23.0,13.0,18.0,14.0,14.0,9.0,11.0,174.0
Lawngtlai,14.11,In-Patient Head Count at midnight,TOTAL,,98.0,1152.0,969.0,,10.0,951.0,936.0,463.0,462.0,14.0,889.0,5944.0
Lawngtlai,14.12.1,OPD attendance (All),TOTAL,3599.0,5971.0,6397.0,8051.0,7264.0,7159.0,6690.0,6182.0,4839.0,3962.0,5705.0,6445.0,72264.0
Lawngtlai,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,16.0,23.0,20.0,20.0,22.0,14.0,28.0,9.0,9.0,28.0,24.0,213.0
Lawngtlai,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,0.0,0.0,,,,,,0.0,,,,0.0
Lawngtlai,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Lawngtlai,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,42.0,67.0,104.0,115.0,94.0,124.0,96.0,102.0,67.0,99.0,105.0,67.0,1082.0
Lawngtlai,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Lawngtlai,14.14.a,Number of patients given AYUSH treatment,TOTAL,157.0,201.0,242.0,102.0,34.0,37.0,81.0,160.0,139.0,,7.0,73.0,1233.0
Lawngtlai,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,11.0,75.0,98.0,84.0,118.0,99.0,117.0,124.0,90.0,16.0,134.0,76.0,1042.0
Lawngtlai,14.14.c,Number of Adolescents counselled,TOTAL,13.0,33.0,24.0,39.0,9.0,9.0,34.0,123.0,28.0,9.0,58.0,218.0,597.0
Lawngtlai,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Lawngtlai,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,325.0,517.0,515.0,501.0,723.0,551.0,506.0,611.0,345.0,364.0,657.0,601.0,6216.0
Lawngtlai,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,22.0,27.0,23.0,35.0,29.0,12.0,15.0,16.0,5.0,10.0,26.0,18.0,238.0
Lawngtlai,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,75.0,117.0,55.0,107.0,98.0,136.0,93.0,59.0,56.0,47.0,92.0,67.0,1002.0
Lawngtlai,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,1.0,0.0,1.0,1.0,1.0,,,0.0,,,3.0,7.0
Lawngtlai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,30.0,44.0,23.0,40.0,23.0,114.0,30.0,9.0,28.0,18.0,85.0,52.0,496.0
Lawngtlai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,1.0,0.0,1.0,3.0,,,,0.0,1.0,,1.0,7.0
Lawngtlai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,92.0,98.0,89.0,117.0,99.0,87.0,91.0,76.0,115.0,100.0,104.0,121.0,1189.0
Lawngtlai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,0.0,0.0,,,9.0,16.0,,,,,,25.0
Lawngtlai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,197.0,259.0,167.0,264.0,220.0,337.0,214.0,144.0,199.0,165.0,281.0,240.0,2687.0
Lawngtlai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,2.0,0.0,2.0,4.0,10.0,16.0,,0.0,1.0,,4.0,39.0
Lawngtlai,15.2,Number of Widal tests conducted,Number tested,196.0,510.0,409.0,403.0,457.0,216.0,428.0,376.0,214.0,180.0,221.0,215.0,3825.0
Lawngtlai,15.3.a,Number of VDRL tests conducted on males,Number tested,8.0,6.0,13.0,8.0,6.0,5.0,22.0,8.0,3.0,9.0,6.0,5.0,99.0
Lawngtlai,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,3.0,10.0,9.0,6.0,14.0,9.0,2.0,6.0,3.0,4.0,11.0,3.0,80.0
Lawngtlai,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,58.0,87.0,70.0,119.0,69.0,47.0,9.0,4.0,11.0,57.0,104.0,104.0,739.0
Lawngtlai,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,69.0,103.0,92.0,133.0,89.0,61.0,33.0,18.0,17.0,70.0,121.0,112.0,918.0
Lawngtlai,15.4.1,Number of blood smears examined for Malaria,TOTAL,443.0,723.0,767.0,797.0,915.0,779.0,798.0,505.0,557.0,294.0,365.0,410.0,7353.0
Lawngtlai,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,18.0,19.0,23.0,9.0,10.0,25.0,13.0,4.0,6.0,1.0,,2.0,130.0
Lawngtlai,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,60.0,81.0,106.0,46.0,58.0,98.0,36.0,41.0,25.0,18.0,17.0,27.0,613.0
Lawngtlai,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Lawngtlai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Lawngtlai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Lawngtlai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Lawngtlai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lawngtlai,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,1.0,,,1.0,1.0,3.0
Lawngtlai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Lawngtlai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lawngtlai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Lawngtlai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
Lawngtlai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lawngtlai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,,,,,,,1.0
Lawngtlai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,1.0,1.0,,,,,2.0
Lawngtlai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lawngtlai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,1.0,1.0,,,,,2.0
Lawngtlai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,,,1.0
Lawngtlai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lawngtlai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,1.0,,,,,1.0
Lawngtlai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,1.0,,2.0,2.0,2.0,3.0,2.0,,,13.0
Lawngtlai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,2.0,,,,1.0,,,3.0
Lawngtlai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,1.0,,4.0,2.0,2.0,3.0,3.0,,,16.0
Lawngtlai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,1.0,,,,,,,1.0,,,,3.0
Lawngtlai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lawngtlai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,1.0,,,,,,,1.0,,,,3.0
Lawngtlai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,1.0,,,1.0,4.0,1.0,1.0,,1.0,10.0
Lawngtlai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,1.0,,,,,,,2.0
Lawngtlai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,2.0,,1.0,1.0,4.0,1.0,1.0,,1.0,12.0
Lawngtlai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lawngtlai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lawngtlai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Lawngtlai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,,,,,2.0,2.0,3.0,1.0,,2.0,11.0
Lawngtlai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,1.0,1.0,,,,,1.0,,,,5.0
Lawngtlai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,1.0,1.0,,,2.0,2.0,4.0,1.0,,2.0,16.0
Lawngtlai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Lawngtlai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,,,,,,,,1.0
Lawngtlai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Lawngtlai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,1.0,,,,1.0
Lawngtlai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Lawngtlai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,1.0,,2.0,,,,1.0,,,,5.0
Lawngtlai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,1.0,2.0,1.0,,,,1.0,,,6.0
Lawngtlai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,1.0,1.0,1.0,4.0,1.0,,,1.0,1.0,,,12.0
Lawngtlai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Lawngtlai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,2.0,1.0,,1.0,,1.0,1.0,1.0,,,7.0
Lawngtlai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,2.0,1.0,,1.0,,1.0,1.0,1.0,,,8.0
Lawngtlai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,2.0,,,1.0,,,,,,,4.0
Lawngtlai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,2.0,,,,1.0,2.0,,,1.0,6.0
Lawngtlai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,1.0,,,,1.0,,,,,,1.0,4.0
Lawngtlai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,2.0,2.0,2.0,,2.0,,1.0,2.0,,,2.0,14.0
Lawngtlai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Lawngtlai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,,1.0,,1.0,2.0,,,1.0,,1.0,8.0
Lawngtlai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,,,4.0,1.0,4.0,3.0,2.0,1.0,,,,17.0
Lawngtlai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,1.0,,5.0,1.0,5.0,5.0,2.0,1.0,1.0,,1.0,25.0
Lawngtlai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Lawngtlai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,,1.0,1.0,,1.0,,,,,,1.0,6.0
Lawngtlai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,2.0,1.0,,1.0,,,,,,1.0,7.0
Lawngtlai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Lawngtlai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Lawngtlai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Lawngtlai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Lawngtlai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Lawngtlai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,,,,,,,,1.0
Lawngtlai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Lawngtlai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Lawngtlai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,1.0,,,,,,,,1.0
Lawngtlai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,1.0,,,,,,,,,2.0
Lawngtlai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,2.0,1.0,1.0,1.0,1.0,,,1.0,2.0,2.0,2.0,15.0
Lawngtlai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Lawngtlai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,3.0,1.0,2.0,1.0,1.0,,,1.0,3.0,2.0,2.0,18.0
Lawngtlai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,1.0,,,,,,,,2.0
Lawngtlai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,,1.0,,,,,,,,2.0
Lawngtlai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Lawngtlai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Lawngtlai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Lawngtlai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Lawngtlai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,2.0,2.0,1.0,1.0,3.0,1.0,1.0,3.0,1.0,1.0,2.0,21.0
Lawngtlai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,2.0,,1.0,,,2.0,5.0
Lawngtlai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,2.0,2.0,1.0,1.0,3.0,3.0,2.0,4.0,1.0,1.0,4.0,27.0
Lawngtlai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,1.0,,,1.0,,2.0
Lawngtlai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,4.0,6.0,3.0,3.0,4.0,3.0,2.0,3.0,6.0,2.0,2.0,38.0
Lawngtlai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,7.0,5.0,3.0,5.0,6.0,5.0,4.0,3.0,3.0,8.0,2.0,55.0
Lawngtlai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,4.0,11.0,11.0,6.0,8.0,10.0,8.0,7.0,6.0,9.0,11.0,4.0,95.0
Lawngtlai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,2.0,1.0,,,1.0,,,,,,,6.0
Lawngtlai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,1.0,2.0,4.0,,3.0,1.0,2.0,2.0,1.0,2.0,2.0,22.0
Lawngtlai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,2.0,6.0,4.0,3.0,5.0,1.0,3.0,1.0,5.0,6.0,,39.0
Lawngtlai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,7.0,5.0,9.0,8.0,3.0,9.0,2.0,5.0,3.0,6.0,8.0,2.0,67.0
Lunglei,1.1,Total number of pregnant women Registered for ANC,TOTAL,229.0,196.0,230.0,219.0,226.0,208.0,203.0,194.0,193.0,155.0,245.0,241.0,2539.0
Lunglei,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,175.0,151.0,176.0,169.0,187.0,165.0,164.0,158.0,143.0,122.0,172.0,196.0,1978.0
Lunglei,1.2,Number of Pregnant women registered under JSY,TOTAL,175.0,136.0,159.0,154.0,164.0,146.0,152.0,136.0,114.0,118.0,142.0,175.0,1771.0
Lunglei,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,141.0,126.0,142.0,179.0,175.0,141.0,143.0,155.0,166.0,132.0,142.0,129.0,1771.0
Lunglei,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,142.0,124.0,155.0,139.0,170.0,131.0,114.0,135.0,137.0,83.0,132.0,132.0,1594.0
Lunglei,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,194.0,209.0,205.0,170.0,225.0,197.0,162.0,218.0,186.0,156.0,164.0,183.0,2269.0
Lunglei,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,59.0,75.0,90.0,51.0,58.0,45.0,28.0,115.0,147.0,117.0,161.0,167.0,1113.0
Lunglei,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,7.0,6.0,6.0,6.0,10.0,6.0,3.0,11.0,2.0,1.0,4.0,4.0,66.0
Lunglei,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,,0.0,1.0,3.0
Lunglei,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,88.0,83.0,140.0,127.0,267.0,98.0,244.0,232.0,331.0,74.0,221.0,303.0,2208.0
Lunglei,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,1.0
Lunglei,1.8,Number of pregnancy test kits used at SC level,TOTAL,85.0,64.0,131.0,129.0,126.0,68.0,71.0,59.0,52.0,30.0,37.0,71.0,923.0
Lunglei,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,5.0,6.0,9.0,5.0,5.0,7.0,8.0,6.0,5.0,12.0,12.0,85.0
Lunglei,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,20.0,30.0,34.0,23.0,28.0,34.0,22.0,30.0,24.0,28.0,31.0,17.0,321.0
Lunglei,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,25.0,35.0,40.0,32.0,33.0,39.0,29.0,38.0,30.0,33.0,43.0,29.0,406.0
Lunglei,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,13.0,9.0,22.0,10.0,13.0,20.0,8.0,8.0,10.0,13.0,11.0,6.0,143.0
Lunglei,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,132.0,102.0,124.0,91.0,121.0,116.0,117.0,132.0,129.0,87.0,127.0,118.0,1396.0
Lunglei,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,107.0,76.0,87.0,69.0,93.0,93.0,89.0,112.0,108.0,59.0,93.0,83.0,1069.0
Lunglei,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,103.0,22.0,170.0,88.0,7.0,1.0,107.0,62.0,16.0,5.0,3.0,7.0,591.0
Lunglei,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,36.0,8.0,38.0,12.0,11.0,1.0,6.0,0.0,3.0,0.0,0.0,3.0,118.0
Lunglei,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,47.0,50.0,37.0,40.0,42.0,50.0,39.0,49.0,50.0,37.0,52.0,33.0,526.0
Lunglei,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,47.0,44.0,0.0,0.0,72.0,60.0,19.0,0.0,,,242.0
Lunglei,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,48.0,,,0.0,,,,,,,48.0
Lunglei,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Lunglei,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Lunglei,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,23.0,27.0,15.0,14.0,16.0,24.0,17.0,19.0,21.0,10.0,14.0,23.0,223.0
Lunglei,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lunglei,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,23.0,27.0,15.0,14.0,16.0,24.0,17.0,19.0,21.0,10.0,14.0,23.0,223.0
Lunglei,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,12.0,22.0,16.0,15.0,17.0,15.0,14.0,14.0,18.0,10.0,16.0,11.0,180.0
Lunglei,4.1.1.a,Number of male live births,TOTAL,98.0,96.0,103.0,76.0,102.0,101.0,93.0,124.0,107.0,68.0,111.0,90.0,1169.0
Lunglei,4.1.1.b,Number of female live births,TOTAL,104.0,89.0,97.0,86.0,93.0,102.0,91.0,95.0,102.0,86.0,107.0,86.0,1138.0
Lunglei,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,202.0,185.0,200.0,162.0,195.0,203.0,184.0,219.0,209.0,154.0,218.0,176.0,2307.0
Lunglei,4.1.2,Number of still births,TOTAL,2.0,2.0,2.0,2.0,1.0,2.0,2.0,1.0,0.0,3.0,4.0,5.0,26.0
Lunglei,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,15.0,22.0,16.0,14.0,21.0,31.0,17.0,27.0,19.0,4.0,22.0,18.0,226.0
Lunglei,4.2.1,Number of Newborns weighed at birth,TOTAL,198.0,180.0,191.0,160.0,194.0,200.0,184.0,212.0,207.0,154.0,211.0,175.0,2266.0
Lunglei,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,11.0,6.0,11.0,8.0,8.0,11.0,5.0,8.0,9.0,7.0,4.0,4.0,92.0
Lunglei,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,195.0,169.0,186.0,152.0,187.0,192.0,176.0,207.0,198.0,142.0,208.0,171.0,2183.0
Lunglei,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Lunglei,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,0.0,,,,0.0
Lunglei,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lunglei,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Lunglei,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Lunglei,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Lunglei,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Lunglei,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,0.0,,,,0.0
Lunglei,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,197.0,170.0,182.0,147.0,179.0,179.0,167.0,180.0,178.0,123.0,175.0,150.0,2027.0
Lunglei,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,164.0,166.0,171.0,147.0,176.0,185.0,174.0,188.0,165.0,157.0,183.0,154.0,2030.0
Lunglei,6.3,PNC maternal complications attended,TOTAL,2.0,0.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,,1.0,1.0,9.0
Lunglei,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,1.0,2.0,2.0,1.0,1.0,1.0,5.0,1.0,,3.0,2.0,22.0
Lunglei,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,13.0,14.0,10.0,18.0,11.0,7.0,7.0,10.0,,17.0,5.0,120.0
Lunglei,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,14.0,16.0,12.0,19.0,12.0,8.0,12.0,11.0,,20.0,7.0,142.0
Lunglei,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,12.0,10.0,8.0,34.0,48.0,40.0,38.0,70.0,34.0,,10.0,9.0,313.0
Lunglei,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,3.0,17.0,23.0,41.0,19.0,22.0,3.0,28.0,32.0,,37.0,25.0,250.0
Lunglei,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,15.0,27.0,31.0,75.0,67.0,62.0,41.0,98.0,66.0,,47.0,34.0,563.0
Lunglei,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lunglei,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Lunglei,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lunglei,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lunglei,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lunglei,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Lunglei,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lunglei,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Lunglei,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,2.0,0.0,0.0,0.0,4.0,0.0,1.0,1.0,1.0,,4.0,3.0,16.0
Lunglei,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lunglei,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,2.0,1.0,3.0,3.0,2.0,5.0,,,2.0,4.0,2.0,1.0,25.0
Lunglei,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lunglei,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,4.0,1.0,3.0,3.0,6.0,5.0,1.0,1.0,3.0,4.0,6.0,4.0,41.0
Lunglei,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,7.0,7.0,8.0,5.0,4.0,15.0,,9.0,8.0,4.0,6.0,4.0,77.0
Lunglei,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,,,3.0
Lunglei,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lunglei,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,8.0,3.0,0.0,3.0,6.0,9.0,8.0,3.0,,8.0,5.0,53.0
Lunglei,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lunglei,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,8.0,3.0,1.0,3.0,6.0,9.0,8.0,4.0,1.0,8.0,5.0,56.0
Lunglei,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,,0.0,,,,6.0,,,,,0.0,6.0
Lunglei,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,5.0,2.0,1.0,3.0,6.0,5.0,0.0,1.0,3.0,4.0,8.0,0.0,38.0
Lunglei,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,7.0,1.0,0.0,1.0,3.0,3.0,2.0,4.0,10.0,1.0,7.0,2.0,41.0
Lunglei,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Lunglei,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10.0,15.0,19.0,10.0,6.0,17.0,12.0,19.0,22.0,,26.0,11.0,167.0
Lunglei,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Lunglei,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,22.0,18.0,20.0,14.0,15.0,25.0,14.0,24.0,35.0,5.0,41.0,13.0,246.0
Lunglei,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,1.0,1.0
Lunglei,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2.0,3.0,0.0,,,,3.0,,,,5.0,,13.0
Lunglei,9.06,Number of IUCD removals,TOTAL,15.0,23.0,6.0,13.0,5.0,5.0,13.0,12.0,5.0,0.0,22.0,5.0,124.0
Lunglei,9.07,Number of Oral Pills cycles distributed,TOTAL,1225.0,984.0,1118.0,1002.0,1119.0,871.0,684.0,475.0,476.0,330.0,426.0,768.0,9478.0
Lunglei,9.08,Number of Condom pieces distributed,TOTAL,926.0,1060.0,1137.0,1208.0,1087.0,1059.0,688.0,892.0,521.0,532.0,613.0,800.0,10523.0
Lunglei,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,63.0,46.0,120.0,65.0,71.0,74.0,52.0,62.0,35.0,47.0,59.0,36.0,730.0
Lunglei,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,1.0,1.0,,,,-1.0
Lunglei,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,174.0,181.0,225.0,214.0,214.0,179.0,74.0,278.0,244.0,158.0,255.0,200.0,2396.0
Lunglei,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,2.0
Lunglei,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,180.0,155.0,196.0,177.0,166.0,166.0,155.0,215.0,181.0,177.0,237.0,149.0,2154.0
Lunglei,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,162.0,176.0,170.0,169.0,186.0,166.0,134.0,169.0,189.0,157.0,186.0,209.0,2073.0
Lunglei,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,164.0,142.0,165.0,173.0,188.0,153.0,136.0,186.0,175.0,160.0,180.0,178.0,2000.0
Lunglei,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,126.0,106.0,78.0,103.0,122.0,134.0,107.0,120.0,121.0,62.0,142.0,118.0,1339.0
Lunglei,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,171.0,156.0,161.0,197.0,172.0,165.0,152.0,210.0,181.0,171.0,229.0,148.0,2113.0
Lunglei,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,173.0,166.0,152.0,165.0,205.0,169.0,131.0,170.0,182.0,156.0,183.0,205.0,2057.0
Lunglei,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,177.0,134.0,143.0,175.0,185.0,169.0,127.0,197.0,176.0,163.0,243.0,180.0,2069.0
Lunglei,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,27.0,31.0,82.0,59.0,79.0,63.0,23.0,77.0,75.0,7.0,7.0,59.0,589.0
Lunglei,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,2.0
Lunglei,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,154.0,145.0,150.0,153.0,167.0,146.0,132.0,186.0,148.0,121.0,232.0,181.0,1915.0
Lunglei,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,131.0,161.0,179.0,164.0,133.0,160.0,92.0,167.0,154.0,100.0,152.0,135.0,1728.0
Lunglei,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Lunglei,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,69.0,78.0,80.0,81.0,85.0,73.0,62.0,93.0,87.0,60.0,104.0,110.0,982.0
Lunglei,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,76.0,67.0,70.0,71.0,77.0,72.0,69.0,88.0,60.0,59.0,116.0,71.0,896.0
Lunglei,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,145.0,145.0,150.0,152.0,162.0,145.0,131.0,181.0,147.0,119.0,220.0,181.0,1878.0
Lunglei,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,153.0,190.0,187.0,176.0,111.0,157.0,100.0,168.0,163.0,109.0,138.0,118.0,1770.0
Lunglei,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,152.0,190.0,155.0,186.0,122.0,167.0,94.0,161.0,165.0,109.0,147.0,120.0,1768.0
Lunglei,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,9.0,10.0,1.0,4.0,5.0,1.0,4.0,2.0,1.0,6.0,2.0,3.0,48.0
Lunglei,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,7.0,10.0,5.0,10.0,2.0,2.0,6.0,1.0,3.0,6.0,6.0,3.0,61.0
Lunglei,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,16.0,20.0,6.0,14.0,7.0,3.0,10.0,3.0,4.0,12.0,8.0,6.0,109.0
Lunglei,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,96.0,80.0,126.0,92.0,115.0,223.0,99.0,476.0,234.0,101.0,264.0,120.0,2026.0
Lunglei,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,86.0,73.0,108.0,73.0,115.0,213.0,226.0,397.0,268.0,115.0,354.0,89.0,2117.0
Lunglei,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,85.0,77.0,110.0,74.0,123.0,272.0,208.0,336.0,214.0,86.0,304.0,87.0,1976.0
Lunglei,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Lunglei,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Lunglei,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Lunglei,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,118.0,98.0,107.0,99.0,108.0,99.0,105.0,102.0,107.0,88.0,107.0,84.0,1222.0
Lunglei,10.4.2,Number of Immunisation sessions held during the month,TOTAL,107.0,96.0,106.0,95.0,107.0,98.0,87.0,99.0,99.0,77.0,101.0,77.0,1149.0
Lunglei,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,105.0,86.0,102.0,91.0,104.0,95.0,85.0,91.0,97.0,76.0,96.0,73.0,1101.0
Lunglei,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,130.0,132.0,133.0,129.0,129.0,89.0,117.0,189.0,127.0,144.0,221.0,179.0,1719.0
Lunglei,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,93.0,135.0,132.0,146.0,100.0,80.0,100.0,153.0,140.0,121.0,143.0,103.0,1446.0
Lunglei,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,74.0,125.0,110.0,95.0,71.0,76.0,108.0,134.0,96.0,114.0,162.0,111.0,1276.0
Lunglei,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,6.0
Lunglei,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,102.0,79.0,42.0,53.0,43.0,48.0,30.0,49.0,54.0,51.0,93.0,115.0,759.0
Lunglei,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,22.0,15.0,25.0,14.0,12.0,5.0,3.0,8.0,10.0,3.0,3.0,2.0,122.0
Lunglei,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,32.0,44.0,42.0,46.0,17.0,45.0,40.0,45.0,37.0,17.0,56.0,44.0,465.0
Lunglei,13.1,Number of Patients operated for cataract,TOTAL,16.0,20.0,15.0,21.0,5.0,14.0,20.0,16.0,12.0,,25.0,18.0,182.0
Lunglei,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,16.0,20.0,15.0,16.0,5.0,14.0,20.0,16.0,12.0,,25.0,18.0,177.0
Lunglei,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,,,3.0,8.0
Lunglei,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,3.0,3.0
Lunglei,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Lunglei,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Lunglei,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,1.0,1.0,1.0,2.0,2.0,2.0,1.0,1.0,1.0,2.0,1.0,-1.0
Lunglei,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,8.0,9.0,8.0,8.0,7.0,7.0,8.0,9.0,5.0,9.0,7.0,-1.0
Lunglei,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,80.0,76.0,94.0,85.0,89.0,81.0,83.0,85.0,96.0,82.0,89.0,88.0,-1.0
Lunglei,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Lunglei,14.05,Number of RKS meetings held during the month,TOTAL,3.0,3.0,3.0,3.0,3.0,4.0,3.0,4.0,5.0,2.0,3.0,3.0,39.0
Lunglei,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,9.0,10.0,9.0,9.0,9.0,8.0,8.0,9.0,7.0,10.0,9.0,-1.0
Lunglei,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,16.0,15.0,14.0,18.0,28.0,29.0,22.0,33.0,48.0,19.0,39.0,20.0,301.0
Lunglei,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,1.0,1.0,-1.0
Lunglei,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,0.0,,-1.0
Lunglei,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Lunglei,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Lunglei,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Lunglei,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,185.0,191.0,169.0,186.0,187.0,174.0,157.0,170.0,141.0,76.0,192.0,165.0,1993.0
Lunglei,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,293.0,297.0,327.0,335.0,301.0,290.0,334.0,295.0,248.0,264.0,258.0,226.0,3468.0
Lunglei,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,157.0,144.0,164.0,192.0,192.0,151.0,152.0,151.0,143.0,91.0,152.0,154.0,1843.0
Lunglei,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,441.0,429.0,432.0,498.0,487.0,427.0,524.0,437.0,408.0,291.0,428.0,336.0,5138.0
Lunglei,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,342.0,335.0,333.0,378.0,379.0,325.0,309.0,321.0,284.0,167.0,344.0,319.0,3836.0
Lunglei,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,734.0,726.0,759.0,833.0,788.0,717.0,858.0,732.0,656.0,555.0,686.0,562.0,8606.0
Lunglei,14.10.2.a,Number of death cases of Inpatient males,TOTAL,19.0,11.0,14.0,11.0,8.0,15.0,11.0,28.0,14.0,17.0,22.0,15.0,185.0
Lunglei,14.10.2.b,Number of death cases of Inpatient females,TOTAL,9.0,5.0,10.0,5.0,7.0,8.0,10.0,11.0,9.0,7.0,9.0,6.0,96.0
Lunglei,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,28.0,16.0,24.0,16.0,15.0,23.0,21.0,39.0,23.0,24.0,31.0,21.0,281.0
Lunglei,14.11,In-Patient Head Count at midnight,TOTAL,3064.0,3513.0,3150.0,4985.0,5689.0,5579.0,5225.0,5761.0,4187.0,2962.0,4651.0,4731.0,53497.0
Lunglei,14.12.1,OPD attendance (All),TOTAL,14107.0,15292.0,19206.0,18822.0,18215.0,18912.0,17853.0,15695.0,14227.0,6801.0,14294.0,14479.0,187903.0
Lunglei,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,129.0,135.0,122.0,136.0,131.0,138.0,120.0,127.0,114.0,79.0,132.0,137.0,1500.0
Lunglei,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Lunglei,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Lunglei,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,229.0,197.0,200.0,219.0,173.0,210.0,152.0,166.0,181.0,94.0,198.0,161.0,2180.0
Lunglei,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Lunglei,14.14.a,Number of patients given AYUSH treatment,TOTAL,544.0,644.0,925.0,671.0,787.0,783.0,737.0,803.0,556.0,85.0,522.0,494.0,7551.0
Lunglei,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,713.0,656.0,850.0,898.0,820.0,1036.0,881.0,737.0,631.0,536.0,857.0,941.0,9556.0
Lunglei,14.14.c,Number of Adolescents counselled,TOTAL,145.0,33.0,107.0,28.0,4.0,9.0,4.0,16.0,28.0,52.0,71.0,36.0,533.0
Lunglei,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Lunglei,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1082.0,1141.0,1482.0,1683.0,1447.0,1470.0,1274.0,668.0,1035.0,1114.0,1275.0,1245.0,14916.0
Lunglei,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,20.0,22.0,35.0,31.0,32.0,27.0,23.0,21.0,9.0,22.0,26.0,33.0,301.0
Lunglei,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,229.0,302.0,273.0,428.0,276.0,450.0,263.0,386.0,201.0,201.0,323.0,323.0,3655.0
Lunglei,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,3.0,4.0,2.0,3.0,3.0,3.0,7.0,1.0,2.0,8.0,5.0,45.0
Lunglei,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,120.0,197.0,176.0,181.0,221.0,195.0,177.0,203.0,96.0,154.0,216.0,172.0,2108.0
Lunglei,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,4.0,1.0,3.0,3.0,1.0,2.0,3.0,0.0,4.0,1.0,0.0,25.0
Lunglei,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,216.0,295.0,264.0,323.0,325.0,288.0,272.0,343.0,235.0,158.0,327.0,355.0,3401.0
Lunglei,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,1.0,0.0,0.0,0.0,2.0,1.0,1.0,0.0,0.0,1.0,7.0
Lunglei,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,565.0,794.0,713.0,932.0,822.0,933.0,712.0,932.0,532.0,513.0,866.0,850.0,9164.0
Lunglei,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,7.0,8.0,6.0,5.0,6.0,4.0,7.0,11.0,2.0,6.0,9.0,6.0,77.0
Lunglei,15.2,Number of Widal tests conducted,Number tested,162.0,196.0,283.0,306.0,259.0,343.0,293.0,392.0,128.0,55.0,97.0,196.0,2710.0
Lunglei,15.3.a,Number of VDRL tests conducted on males,Number tested,91.0,120.0,110.0,299.0,147.0,276.0,174.0,269.0,125.0,194.0,227.0,192.0,2224.0
Lunglei,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,70.0,106.0,115.0,154.0,142.0,112.0,126.0,158.0,64.0,144.0,167.0,159.0,1517.0
Lunglei,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,154.0,109.0,189.0,247.0,197.0,204.0,199.0,214.0,104.0,139.0,140.0,103.0,1999.0
Lunglei,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,315.0,335.0,414.0,700.0,486.0,592.0,499.0,641.0,293.0,477.0,534.0,454.0,5740.0
Lunglei,15.4.1,Number of blood smears examined for Malaria,TOTAL,380.0,593.0,716.0,1189.0,1085.0,1142.0,1260.0,1054.0,495.0,268.0,492.0,421.0,9095.0
Lunglei,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10.0,5.0,5.0,7.0,5.0,4.0,0.0,1.0,1.0,0.0,0.0,0.0,38.0
Lunglei,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,18.0,22.0,30.0,36.0,32.0,14.0,9.0,10.0,3.0,4.0,4.0,3.0,185.0
Lunglei,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,631.0,1257.0,1049.0,,818.0,,0.0,464.0,1608.0,1082.0,664.0,1135.0,8708.0
Lunglei,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000.0,0.0,0.0,,1000.0,,1000.0,2000.0,0.0,0.0,1000.0,0.0,6000.0
Lunglei,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,374.0,208.0,111.0,,1330.0,,536.0,856.0,526.0,418.0,529.0,104.0,4992.0
Lunglei,16.1.1,Stock position of DPT vaccines,5. Total Stock,1257.0,1049.0,938.0,0.0,488.0,0.0,464.0,1608.0,1082.0,664.0,1135.0,1031.0,9716.0
Lunglei,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2761.0,3843.0,3522.0,,1768.0,,2092.0,3293.0,2506.0,1793.0,2157.0,1425.0,25160.0
Lunglei,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2000.0,0.0,0.0,,0.0,,2000.0,0.0,0.0,1000.0,0.0,1200.0,6200.0
Lunglei,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,918.0,321.0,1012.0,,872.0,,799.0,787.0,713.0,636.0,732.0,989.0,7779.0
Lunglei,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3843.0,3522.0,2510.0,0.0,896.0,0.0,3293.0,2506.0,1793.0,2157.0,1425.0,1636.0,23581.0
Lunglei,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,872.0,620.0,723.0,,470.0,,373.0,3847.0,4247.0,2560.0,2300.0,2980.0,18992.0
Lunglei,16.1.2,Stock position of OPV vaccines,2. Stocks Received,940.0,800.0,1500.0,,2000.0,,5000.0,2000.0,0.0,16140.0,2000.0,18000.0,48380.0
Lunglei,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1812.0,697.0,961.0,,1744.0,,1526.0,1600.0,1687.0,16400.0,1320.0,20303.0,48050.0
Lunglei,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,723.0,1262.0,0.0,726.0,0.0,3847.0,4247.0,2560.0,2300.0,2980.0,677.0,19322.0
Lunglei,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1733.0,2908.0,2517.0,,1586.0,,2014.0,1959.0,1793.0,877.0,2255.0,1142.0,18784.0
Lunglei,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000.0,0.0,500.0,,2660.0,,1000.0,1000.0,0.0,2000.0,0.0,1500.0,10660.0
Lunglei,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1380.0,391.0,683.0,,882.0,,1055.0,1166.0,916.0,622.0,1113.0,839.0,9047.0
Lunglei,16.1.3,Stock position of TT vaccines,5. Total Stock,2353.0,2517.0,2334.0,0.0,3364.0,0.0,1959.0,1793.0,877.0,2255.0,1142.0,1803.0,20397.0
Lunglei,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2050.0,2040.0,1500.0,,320.0,,0.0,580.0,2000.0,1180.0,360.0,1670.0,11700.0
Lunglei,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000.0,0.0,500.0,,1000.0,,1000.0,2500.0,0.0,0.0,2000.0,0.0,8000.0
Lunglei,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,470.0,540.0,830.0,,850.0,,420.0,1080.0,820.0,820.0,690.0,940.0,7460.0
Lunglei,16.1.5,Stock position of BCG vaccines,5. Total Stock,2580.0,1500.0,1170.0,0.0,470.0,0.0,580.0,2000.0,1180.0,360.0,1670.0,730.0,12240.0
Lunglei,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,725.0,1255.0,985.0,,1035.0,,1965.0,2015.0,1500.0,1055.0,1215.0,460.0,12210.0
Lunglei,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,0.0,500.0,,1000.0,,500.0,0.0,,500.0,0.0,500.0,4000.0
Lunglei,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,470.0,270.0,515.0,,590.0,,450.0,515.0,445.0,340.0,755.0,560.0,4910.0
Lunglei,16.1.6,Stock position of Measles vaccines,5. Total Stock,1255.0,985.0,970.0,0.0,1445.0,0.0,2015.0,1500.0,1055.0,1215.0,460.0,400.0,11300.0
Lunglei,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,265.0,546.0,486.0,,266.0,,436.0,366.0,746.0,696.0,1126.0,1056.0,5989.0
Lunglei,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,500.0,0.0,0.0,,500.0,,0.0,500.0,0.0,500.0,0.0,0.0,2000.0
Lunglei,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,219.0,60.0,120.0,,160.0,,70.0,120.0,50.0,70.0,70.0,76.0,1015.0
Lunglei,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,546.0,486.0,366.0,0.0,606.0,0.0,366.0,746.0,696.0,1126.0,1056.0,980.0,6974.0
Lunglei,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,926.0,926.0,726.0,,726.0,,726.0,676.0,676.0,676.0,676.0,676.0,7410.0
Lunglei,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,200.0,0.0,,0.0,,50.0,0.0,0.0,0.0,0.0,150.0,400.0
Lunglei,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,926.0,726.0,726.0,0.0,726.0,0.0,676.0,676.0,676.0,676.0,676.0,526.0,7010.0
Lunglei,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,0.0,0.0,,,0.0,3344.0,3344.0
Lunglei,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,0.0,0.0,,,20184.0,0.0,20184.0
Lunglei,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,0.0,0.0,,,16840.0,0.0,16840.0
Lunglei,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3344.0,3344.0,6688.0
Lunglei,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2530.0,2530.0,2400.0,,2400.0,,2300.0,2200.0,2100.0,1800.0,1600.0,2900.0,22760.0
Lunglei,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,18400.0,0.0,18400.0
Lunglei,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,130.0,0.0,,0.0,,100.0,100.0,300.0,200.0,17100.0,1050.0,18980.0
Lunglei,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2530.0,2400.0,2400.0,0.0,2400.0,0.0,2200.0,2100.0,1800.0,1600.0,2900.0,1850.0,22180.0
Lunglei,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,0.0,645.0,645.0
Lunglei,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,1890.0,0.0,1890.0
Lunglei,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,1245.0,0.0,1245.0
Lunglei,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,645.0,645.0,1290.0
Lunglei,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Lunglei,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Lunglei,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Lunglei,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Lunglei,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,14925.0,14925.0,14925.0,,14925.0,,14925.0,14925.0,14925.0,14875.0,14000.0,0.0,133350.0
Lunglei,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0
Lunglei,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,,0.0,,0.0,0.0,50.0,875.0,14000.0,0.0,14925.0
Lunglei,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,14925.0,14925.0,14925.0,0.0,14925.0,0.0,14925.0,14925.0,14875.0,14000.0,0.0,0.0,118425.0
Lunglei,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,803.0,541.0,195.0,,295.0,,1526.0,1463.0,2093.0,1961.0,2607.0,2487.0,13971.0
Lunglei,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,445.0,,0.0,,0.0,1000.0,0.0,1000.0,0.0,800.0,3245.0
Lunglei,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,262.0,346.0,237.0,,295.0,,63.0,370.0,132.0,354.0,120.0,651.0,2830.0
Lunglei,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,541.0,195.0,403.0,0.0,0.0,0.0,1463.0,2093.0,1961.0,2607.0,2487.0,2636.0,14386.0
Lunglei,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2164.0,1052.0,129.0,,3029.0,,3200.0,1850.0,5086.0,3906.0,6926.0,3682.0,31024.0
Lunglei,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,5463.0,,0.0,,0.0,5000.0,0.0,5000.0,0.0,5000.0,20463.0
Lunglei,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,1112.0,923.0,1349.0,,1850.0,,1350.0,1764.0,1180.0,1980.0,3244.0,3347.0,18099.0
Lunglei,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,1052.0,129.0,4243.0,0.0,1179.0,0.0,1850.0,5086.0,3906.0,6926.0,3682.0,5335.0,33388.0
Lunglei,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,341.0,46.0,0.0,,40.0,,1300.0,1260.0,945.0,885.0,825.0,644.0,6286.0
Lunglei,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,180.0,,0.0,,0.0,0.0,0.0,0.0,0.0,500.0,680.0
Lunglei,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Lunglei,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,295.0,46.0,55.0,,40.0,,40.0,315.0,60.0,60.0,181.0,430.0,1522.0
Lunglei,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,46.0,0.0,125.0,0.0,0.0,0.0,1260.0,945.0,885.0,825.0,644.0,714.0,5444.0
Lunglei,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Lunglei,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,1.0,,,1.0,1.0,,1.0,4.0
Lunglei,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lunglei,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,,,1.0,1.0,,1.0,4.0
Lunglei,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,,,1.0
Lunglei,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lunglei,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,1.0,,,,,1.0
Lunglei,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,1.0,2.0,1.0,,,,,1.0,,5.0
Lunglei,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Lunglei,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,1.0,2.0,1.0,,,,,1.0,,5.0
Lunglei,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,,,1.0,,1.0,1.0,,,1.0,5.0
Lunglei,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Lunglei,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,1.0,1.0,,1.0,,1.0,1.0,,,1.0,6.0
Lunglei,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,1.0,2.0,3.0,1.0,2.0,,10.0
Lunglei,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Lunglei,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,1.0,2.0,3.0,1.0,2.0,1.0,11.0
Lunglei,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lunglei,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Lunglei,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,,,,,1.0
Lunglei,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,2.0,,3.0,,,5.0
Lunglei,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,1.0,,2.0
Lunglei,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,2.0,,4.0,1.0,,7.0
Lunglei,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Lunglei,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Lunglei,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Lunglei,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,2.0,,1.0,4.0,3.0,1.0,,1.0,,13.0
Lunglei,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,1.0,1.0,,,,,,,1.0,,4.0
Lunglei,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,2.0,3.0,,1.0,4.0,3.0,1.0,,2.0,,17.0
Lunglei,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Lunglei,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Lunglei,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,1.0,,,1.0
Lunglei,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,1.0,,,,,,2.0,,,1.0,1.0,8.0
Lunglei,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,1.0,,,2.0,,,,,3.0
Lunglei,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,1.0,,,1.0,,,4.0,,,1.0,1.0,11.0
Lunglei,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,1.0,,,,2.0
Lunglei,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,2.0,1.0,,2.0,2.0,3.0,2.0,,,1.0,14.0
Lunglei,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,1.0,1.0,,1.0,,1.0,1.0,1.0,,3.0,1.0,11.0
Lunglei,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,1.0,3.0,1.0,1.0,3.0,3.0,4.0,4.0,,3.0,2.0,27.0
Lunglei,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,2.0,1.0,,,,,,,,3.0
Lunglei,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Lunglei,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Lunglei,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,2.0,1.0,,,,,,,,3.0
Lunglei,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,1.0,,,,,,,,2.0
Lunglei,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,2.0,1.0,,1.0,1.0,1.0,2.0,3.0,,,13.0
Lunglei,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,4.0,,,,,1.0,,1.0,,7.0
Lunglei,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,2.0,3.0,5.0,1.0,1.0,1.0,1.0,3.0,3.0,1.0,,22.0
Lunglei,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Lunglei,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Lunglei,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Lunglei,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,1.0,3.0,1.0,1.0,2.0,4.0,2.0,3.0,2.0,4.0,1.0,26.0
Lunglei,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,4.0,3.0,3.0,2.0,4.0,8.0,5.0,6.0,3.0,6.0,46.0
Lunglei,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,2.0,7.0,4.0,4.0,4.0,8.0,10.0,8.0,8.0,7.0,7.0,72.0
Lunglei,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,1.0,,1.0,,,,2.0
Lunglei,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,1.0,1.0,,1.0,1.0,,,,1.0,6.0
Lunglei,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,1.0,1.0,1.0,,2.0,1.0,1.0,,,1.0,8.0
Lunglei,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Lunglei,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Lunglei,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Lunglei,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Lunglei,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Lunglei,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Lunglei,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Lunglei,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Lunglei,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Lunglei,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Lunglei,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,1.0,,,,1.0
Lunglei,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Lunglei,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Lunglei,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,,,,,,,,,,1.0
Lunglei,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,,,,,1.0,1.0,,,,3.0
Lunglei,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,2.0,3.0,2.0,2.0,,3.0,2.0,2.0,,6.0,1.0,1.0,24.0
Lunglei,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,3.0,1.0,,,,,,1.0,,3.0,,9.0
Lunglei,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,6.0,3.0,2.0,,3.0,2.0,3.0,2.0,6.0,4.0,1.0,36.0
Lunglei,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,1.0,,1.0,1.0,,,4.0,1.0,1.0,3.0,1.0,13.0
Lunglei,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Lunglei,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,1.0,,1.0,1.0,,,4.0,1.0,1.0,3.0,1.0,13.0
Lunglei,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Lunglei,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Lunglei,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,1.0,,,,,,1.0
Lunglei,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,,1.0,,,,,,2.0
Lunglei,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,7.0,2.0,4.0,4.0,3.0,4.0,3.0,6.0,5.0,8.0,2.0,5.0,53.0
Lunglei,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,5.0,6.0,2.0,,3.0,4.0,3.0,2.0,,6.0,4.0,1.0,36.0
Lunglei,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,8.0,6.0,4.0,7.0,8.0,7.0,8.0,5.0,14.0,6.0,6.0,91.0
Lunglei,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Lunglei,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,11.0,8.0,10.0,6.0,2.0,6.0,5.0,6.0,4.0,7.0,4.0,8.0,77.0
Lunglei,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,7.0,12.0,10.0,17.0,10.0,10.0,14.0,14.0,12.0,18.0,12.0,12.0,148.0
Lunglei,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,18.0,20.0,20.0,23.0,12.0,16.0,19.0,20.0,16.0,25.0,16.0,20.0,225.0
Lunglei,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Lunglei,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,3.0,2.0,2.0,3.0,4.0,4.0,,2.0,3.0,3.0,2.0,30.0
Lunglei,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,6.0,7.0,2.0,9.0,3.0,,6.0,3.0,1.0,4.0,5.0,3.0,49.0
Lunglei,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,8.0,10.0,4.0,11.0,6.0,4.0,10.0,4.0,3.0,7.0,8.0,5.0,80.0
Mamit,1.1,Total number of pregnant women Registered for ANC,TOTAL,120.0,156.0,152.0,118.0,145.0,148.0,128.0,129.0,103.0,134.0,181.0,205.0,1719.0
Mamit,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,89.0,104.0,102.0,81.0,108.0,103.0,84.0,95.0,76.0,85.0,130.0,127.0,1184.0
Mamit,1.2,Number of Pregnant women registered under JSY,TOTAL,93.0,102.0,88.0,78.0,104.0,114.0,99.0,89.0,62.0,75.0,112.0,139.0,1155.0
Mamit,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,73.0,77.0,78.0,63.0,81.0,91.0,80.0,88.0,84.0,97.0,98.0,87.0,997.0
Mamit,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,97.0,134.0,103.0,74.0,67.0,88.0,90.0,98.0,76.0,88.0,95.0,129.0,1139.0
Mamit,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,135.0,113.0,123.0,131.0,109.0,112.0,134.0,126.0,118.0,115.0,141.0,161.0,1518.0
Mamit,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,67.0,71.0,74.0,70.0,71.0,79.0,55.0,105.0,95.0,105.0,127.0,167.0,1086.0
Mamit,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,2.0,2.0,2.0,0.0,2.0,0.0,2.0,0.0,3.0,3.0,1.0,1.0,18.0
Mamit,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,47.0,57.0,62.0,111.0,118.0,57.0,72.0,79.0,69.0,42.0,66.0,72.0,852.0
Mamit,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,1.8,Number of pregnancy test kits used at SC level,TOTAL,139.0,131.0,169.0,133.0,116.0,121.0,133.0,122.0,126.0,126.0,140.0,121.0,1577.0
Mamit,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,11.0,6.0,10.0,4.0,3.0,8.0,5.0,10.0,5.0,7.0,5.0,6.0,80.0
Mamit,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,21.0,32.0,30.0,26.0,18.0,24.0,29.0,18.0,33.0,31.0,18.0,27.0,307.0
Mamit,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,32.0,38.0,40.0,30.0,21.0,32.0,34.0,28.0,38.0,38.0,23.0,33.0,387.0
Mamit,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,21.0,21.0,28.0,17.0,11.0,20.0,21.0,16.0,21.0,18.0,13.0,14.0,221.0
Mamit,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,53.0,70.0,51.0,54.0,64.0,73.0,64.0,60.0,55.0,53.0,71.0,63.0,731.0
Mamit,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,42.0,48.0,35.0,24.0,54.0,54.0,32.0,38.0,38.0,30.0,48.0,55.0,498.0
Mamit,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,6.0,5.0,52.0,8.0,28.0,163.0,47.0,17.0,11.0,13.0,7.0,10.0,367.0
Mamit,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,4.0,7.0,10.0,9.0,41.0,11.0,9.0,9.0,13.0,7.0,10.0,130.0
Mamit,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Mamit,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Mamit,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Mamit,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Mamit,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Mamit,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,1.0,1.0,6.0,2.0,0.0,2.0,1.0,1.0,1.0,3.0,2.0,20.0
Mamit,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mamit,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,1.0,1.0,7.0,2.0,1.0,3.0,1.0,1.0,1.0,3.0,2.0,23.0
Mamit,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Mamit,4.1.1.a,Number of male live births,TOTAL,38.0,57.0,34.0,47.0,44.0,53.0,49.0,42.0,45.0,48.0,52.0,55.0,564.0
Mamit,4.1.1.b,Number of female live births,TOTAL,46.0,51.0,57.0,36.0,41.0,51.0,49.0,46.0,48.0,43.0,41.0,41.0,550.0
Mamit,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,84.0,108.0,91.0,83.0,85.0,104.0,98.0,88.0,93.0,91.0,93.0,96.0,1114.0
Mamit,4.1.2,Number of still births,TOTAL,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,4.0
Mamit,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2.0,2.0,3.0,3.0,8.0,3.0,1.0,2.0,5.0,0.0,2.0,3.0,34.0
Mamit,4.2.1,Number of Newborns weighed at birth,TOTAL,71.0,98.0,87.0,77.0,77.0,95.0,93.0,81.0,82.0,72.0,86.0,88.0,1007.0
Mamit,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,2.0,1.0,2.0,3.0,6.0,3.0,6.0,2.0,7.0,0.0,1.0,0.0,33.0
Mamit,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,73.0,101.0,86.0,79.0,80.0,102.0,94.0,83.0,85.0,83.0,88.0,90.0,1044.0
Mamit,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Mamit,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,1.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Mamit,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mamit,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,1.0,2.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,7.0
Mamit,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Mamit,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mamit,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Mamit,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mamit,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mamit,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,53.0,82.0,67.0,63.0,70.0,87.0,75.0,69.0,70.0,61.0,76.0,80.0,853.0
Mamit,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,56.0,50.0,59.0,64.0,67.0,75.0,65.0,75.0,59.0,73.0,49.0,69.0,761.0
Mamit,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mamit,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,8.0,22.0,27.0,4.0,0.0,7.0,14.0,8.0,8.0,6.0,15.0,16.0,135.0
Mamit,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,13.0,5.0,11.0,10.0,50.0,39.0,40.0,14.0,30.0,8.0,8.0,44.0,272.0
Mamit,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,21.0,27.0,38.0,14.0,50.0,46.0,54.0,22.0,38.0,14.0,23.0,60.0,407.0
Mamit,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mamit,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mamit,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mamit,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mamit,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mamit,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,5.0
Mamit,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mamit,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,1.0,1.0,2.0,0.0,0.0,0.0,1.0,1.0,0.0,6.0
Mamit,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mamit,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,3.0,0.0,1.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,7.0
Mamit,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,2.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Mamit,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,5.0
Mamit,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mamit,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,3.0,3.0,0.0,2.0,1.0,1.0,4.0,1.0,1.0,0.0,0.0,18.0
Mamit,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mamit,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,2.0,5.0,0.0,6.0,9.0,7.0,6.0,4.0,2.0,3.0,3.0,3.0,50.0
Mamit,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mamit,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,3.0,3.0,4.0,4.0,4.0,2.0,2.0,3.0,3.0,0.0,2.0,2.0,32.0
Mamit,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,1.0,4.0,1.0,1.0,3.0,4.0,0.0,0.0,0.0,1.0,4.0,3.0,22.0
Mamit,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mamit,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,6.0,12.0,5.0,11.0,18.0,13.0,8.0,7.0,5.0,4.0,9.0,8.0,106.0
Mamit,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mamit,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mamit,9.06,Number of IUCD removals,TOTAL,2.0,0.0,2.0,0.0,7.0,2.0,6.0,2.0,2.0,4.0,5.0,3.0,35.0
Mamit,9.07,Number of Oral Pills cycles distributed,TOTAL,284.0,506.0,540.0,399.0,703.0,617.0,645.0,646.0,692.0,518.0,567.0,529.0,6646.0
Mamit,9.08,Number of Condom pieces distributed,TOTAL,1092.0,1534.0,1388.0,1045.0,1410.0,1408.0,1144.0,761.0,927.0,680.0,476.0,473.0,12338.0
Mamit,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,30.0,15.0,211.0,22.0,28.0,30.0,20.0,75.0,24.0,10.0,27.0,29.0,521.0
Mamit,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,1.0,,,,-1.0
Mamit,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,166.0,152.0,118.0,87.0,91.0,117.0,109.0,113.0,123.0,94.0,117.0,128.0,1415.0
Mamit,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,5.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,11.0
Mamit,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,10.0,30.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,52.0
Mamit,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,15.0,11.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Mamit,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,158.0,144.0,112.0,121.0,77.0,101.0,118.0,114.0,127.0,122.0,122.0,117.0,1433.0
Mamit,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,126.0,164.0,118.0,108.0,99.0,84.0,113.0,121.0,105.0,128.0,101.0,133.0,1400.0
Mamit,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,103.0,150.0,117.0,124.0,113.0,109.0,85.0,109.0,113.0,121.0,109.0,107.0,1360.0
Mamit,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,21.0,44.0,31.0,34.0,39.0,51.0,52.0,45.0,45.0,38.0,47.0,37.0,484.0
Mamit,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,158.0,145.0,113.0,121.0,77.0,101.0,112.0,104.0,113.0,115.0,112.0,117.0,1388.0
Mamit,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,130.0,174.0,125.0,102.0,103.0,84.0,112.0,121.0,106.0,123.0,94.0,132.0,1406.0
Mamit,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,108.0,159.0,118.0,123.0,107.0,109.0,82.0,106.0,108.0,119.0,103.0,107.0,1349.0
Mamit,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,21.0,43.0,25.0,32.0,36.0,51.0,52.0,42.0,37.0,29.0,41.0,26.0,435.0
Mamit,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,5.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,11.0
Mamit,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,8.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Mamit,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,15.0,9.0,3.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,30.0
Mamit,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,134.0,120.0,89.0,93.0,103.0,100.0,82.0,98.0,99.0,111.0,91.0,96.0,1216.0
Mamit,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,110.0,98.0,81.0,101.0,64.0,93.0,66.0,96.0,74.0,91.0,82.0,74.0,1030.0
Mamit,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,64.0,62.0,39.0,42.0,52.0,47.0,36.0,57.0,55.0,54.0,60.0,54.0,622.0
Mamit,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,55.0,54.0,47.0,50.0,45.0,44.0,42.0,42.0,42.0,53.0,38.0,41.0,553.0
Mamit,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,119.0,116.0,86.0,92.0,97.0,91.0,78.0,99.0,97.0,107.0,98.0,95.0,1175.0
Mamit,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,121.0,99.0,85.0,97.0,68.0,91.0,70.0,105.0,74.0,92.0,91.0,87.0,1080.0
Mamit,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,118.0,99.0,83.0,102.0,68.0,91.0,70.0,105.0,74.0,92.0,91.0,86.0,1079.0
Mamit,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,28.0,22.0,14.0,26.0,22.0,25.0,12.0,26.0,18.0,20.0,23.0,20.0,256.0
Mamit,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,35.0,25.0,14.0,29.0,23.0,23.0,15.0,28.0,25.0,24.0,26.0,18.0,285.0
Mamit,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,63.0,47.0,28.0,55.0,45.0,48.0,27.0,54.0,43.0,44.0,49.0,38.0,541.0
Mamit,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,19.0,70.0,40.0,41.0,85.0,51.0,30.0,98.0,67.0,22.0,87.0,57.0,667.0
Mamit,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,65.0,65.0,60.0,189.0,136.0,70.0,28.0,57.0,47.0,25.0,135.0,80.0,957.0
Mamit,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,42.0,45.0,39.0,178.0,80.0,35.0,83.0,37.0,109.0,98.0,77.0,72.0,895.0
Mamit,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mamit,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,74.0,66.0,63.0,62.0,56.0,58.0,63.0,66.0,65.0,62.0,62.0,64.0,761.0
Mamit,10.4.2,Number of Immunisation sessions held during the month,TOTAL,73.0,66.0,62.0,57.0,51.0,53.0,58.0,60.0,62.0,53.0,58.0,58.0,711.0
Mamit,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,51.0,56.0,48.0,43.0,38.0,42.0,46.0,48.0,46.0,39.0,45.0,41.0,543.0
Mamit,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,111.0,112.0,88.0,89.0,98.0,97.0,85.0,95.0,95.0,113.0,95.0,78.0,1156.0
Mamit,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,62.0,70.0,60.0,94.0,80.0,88.0,69.0,77.0,60.0,89.0,85.0,62.0,896.0
Mamit,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,37.0,67.0,43.0,63.0,67.0,51.0,50.0,52.0,74.0,48.0,62.0,70.0,684.0
Mamit,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,18.0,12.0,6.0,8.0,24.0,20.0,9.0,6.0,8.0,1.0,1.0,5.0,118.0
Mamit,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,78.0,75.0,97.0,83.0,95.0,69.0,68.0,49.0,59.0,48.0,57.0,92.0,870.0
Mamit,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,20.0,54.0,61.0,47.0,79.0,51.0,31.0,10.0,6.0,6.0,2.0,2.0,369.0
Mamit,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,19.0,24.0,47.0,59.0,44.0,40.0,13.0,12.0,16.0,15.0,31.0,41.0,361.0
Mamit,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,13.3,Number of School children detected with Refractive errors,TOTAL,12.0,10.0,7.0,19.0,13.0,19.0,14.0,8.0,8.0,6.0,7.0,0.0,123.0
Mamit,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Mamit,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,1.0,2.0,2.0,2.0,2.0,2.0,1.0,2.0,1.0,1.0,1.0,-1.0
Mamit,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Mamit,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,32.0,33.0,33.0,32.0,40.0,36.0,32.0,33.0,35.0,23.0,25.0,26.0,-1.0
Mamit,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Mamit,14.05,Number of RKS meetings held during the month,TOTAL,4.0,2.0,3.0,2.0,2.0,3.0,1.0,2.0,2.0,4.0,5.0,3.0,33.0
Mamit,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,5.0,5.0,5.0,6.0,5.0,4.0,4.0,5.0,4.0,4.0,4.0,-1.0
Mamit,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,11.0,17.0,23.0,16.0,3.0,14.0,12.0,6.0,1.0,4.0,4.0,2.0,113.0
Mamit,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Mamit,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Mamit,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Mamit,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Mamit,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Mamit,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,75.0,85.0,83.0,102.0,101.0,98.0,75.0,65.0,46.0,54.0,58.0,45.0,887.0
Mamit,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,104.0,94.0,87.0,105.0,122.0,94.0,90.0,95.0,64.0,48.0,74.0,57.0,1034.0
Mamit,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,69.0,89.0,93.0,77.0,81.0,82.0,59.0,60.0,51.0,47.0,64.0,53.0,825.0
Mamit,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,145.0,172.0,142.0,133.0,169.0,159.0,145.0,116.0,110.0,103.0,159.0,111.0,1664.0
Mamit,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,144.0,174.0,176.0,179.0,182.0,180.0,134.0,125.0,97.0,101.0,122.0,98.0,1712.0
Mamit,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,249.0,266.0,229.0,238.0,291.0,253.0,235.0,211.0,174.0,151.0,233.0,168.0,2698.0
Mamit,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,5.0,4.0,5.0,4.0,4.0,5.0,5.0,4.0,1.0,4.0,3.0,50.0
Mamit,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,2.0,2.0,2.0,3.0,3.0,4.0,0.0,5.0,2.0,2.0,1.0,30.0
Mamit,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10.0,7.0,6.0,7.0,7.0,7.0,9.0,5.0,9.0,3.0,6.0,4.0,80.0
Mamit,14.11,In-Patient Head Count at midnight,TOTAL,579.0,673.0,642.0,722.0,1506.0,1220.0,1033.0,1041.0,730.0,616.0,1045.0,689.0,10496.0
Mamit,14.12.1,OPD attendance (All),TOTAL,5694.0,6913.0,8569.0,8087.0,7745.0,6554.0,6967.0,6756.0,5078.0,4295.0,5554.0,5831.0,78043.0
Mamit,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,4.0,8.0,7.0,13.0,8.0,3.0,5.0,5.0,2.0,3.0,4.0,2.0,64.0
Mamit,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Mamit,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,184.0,217.0,188.0,177.0,194.0,161.0,210.0,213.0,177.0,208.0,192.0,175.0,2296.0
Mamit,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Mamit,14.14.a,Number of patients given AYUSH treatment,TOTAL,34.0,51.0,174.0,153.0,163.0,172.0,164.0,375.0,205.0,121.0,145.0,123.0,1880.0
Mamit,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,103.0,84.0,151.0,144.0,170.0,176.0,92.0,152.0,92.0,103.0,156.0,170.0,1593.0
Mamit,14.14.c,Number of Adolescents counselled,TOTAL,11.0,11.0,32.0,57.0,108.0,159.0,120.0,68.0,44.0,36.0,124.0,160.0,930.0
Mamit,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Mamit,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,227.0,508.0,418.0,530.0,532.0,447.0,438.0,386.0,355.0,212.0,330.0,328.0,4711.0
Mamit,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,9.0,11.0,6.0,4.0,11.0,6.0,13.0,4.0,7.0,4.0,3.0,9.0,87.0
Mamit,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,74.0,126.0,105.0,96.0,89.0,86.0,120.0,111.0,87.0,52.0,75.0,129.0,1150.0
Mamit,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,3.0,2.0,0.0,2.0,3.0,0.0,3.0,1.0,2.0,0.0,3.0,20.0
Mamit,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,50.0,55.0,40.0,49.0,52.0,43.0,36.0,52.0,55.0,96.0,51.0,46.0,625.0
Mamit,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,7.0
Mamit,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,72.0,106.0,85.0,69.0,93.0,73.0,76.0,62.0,61.0,36.0,112.0,137.0,982.0
Mamit,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,1.0,4.0
Mamit,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,196.0,287.0,230.0,214.0,234.0,202.0,232.0,225.0,203.0,184.0,238.0,312.0,2757.0
Mamit,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,3.0,3.0,1.0,3.0,6.0,0.0,3.0,2.0,3.0,0.0,6.0,31.0
Mamit,15.2,Number of Widal tests conducted,Number tested,147.0,154.0,160.0,165.0,205.0,147.0,170.0,168.0,110.0,55.0,92.0,62.0,1635.0
Mamit,15.3.a,Number of VDRL tests conducted on males,Number tested,16.0,22.0,29.0,6.0,2.0,7.0,16.0,32.0,12.0,10.0,23.0,17.0,192.0
Mamit,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,7.0,6.0,9.0,5.0,2.0,47.0,11.0,9.0,7.0,45.0,9.0,32.0,189.0
Mamit,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,39.0,71.0,53.0,46.0,60.0,46.0,45.0,47.0,36.0,26.0,101.0,120.0,690.0
Mamit,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,62.0,99.0,91.0,57.0,64.0,100.0,72.0,88.0,55.0,81.0,133.0,169.0,1071.0
Mamit,15.4.1,Number of blood smears examined for Malaria,TOTAL,355.0,745.0,642.0,799.0,1109.0,693.0,918.0,733.0,323.0,203.0,279.0,218.0,7017.0
Mamit,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,37.0,49.0,50.0,11.0,1.0,4.0,2.0,29.0,1.0,0.0,0.0,0.0,184.0
Mamit,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,7.0,106.0,110.0,137.0,232.0,196.0,127.0,5.0,3.0,2.0,0.0,2.0,927.0
Mamit,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1060.0,550.0,790.0,,,,,,,,,,2400.0
Mamit,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,500.0,200.0,,,,,,,,,,700.0
Mamit,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,410.0,260.0,250.0,,,,,,,,,,920.0
Mamit,16.1.1,Stock position of DPT vaccines,5. Total Stock,650.0,790.0,740.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2180.0
Mamit,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,180.0,500.0,1740.0,,,,,,,,,,2420.0
Mamit,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,800.0,1500.0,1000.0,,,,,,,,,,3300.0
Mamit,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,580.0,260.0,590.0,,,,,,,,,,1430.0
Mamit,16.1.1A,Stock Position of Pentavalent,5. Total Stock,400.0,1740.0,2150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4290.0
Mamit,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1260.0,860.0,2140.0,,,,,,,,,,4260.0
Mamit,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,1800.0,1000.0,,,,,,,,,,2800.0
Mamit,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,830.0,520.0,980.0,,,,,,,,,,2330.0
Mamit,16.1.2,Stock position of OPV vaccines,5. Total Stock,430.0,2140.0,2160.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4730.0
Mamit,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1460.0,2810.0,2660.0,,,,,,,,,,6930.0
Mamit,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.3,Stock position of TT vaccines,4. Stock Distributed,460.0,150.0,500.0,,,,,,,,,,1110.0
Mamit,16.1.3,Stock position of TT vaccines,5. Total Stock,1000.0,2660.0,2160.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5820.0
Mamit,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3040.0,2750.0,2160.0,,,,,,,,,,7950.0
Mamit,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,490.0,590.0,550.0,,,,,,,,,,1630.0
Mamit,16.1.5,Stock position of BCG vaccines,5. Total Stock,2550.0,2160.0,1610.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6320.0
Mamit,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4080.0,4460.0,4230.0,,,,,,,,,,12770.0
Mamit,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,360.0,230.0,260.0,,,,,,,,,,850.0
Mamit,16.1.6,Stock position of Measles vaccines,5. Total Stock,3720.0,4230.0,3970.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11920.0
Mamit,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2150.0,3300.0,2500.0,,,,,,,,,,7950.0
Mamit,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,160.0,800.0,130.0,,,,,,,,,,1090.0
Mamit,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1990.0,2500.0,2370.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6860.0
Mamit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,300.0,0.0,0.0,,,,,,,,,,300.0
Mamit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0
Mamit,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,29460.0,2770.0,2770.0,,,,,,,,,,35000.0
Mamit,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,26690.0,0.0,920.0,,,,,,,,,,27610.0
Mamit,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,2770.0,2770.0,1850.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7390.0
Mamit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,19100.0,8150.0,8150.0,,,,,,,,,,35400.0
Mamit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,10950.0,0.0,400.0,,,,,,,,,,11350.0
Mamit,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,8150.0,8150.0,7750.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24050.0
Mamit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1597.0,50.0,50.0,,,,,,,,,,1697.0
Mamit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,1547.0,0.0,0.0,,,,,,,,,,1547.0
Mamit,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,50.0,50.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0
Mamit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,100.0,100.0,100.0,,,,,,,,,,300.0
Mamit,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,100.0,100.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0
Mamit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,39600.0,600.0,600.0,,,,,,,,,,40800.0
Mamit,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,39000.0,0.0,0.0,,,,,,,,,,39000.0
Mamit,16.3.07,Stock Position of IFA Tablets,5. Total Stock,600.0,600.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0
Mamit,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,1735.0,0.0,0.0,,,,,,,,,,1735.0
Mamit,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,1735.0,0.0,0.0,,,,,,,,,,1735.0
Mamit,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,18.0,5.0,0.0,,,,,,,,,,23.0
Mamit,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,13.0,5.0,0.0,,,,,,,,,,18.0
Mamit,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Mamit,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,15.0,0.0,0.0,,,,,,,,,,15.0
Mamit,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,15.0,0.0,0.0,,,,,,,,,,15.0
Mamit,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Mamit,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mamit,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Mamit,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,1.0,,1.0,,1.0,,1.0,1.0,6.0
Mamit,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mamit,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,1.0,,1.0,,1.0,,1.0,1.0,6.0
Mamit,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
Mamit,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mamit,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,,,,,,,1.0
Mamit,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mamit,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mamit,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Mamit,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,,,,,1.0,,,,,2.0
Mamit,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mamit,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,,,,,1.0,,,,,2.0
Mamit,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,1.0,,,1.0,,1.0,,4.0
Mamit,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mamit,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,,1.0,,,1.0,,1.0,,4.0
Mamit,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Mamit,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mamit,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,,,,,,,,1.0
Mamit,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,,,,,,,2.0,1.0,,4.0
Mamit,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,,,,1.0,,,,2.0
Mamit,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,1.0,,,,,1.0,2.0,1.0,,6.0
Mamit,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mamit,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Mamit,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,1.0,,,,,,,,,,,,1.0
Mamit,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,1.0,,,,,,,,,1.0,3.0
Mamit,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Mamit,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,1.0,1.0,,,,,,,,1.0,4.0
Mamit,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,2.0,,,,,,,,,,,,2.0
Mamit,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Mamit,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Mamit,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,,,,,,,,,,,2.0
Mamit,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Mamit,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Mamit,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,,,,,,1.0,,,,2.0
Mamit,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,1.0,,1.0,1.0,,2.0,,,,6.0
Mamit,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,2.0,1.0,,,1.0,,1.0,,1.0,7.0
Mamit,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,,1.0,3.0,1.0,1.0,1.0,1.0,2.0,1.0,,1.0,13.0
Mamit,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,1.0,1.0,,,,,,2.0
Mamit,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,1.0,,1.0,1.0,1.0,,,,,,5.0
Mamit,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Mamit,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,1.0,,1.0,2.0,2.0,,,,,,7.0
Mamit,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,,,1.0,1.0,1.0,,,,4.0
Mamit,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,2.0,,,1.0,3.0,1.0,,1.0,2.0,1.0,11.0
Mamit,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,2.0,1.0,,1.0,,,,1.0,,6.0
Mamit,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,2.0,2.0,2.0,1.0,1.0,5.0,2.0,1.0,1.0,3.0,1.0,21.0
Mamit,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Mamit,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Mamit,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Mamit,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,1.0,,,1.0,,,1.0,1.0,1.0,1.0,,6.0
Mamit,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,,,,1.0,,,1.0,3.0,4.0,,10.0
Mamit,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,1.0,,,1.0,1.0,,1.0,2.0,4.0,5.0,,16.0
Mamit,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,1.0,,1.0,,2.0
Mamit,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,1.0,,,1.0,,,,,,3.0
Mamit,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,1.0,1.0,,,1.0,,1.0,,1.0,,5.0
Mamit,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mamit,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mamit,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mamit,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Mamit,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mamit,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,,,1.0
Mamit,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Mamit,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mamit,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Mamit,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Mamit,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mamit,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Mamit,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mamit,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mamit,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mamit,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Mamit,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mamit,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,1.0,,,,1.0
Mamit,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Mamit,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,1.0,,1.0,1.0,1.0,1.0,,1.0,,1.0,,7.0
Mamit,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,,,,,2.0,,,2.0,,1.0,6.0
Mamit,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,1.0,,1.0,1.0,1.0,3.0,,1.0,3.0,1.0,1.0,14.0
Mamit,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,1.0,,,,1.0,1.0,1.0,,4.0
Mamit,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,1.0,1.0,,,2.0
Mamit,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,1.0,,,,2.0,2.0,1.0,,6.0
Mamit,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Mamit,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Mamit,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,1.0,,,,,,1.0
Mamit,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Mamit,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,1.0,,1.0,,1.0,,,1.0,4.0,1.0,11.0
Mamit,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,,,,,,1.0,1.0,,1.0,,1.0,6.0
Mamit,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,1.0,1.0,,1.0,,2.0,1.0,,2.0,4.0,2.0,17.0
Mamit,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,2.0,,,1.0,,,,,,3.0
Mamit,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,2.0,5.0,6.0,3.0,5.0,2.0,3.0,6.0,4.0,2.0,39.0
Mamit,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,6.0,5.0,2.0,6.0,3.0,6.0,3.0,4.0,8.0,5.0,6.0,59.0
Mamit,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,7.0,7.0,9.0,12.0,6.0,12.0,5.0,7.0,14.0,9.0,8.0,101.0
Mamit,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,1.0,,,1.0,2.0,,,,4.0
Mamit,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,1.0,1.0,2.0,1.0,2.0,1.0,2.0,,1.0,2.0,2.0,16.0
Mamit,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,8.0,1.0,2.0,3.0,6.0,3.0,2.0,,2.0,2.0,3.0,3.0,35.0
Mamit,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,9.0,2.0,3.0,5.0,8.0,5.0,3.0,3.0,4.0,3.0,5.0,5.0,55.0
Saiha,1.1,Total number of pregnant women Registered for ANC,TOTAL,132.0,125.0,120.0,126.0,132.0,102.0,85.0,109.0,124.0,77.0,136.0,141.0,1409.0
Saiha,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,89.0,88.0,84.0,95.0,104.0,78.0,66.0,75.0,83.0,49.0,97.0,100.0,1008.0
Saiha,1.2,Number of Pregnant women registered under JSY,TOTAL,118.0,107.0,80.0,98.0,101.0,82.0,76.0,74.0,82.0,44.0,84.0,100.0,1046.0
Saiha,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,65.0,87.0,78.0,82.0,79.0,78.0,94.0,77.0,83.0,66.0,62.0,87.0,938.0
Saiha,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,52.0,61.0,48.0,47.0,61.0,56.0,39.0,58.0,75.0,22.0,74.0,55.0,648.0
Saiha,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,86.0,93.0,110.0,79.0,90.0,106.0,108.0,77.0,125.0,50.0,101.0,106.0,1131.0
Saiha,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,77.0,99.0,83.0,100.0,98.0,103.0,95.0,63.0,88.0,51.0,63.0,81.0,1001.0
Saiha,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,5.0,0.0,0.0,0.0,1.0,1.0,8.0
Saiha,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Saiha,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,112.0,123.0,115.0,115.0,147.0,114.0,109.0,115.0,122.0,71.0,104.0,141.0,1388.0
Saiha,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Saiha,1.8,Number of pregnancy test kits used at SC level,TOTAL,53.0,70.0,83.0,87.0,73.0,83.0,53.0,55.0,43.0,25.0,26.0,36.0,687.0
Saiha,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,10.0,3.0,9.0,6.0,10.0,17.0,11.0,18.0,9.0,11.0,15.0,13.0,132.0
Saiha,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,35.0,36.0,24.0,20.0,13.0,13.0,11.0,14.0,13.0,27.0,20.0,16.0,242.0
Saiha,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,45.0,39.0,33.0,26.0,23.0,30.0,22.0,32.0,22.0,38.0,35.0,29.0,374.0
Saiha,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,36.0,30.0,20.0,14.0,14.0,23.0,17.0,18.0,18.0,21.0,27.0,12.0,250.0
Saiha,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,74.0,73.0,65.0,63.0,67.0,79.0,85.0,67.0,75.0,81.0,60.0,89.0,878.0
Saiha,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,67.0,63.0,53.0,52.0,59.0,68.0,78.0,47.0,55.0,67.0,47.0,69.0,725.0
Saiha,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,2.0,4.0,10.0,8.0,10.0,12.0,17.0,1.0,2.0,0.0,5.0,4.0,75.0
Saiha,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Saiha,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,5.0,7.0,7.0,7.0,5.0,7.0,6.0,10.0,12.0,12.0,12.0,18.0,108.0
Saiha,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saiha,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,5.0,7.0,7.0,7.0,5.0,7.0,6.0,10.0,12.0,12.0,12.0,18.0,108.0
Saiha,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,1.0,2.0,4.0,6.0,6.0,9.0,9.0,0.0,0.0,0.0,3.0,0.0,40.0
Saiha,4.1.1.a,Number of male live births,TOTAL,60.0,54.0,63.0,62.0,46.0,68.0,62.0,60.0,48.0,65.0,52.0,55.0,695.0
Saiha,4.1.1.b,Number of female live births,TOTAL,61.0,62.0,43.0,35.0,53.0,53.0,61.0,39.0,47.0,54.0,49.0,67.0,624.0
Saiha,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,121.0,116.0,106.0,97.0,99.0,121.0,123.0,99.0,95.0,119.0,101.0,122.0,1319.0
Saiha,4.1.2,Number of still births,TOTAL,0.0,0.0,2.0,0.0,1.0,0.0,1.0,1.0,4.0,0.0,0.0,0.0,9.0
Saiha,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,4.0,6.0,8.0,7.0,8.0,6.0,9.0,6.0,6.0,7.0,4.0,7.0,78.0
Saiha,4.2.1,Number of Newborns weighed at birth,TOTAL,121.0,116.0,104.0,96.0,96.0,115.0,122.0,94.0,92.0,119.0,93.0,119.0,1287.0
Saiha,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,3.0,1.0,4.0,6.0,3.0,2.0,3.0,0.0,4.0,3.0,3.0,2.0,34.0
Saiha,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,112.0,116.0,103.0,95.0,96.0,117.0,119.0,94.0,90.0,119.0,93.0,115.0,1269.0
Saiha,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Saiha,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,18.0,15.0,18.0,10.0,11.0,15.0,7.0,12.0,15.0,15.0,15.0,20.0,171.0
Saiha,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saiha,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,18.0,15.0,18.0,10.0,11.0,15.0,7.0,12.0,15.0,15.0,15.0,20.0,171.0
Saiha,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,10.0,11.0,13.0,5.0,7.0,10.0,5.0,7.0,0.0,10.0,10.0,15.0,103.0
Saiha,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3.0,0.0,2.0,1.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,9.0
Saiha,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,5.0,4.0,2.0,4.0,4.0,4.0,2.0,3.0,5.0,4.0,3.0,3.0,43.0
Saiha,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,2.0,6.0
Saiha,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,100.0,100.0,90.0,80.0,88.0,113.0,115.0,80.0,91.0,95.0,80.0,108.0,1140.0
Saiha,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,68.0,69.0,47.0,36.0,57.0,93.0,60.0,45.0,58.0,94.0,62.0,54.0,743.0
Saiha,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Saiha,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,18.0,20.0,58.0,39.0,39.0,40.0,26.0,24.0,25.0,10.0,11.0,20.0,330.0
Saiha,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2.0,48.0,18.0,16.0,45.0,47.0,10.0,5.0,5.0,4.0,13.0,9.0,222.0
Saiha,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,20.0,68.0,76.0,55.0,84.0,87.0,36.0,29.0,30.0,14.0,24.0,29.0,552.0
Saiha,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saiha,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saiha,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saiha,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saiha,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Saiha,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saiha,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,2.0,6.0,3.0,4.0,3.0,4.0,2.0,10.0,6.0,5.0,3.0,9.0,57.0
Saiha,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saiha,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,3.0,6.0,3.0,4.0,3.0,4.0,2.0,10.0,6.0,5.0,3.0,9.0,58.0
Saiha,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,1.0,1.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,10.0
Saiha,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saiha,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,2.0,3.0,2.0,1.0,2.0,1.0,3.0,2.0,4.0,0.0,5.0,25.0
Saiha,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saiha,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,2.0,3.0,2.0,1.0,2.0,1.0,3.0,2.0,4.0,0.0,5.0,25.0
Saiha,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1.0,3.0,4.0,1.0,6.0,3.0,1.0,2.0,6.0,1.0,1.0,1.0,30.0
Saiha,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Saiha,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,15.0,10.0,23.0,23.0,15.0,13.0,11.0,23.0,19.0,7.0,15.0,16.0,190.0
Saiha,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Saiha,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,16.0,13.0,27.0,24.0,21.0,16.0,12.0,25.0,25.0,8.0,16.0,17.0,220.0
Saiha,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Saiha,9.06,Number of IUCD removals,TOTAL,5.0,3.0,5.0,8.0,5.0,7.0,9.0,6.0,7.0,5.0,7.0,2.0,69.0
Saiha,9.07,Number of Oral Pills cycles distributed,TOTAL,209.0,296.0,286.0,223.0,266.0,286.0,206.0,238.0,293.0,255.0,322.0,328.0,3208.0
Saiha,9.08,Number of Condom pieces distributed,TOTAL,200.0,351.0,295.0,358.0,383.0,378.0,248.0,206.0,231.0,214.0,276.0,140.0,3280.0
Saiha,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,3.0,0.0,6.0,1.0,4.0,6.0,6.0,3.0,11.0,9.0,49.0
Saiha,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Saiha,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,146.0,92.0,157.0,79.0,105.0,103.0,136.0,95.0,136.0,102.0,145.0,127.0,1423.0
Saiha,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,11.0
Saiha,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,6.0,0.0,1.0,1.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,11.0
Saiha,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,15.0,9.0,0.0,0.0,0.0,0.0,3.0,9.0,2.0,0.0,0.0,0.0,38.0
Saiha,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,113.0,54.0,93.0,73.0,83.0,96.0,93.0,87.0,173.0,49.0,126.0,96.0,1136.0
Saiha,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,93.0,73.0,64.0,79.0,103.0,74.0,108.0,54.0,147.0,73.0,118.0,96.0,1082.0
Saiha,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,85.0,92.0,75.0,53.0,87.0,92.0,100.0,71.0,111.0,61.0,126.0,90.0,1043.0
Saiha,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,56.0,57.0,55.0,52.0,49.0,66.0,68.0,60.0,59.0,63.0,47.0,71.0,703.0
Saiha,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,107.0,70.0,61.0,74.0,79.0,98.0,82.0,90.0,180.0,49.0,126.0,95.0,1111.0
Saiha,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,103.0,86.0,45.0,80.0,100.0,76.0,100.0,54.0,158.0,73.0,118.0,96.0,1089.0
Saiha,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,90.0,89.0,60.0,53.0,84.0,91.0,95.0,75.0,99.0,61.0,126.0,90.0,1013.0
Saiha,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,56.0,58.0,55.0,46.0,43.0,61.0,62.0,52.0,53.0,52.0,47.0,71.0,656.0
Saiha,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Saiha,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,6.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Saiha,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,15.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Saiha,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,92.0,79.0,79.0,76.0,106.0,102.0,79.0,62.0,133.0,64.0,104.0,79.0,1055.0
Saiha,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,55.0,71.0,74.0,53.0,76.0,56.0,82.0,71.0,95.0,59.0,110.0,62.0,864.0
Saiha,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,38.0,43.0,37.0,45.0,49.0,50.0,49.0,36.0,74.0,39.0,51.0,33.0,544.0
Saiha,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,35.0,44.0,42.0,30.0,57.0,52.0,30.0,26.0,59.0,25.0,53.0,46.0,499.0
Saiha,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,73.0,87.0,79.0,75.0,106.0,102.0,79.0,62.0,133.0,64.0,104.0,79.0,1043.0
Saiha,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,58.0,82.0,63.0,60.0,69.0,56.0,86.0,71.0,92.0,59.0,102.0,45.0,843.0
Saiha,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,58.0,79.0,61.0,60.0,69.0,56.0,86.0,69.0,92.0,59.0,103.0,61.0,853.0
Saiha,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,14.0,18.0,5.0,8.0,2.0,1.0,17.0,5.0,4.0,2.0,10.0,0.0,86.0
Saiha,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,15.0,23.0,8.0,11.0,2.0,3.0,15.0,3.0,9.0,2.0,4.0,3.0,98.0
Saiha,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,29.0,41.0,13.0,19.0,4.0,4.0,32.0,8.0,13.0,4.0,14.0,3.0,184.0
Saiha,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,53.0,112.0,85.0,113.0,14.0,8.0,58.0,18.0,30.0,9.0,29.0,13.0,542.0
Saiha,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,44.0,70.0,38.0,88.0,9.0,7.0,71.0,5.0,36.0,12.0,12.0,6.0,398.0
Saiha,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,28.0,22.0,36.0,54.0,14.0,11.0,23.0,4.0,24.0,15.0,5.0,2.0,238.0
Saiha,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,2.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,10.0
Saiha,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,9.0,25.0,31.0,5.0,10.0,10.0,28.0,5.0,13.0,8.0,18.0,8.0,170.0
Saiha,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,43.0,43.0,30.0,35.0,42.0,43.0,34.0,35.0,44.0,32.0,41.0,34.0,456.0
Saiha,10.4.2,Number of Immunisation sessions held during the month,TOTAL,42.0,38.0,25.0,27.0,35.0,33.0,32.0,30.0,42.0,24.0,34.0,30.0,392.0
Saiha,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,28.0,25.0,18.0,24.0,26.0,32.0,25.0,12.0,39.0,21.0,28.0,27.0,305.0
Saiha,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,61.0,62.0,61.0,54.0,87.0,103.0,62.0,61.0,124.0,75.0,74.0,51.0,875.0
Saiha,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,14.0,22.0,59.0,27.0,36.0,35.0,43.0,38.0,59.0,22.0,35.0,19.0,409.0
Saiha,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,11.0,17.0,16.0,7.0,18.0,16.0,87.0,24.0,30.0,21.0,31.0,13.0,291.0
Saiha,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,1.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,6.0
Saiha,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,48.0,30.0,33.0,50.0,59.0,24.0,20.0,28.0,24.0,20.0,49.0,66.0,451.0
Saiha,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,4.0,8.0,5.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,21.0
Saiha,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,3.0,5.0,21.0,17.0,13.0,6.0,4.0,6.0,0.0,8.0,5.0,94.0
Saiha,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Saiha,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Saiha,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,22.0,29.0,21.0,38.0,41.0,30.0,31.0,41.0,39.0,17.0,28.0,24.0,-1.0
Saiha,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Saiha,14.05,Number of RKS meetings held during the month,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,12.0
Saiha,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Saiha,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1.0,1.0,1.0,1.0,1.0,3.0,4.0,4.0,4.0,4.0,4.0,4.0,32.0
Saiha,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Saiha,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Saiha,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Saiha,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Saiha,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Saiha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,96.0,100.0,118.0,99.0,83.0,68.0,80.0,71.0,59.0,52.0,70.0,84.0,980.0
Saiha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,157.0,169.0,173.0,145.0,123.0,140.0,129.0,112.0,105.0,123.0,110.0,127.0,1613.0
Saiha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,111.0,110.0,99.0,112.0,97.0,92.0,87.0,94.0,116.0,50.0,74.0,101.0,1143.0
Saiha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,169.0,192.0,186.0,172.0,138.0,138.0,159.0,122.0,128.0,118.0,157.0,156.0,1835.0
Saiha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,207.0,210.0,217.0,211.0,180.0,160.0,167.0,165.0,175.0,102.0,144.0,185.0,2123.0
Saiha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,326.0,361.0,359.0,317.0,261.0,278.0,288.0,234.0,233.0,241.0,267.0,283.0,3448.0
Saiha,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,5.0,3.0,7.0,2.0,4.0,4.0,8.0,3.0,9.0,10.0,7.0,70.0
Saiha,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,2.0,3.0,2.0,4.0,0.0,0.0,3.0,4.0,6.0,3.0,5.0,35.0
Saiha,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,11.0,7.0,6.0,9.0,6.0,4.0,4.0,11.0,7.0,15.0,13.0,12.0,105.0
Saiha,14.11,In-Patient Head Count at midnight,TOTAL,1886.0,2149.0,2302.0,2180.0,1855.0,1774.0,1896.0,1635.0,1608.0,1122.0,1433.0,1656.0,21496.0
Saiha,14.12.1,OPD attendance (All),TOTAL,2753.0,3429.0,3925.0,3829.0,4433.0,3771.0,3270.0,3232.0,2968.0,2077.0,3305.0,3005.0,39997.0
Saiha,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,12.0,29.0,37.0,25.0,23.0,15.0,23.0,31.0,21.0,16.0,26.0,34.0,292.0
Saiha,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Saiha,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,27.0,76.0,84.0,45.0,50.0,72.0,69.0,37.0,57.0,33.0,50.0,42.0,642.0
Saiha,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Saiha,14.14.a,Number of patients given AYUSH treatment,TOTAL,713.0,832.0,853.0,712.0,827.0,852.0,737.0,759.0,832.0,637.0,743.0,712.0,9209.0
Saiha,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,72.0,113.0,138.0,103.0,113.0,110.0,112.0,107.0,99.0,58.0,62.0,50.0,1137.0
Saiha,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,17.0,7.0,87.0,2.0,3.0,3.0,3.0,3.0,125.0
Saiha,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Saiha,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,278.0,379.0,374.0,404.0,366.0,362.0,294.0,262.0,305.0,222.0,262.0,238.0,3746.0
Saiha,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,5.0,12.0,20.0,22.0,16.0,18.0,14.0,7.0,11.0,6.0,6.0,8.0,145.0
Saiha,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,46.0,47.0,59.0,47.0,43.0,40.0,27.0,25.0,19.0,13.0,11.0,24.0,401.0
Saiha,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,2.0,1.0,2.0,1.0,2.0,0.0,1.0,2.0,2.0,2.0,17.0
Saiha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,42.0,2.0,14.0,2.0,7.0,2.0,7.0,5.0,11.0,4.0,13.0,6.0,115.0
Saiha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,5.0
Saiha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3.0,40.0,62.0,40.0,80.0,47.0,62.0,50.0,62.0,26.0,52.0,85.0,609.0
Saiha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,1.0,4.0
Saiha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,91.0,89.0,135.0,89.0,130.0,89.0,96.0,80.0,92.0,43.0,76.0,115.0,1125.0
Saiha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,1.0,2.0,1.0,5.0,1.0,4.0,0.0,2.0,3.0,3.0,3.0,26.0
Saiha,15.2,Number of Widal tests conducted,Number tested,55.0,84.0,123.0,123.0,120.0,68.0,93.0,63.0,53.0,25.0,19.0,44.0,870.0
Saiha,15.3.a,Number of VDRL tests conducted on males,Number tested,18.0,20.0,57.0,39.0,38.0,40.0,26.0,24.0,25.0,10.0,11.0,19.0,327.0
Saiha,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,48.0,14.0,13.0,70.0,45.0,6.0,5.0,3.0,4.0,13.0,4.0,227.0
Saiha,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,32.0,32.0,50.0,52.0,42.0,40.0,52.0,47.0,53.0,26.0,40.0,61.0,527.0
Saiha,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,52.0,100.0,121.0,104.0,150.0,125.0,84.0,76.0,81.0,40.0,64.0,84.0,1081.0
Saiha,15.4.1,Number of blood smears examined for Malaria,TOTAL,74.0,169.0,195.0,215.0,257.0,164.0,148.0,93.0,88.0,58.0,63.0,137.0,1661.0
Saiha,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,4.0,3.0,4.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Saiha,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,4.0,3.0,12.0,3.0,2.0,2.0,0.0,0.0,4.0,4.0,0.0,0.0,34.0
Saiha,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3150.0,0.0,,270.0,200.0,500.0,430.0,1010.0,740.0,,,,6300.0
Saiha,16.1.1,Stock position of DPT vaccines,2. Stocks Received,500.0,500.0,,0.0,500.0,0.0,800.0,0.0,0.0,,,,2300.0
Saiha,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,3010.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,3010.0
Saiha,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,140.0,0.0,,70.0,200.0,70.0,220.0,270.0,0.0,,,,970.0
Saiha,16.1.1,Stock position of DPT vaccines,5. Total Stock,500.0,500.0,0.0,200.0,500.0,430.0,1010.0,740.0,740.0,0.0,0.0,0.0,4620.0
Saiha,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,780.0,,,,780.0
Saiha,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,2000.0,,,,2000.0
Saiha,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,0.0,,,,0.0
Saiha,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,0.0,,,,0.0
Saiha,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2780.0,0.0,0.0,0.0,2780.0
Saiha,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1160.0,800.0,,1500.0,1080.0,2720.0,2340.0,2620.0,1680.0,,,,13900.0
Saiha,16.1.2,Stock position of OPV vaccines,2. Stocks Received,7800.0,0.0,,0.0,2000.0,0.0,800.0,0.0,2000.0,,,,12600.0
Saiha,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,500.0,,,,500.0
Saiha,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7800.0,800.0,,580.0,360.0,380.0,520.0,940.0,1180.0,,,,12560.0
Saiha,16.1.2,Stock position of OPV vaccines,5. Total Stock,1160.0,0.0,0.0,920.0,2720.0,2340.0,2620.0,1680.0,2000.0,0.0,0.0,0.0,13440.0
Saiha,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2210.0,1780.0,,1310.0,1020.0,1860.0,1670.0,1410.0,900.0,,,,12160.0
Saiha,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,,0.0,1000.0,0.0,0.0,0.0,2000.0,,,,3000.0
Saiha,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.3,Stock position of TT vaccines,4. Stock Distributed,430.0,240.0,,290.0,160.0,190.0,260.0,510.0,360.0,,,,2440.0
Saiha,16.1.3,Stock position of TT vaccines,5. Total Stock,1780.0,1540.0,0.0,1020.0,1860.0,1670.0,1410.0,900.0,2540.0,0.0,0.0,0.0,12720.0
Saiha,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1610.0,1470.0,,1790.0,1350.0,1550.0,1090.0,990.0,600.0,,,,10450.0
Saiha,16.1.5,Stock position of BCG vaccines,2. Stocks Received,500.0,0.0,,0.0,500.0,0.0,300.0,0.0,2000.0,,,,3300.0
Saiha,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,640.0,280.0,,440.0,300.0,460.0,400.0,390.0,350.0,,,,3260.0
Saiha,16.1.5,Stock position of BCG vaccines,5. Total Stock,1470.0,1190.0,0.0,1350.0,1550.0,1090.0,990.0,600.0,2250.0,0.0,0.0,0.0,10490.0
Saiha,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1195.0,815.0,,870.0,630.0,935.0,740.0,490.0,230.0,,,,5905.0
Saiha,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,,0.0,500.0,0.0,0.0,0.0,2000.0,,,,2500.0
Saiha,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,380.0,230.0,,240.0,195.0,195.0,250.0,260.0,320.0,,,,2070.0
Saiha,16.1.6,Stock position of Measles vaccines,5. Total Stock,815.0,585.0,0.0,630.0,935.0,740.0,490.0,230.0,1910.0,0.0,0.0,0.0,6335.0
Saiha,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2170.0,2030.0,,1970.0,1930.0,890.0,850.0,800.0,750.0,,,,11390.0
Saiha,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,0.0,1000.0,0.0,0.0,0.0,0.0,,,,1000.0
Saiha,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,140.0,10.0,,40.0,40.0,40.0,50.0,50.0,200.0,,,,570.0
Saiha,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2030.0,2020.0,0.0,1930.0,890.0,850.0,800.0,750.0,550.0,0.0,0.0,0.0,9820.0
Saiha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,0.0,0.0,,,,,0.0
Saiha,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,,,0.0,0.0,0.0,0.0,,,,,0.0
Saiha,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,,,,,0.0
Saiha,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,,,,,0.0
Saiha,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Saiha,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,,,0.0,1500.0,1320.0,1195.0,1050.0,,,,5065.0
Saiha,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,,,1500.0,0.0,0.0,0.0,400.0,,,,1900.0
Saiha,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,,,200.0,180.0,125.0,145.0,96.0,,,,746.0
Saiha,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,1300.0,1320.0,1195.0,1050.0,1354.0,0.0,0.0,0.0,6219.0
Saiha,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,7671.0,6323.0,,2743.0,1942.0,11142.0,10392.0,9467.0,8736.0,,,,58416.0
Saiha,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,,0.0,10000.0,0.0,0.0,0.0,1000.0,,,,11000.0
Saiha,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,1348.0,760.0,,801.0,3000.0,750.0,925.0,731.0,696.0,,,,9011.0
Saiha,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6323.0,5563.0,0.0,1942.0,8942.0,10392.0,9467.0,8736.0,9040.0,0.0,0.0,0.0,60405.0
Saiha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,,195.0,115.0,500.0,370.0,305.0,151.0,,,,1636.0
Saiha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,,0.0,500.0,0.0,0.0,0.0,1000.0,,,,1500.0
Saiha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Saiha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,,80.0,200.0,130.0,65.0,154.0,112.0,,,,741.0
Saiha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,115.0,415.0,370.0,305.0,151.0,1039.0,0.0,0.0,0.0,2395.0
Saiha,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,1.0,,,,,1.0
Saiha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,1.0,,,,,,,,2.0
Saiha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saiha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,1.0,,,,,,,,2.0
Saiha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,,1.0,,,,,,,,,3.0
Saiha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saiha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,,1.0,,,,,,,,,3.0
Saiha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Saiha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saiha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Saiha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,,,,2.0,,,,,,3.0
Saiha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Saiha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,,,,2.0,,,,,,3.0
Saiha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,2.0,1.0,1.0,,,,1.0,,3.0,,,8.0
Saiha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Saiha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,2.0,1.0,1.0,,,,1.0,,4.0,,,9.0
Saiha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saiha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saiha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Saiha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,,1.0,,,,,,,,2.0
Saiha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saiha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,,1.0,,,,,,,,2.0
Saiha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Saiha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Saiha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Saiha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,2.0,1.0,2.0,,,1.0,,,3.0,,3.0,17.0
Saiha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Saiha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,2.0,1.0,2.0,,,1.0,,1.0,3.0,,3.0,18.0
Saiha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Saiha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Saiha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Saiha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Saiha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Saiha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,,,,,,,,,,1.0,,2.0
Saiha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Saiha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Saiha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,1.0,,,1.0
Saiha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Saiha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Saiha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Saiha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,1.0,,1.0,,,,1.0,,,4.0
Saiha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,1.0,,1.0,1.0,1.0,3.0,,,,,9.0
Saiha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,,,1.0,,,,,2.0
Saiha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,2.0,1.0,1.0,2.0,2.0,1.0,4.0,,1.0,,,15.0
Saiha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Saiha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Saiha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Saiha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,2.0,,3.0,,,5.0
Saiha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,1.0,2.0,,1.0,1.0,1.0,,,1.0,7.0
Saiha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,1.0,2.0,,1.0,3.0,1.0,3.0,,1.0,12.0
Saiha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Saiha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,,,,,,,,,,,,2.0
Saiha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,,,,1.0,,,,,,,,3.0
Saiha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Saiha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Saiha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Saiha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Saiha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Saiha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Saiha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Saiha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Saiha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Saiha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,1.0,,2.0
Saiha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Saiha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,1.0,,2.0
Saiha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Saiha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Saiha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Saiha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,,,,,,1.0,,,2.0
Saiha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Saiha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,,,,,,1.0,,,2.0
Saiha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Saiha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,,2.0,,,,,,1.0,2.0,1.0,3.0,10.0
Saiha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,1.0,,,,,,,,1.0,1.0,3.0
Saiha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,1.0,,4.0,,,,,,1.0,2.0,2.0,4.0,14.0
Saiha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,1.0,,,,,,,,1.0,,4.0
Saiha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Saiha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,1.0,1.0,,,,,,,,1.0,,4.0
Saiha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Saiha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Saiha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Saiha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Saiha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,,,,,,,,1.0,2.0
Saiha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,4.0,3.0,,2.0,1.0,1.0,4.0,2.0,7.0,2.0,2.0,30.0
Saiha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,2.0,1.0,1.0,1.0,,,2.0,4.0,2.0,5.0,,18.0
Saiha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,6.0,4.0,1.0,3.0,1.0,1.0,6.0,6.0,9.0,7.0,3.0,50.0
Saiha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,1.0,1.0,,,,2.0
Saiha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,,3.0,,2.0,3.0,2.0,2.0,2.0,3.0,1.0,19.0
Saiha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,4.0,2.0,2.0,,3.0,1.0,2.0,1.0,,4.0,4.0,25.0
Saiha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,4.0,2.0,5.0,,5.0,4.0,5.0,4.0,2.0,7.0,5.0,46.0
Saiha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Saiha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2.0,2.0,,2.0,2.0,2.0,,2.0,3.0,,6.0,3.0,24.0
Saiha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,4.0,3.0,5.0,6.0,8.0,4.0,5.0,7.0,2.0,2.0,6.0,6.0,58.0
Saiha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,6.0,5.0,5.0,8.0,10.0,6.0,5.0,9.0,5.0,3.0,12.0,9.0,83.0
Serchhip,1.1,Total number of pregnant women Registered for ANC,TOTAL,84.0,112.0,120.0,102.0,97.0,104.0,102.0,81.0,73.0,94.0,113.0,118.0,1200.0
Serchhip,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,70.0,96.0,103.0,84.0,85.0,82.0,84.0,54.0,56.0,79.0,93.0,96.0,982.0
Serchhip,1.2,Number of Pregnant women registered under JSY,TOTAL,73.0,101.0,111.0,89.0,87.0,89.0,88.0,48.0,57.0,80.0,95.0,96.0,1014.0
Serchhip,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,56.0,74.0,61.0,73.0,72.0,76.0,67.0,72.0,68.0,71.0,73.0,57.0,820.0
Serchhip,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,60.0,71.0,68.0,66.0,56.0,75.0,56.0,50.0,51.0,50.0,68.0,70.0,741.0
Serchhip,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,87.0,88.0,96.0,98.0,94.0,92.0,103.0,100.0,80.0,73.0,67.0,90.0,1068.0
Serchhip,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,47.0,60.0,67.0,42.0,36.0,39.0,32.0,84.0,84.0,60.0,70.0,68.0,689.0
Serchhip,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,6.0
Serchhip,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,28.0,71.0,67.0,66.0,57.0,58.0,38.0,111.0,42.0,32.0,53.0,48.0,671.0
Serchhip,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,2.0,1.0,0.0,0.0,8.0
Serchhip,1.8,Number of pregnancy test kits used at SC level,TOTAL,59.0,69.0,89.0,78.0,78.0,69.0,77.0,51.0,31.0,30.0,32.0,76.0,739.0
Serchhip,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,7.0
Serchhip,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,2.0,0.0,3.0,2.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Serchhip,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,4.0,1.0,4.0,2.0,1.0,3.0,0.0,1.0,1.0,0.0,1.0,0.0,18.0
Serchhip,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,1.0,3.0,1.0,1.0,2.0,0.0,1.0,0.0,0.0,1.0,0.0,12.0
Serchhip,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,72.0,53.0,57.0,62.0,49.0,78.0,42.0,51.0,66.0,81.0,70.0,56.0,737.0
Serchhip,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,45.0,38.0,42.0,42.0,29.0,58.0,31.0,29.0,52.0,62.0,47.0,40.0,515.0
Serchhip,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,16.0,23.0,13.0,11.0,4.0,113.0,42.0,19.0,18.0,7.0,4.0,0.0,270.0
Serchhip,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,11.0,15.0,4.0,11.0,4.0,96.0,1.0,0.0,1.0,0.0,0.0,0.0,143.0
Serchhip,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Serchhip,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Serchhip,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Serchhip,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Serchhip,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,4.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,11.0
Serchhip,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Serchhip,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,4.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,11.0
Serchhip,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Serchhip,4.1.1.a,Number of male live births,TOTAL,30.0,24.0,36.0,27.0,17.0,44.0,19.0,20.0,33.0,38.0,38.0,21.0,347.0
Serchhip,4.1.1.b,Number of female live births,TOTAL,46.0,30.0,24.0,37.0,33.0,37.0,23.0,28.0,34.0,40.0,32.0,35.0,399.0
Serchhip,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,76.0,54.0,60.0,64.0,50.0,81.0,42.0,48.0,67.0,78.0,70.0,56.0,746.0
Serchhip,4.1.2,Number of still births,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0,0.0,3.0,1.0,0.0,9.0
Serchhip,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,4.0,7.0,8.0,6.0,3.0,6.0,8.0,6.0,5.0,3.0,7.0,6.0,69.0
Serchhip,4.2.1,Number of Newborns weighed at birth,TOTAL,76.0,54.0,59.0,64.0,50.0,81.0,42.0,49.0,67.0,78.0,71.0,56.0,747.0
Serchhip,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,2.0,0.0,2.0,0.0,0.0,0.0,6.0,0.0,0.0,1.0,0.0,0.0,11.0
Serchhip,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,76.0,54.0,59.0,64.0,50.0,81.0,42.0,48.0,67.0,78.0,70.0,56.0,745.0
Serchhip,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Serchhip,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Serchhip,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,75.0,54.0,60.0,64.0,48.0,61.0,42.0,48.0,67.0,78.0,70.0,56.0,723.0
Serchhip,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,14.0,9.0,9.0,12.0,8.0,15.0,5.0,7.0,13.0,17.0,8.0,10.0,127.0
Serchhip,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,5.0,2.0,6.0,5.0,2.0,8.0,3.0,4.0,3.0,1.0,1.0,0.0,40.0
Serchhip,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,5.0,2.0,6.0,5.0,2.0,8.0,3.0,4.0,3.0,1.0,1.0,0.0,40.0
Serchhip,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Serchhip,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Serchhip,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Serchhip,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Serchhip,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0
Serchhip,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Serchhip,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Serchhip,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Serchhip,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Serchhip,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Serchhip,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Serchhip,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Serchhip,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,15.0,5.0,9.0,3.0,6.0,16.0,10.0,13.0,7.0,2.0,3.0,2.0,91.0
Serchhip,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Serchhip,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,15.0,5.0,9.0,3.0,6.0,16.0,10.0,13.0,7.0,2.0,3.0,2.0,91.0
Serchhip,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Serchhip,9.06,Number of IUCD removals,TOTAL,5.0,3.0,5.0,5.0,7.0,5.0,7.0,29.0,0.0,1.0,5.0,4.0,76.0
Serchhip,9.07,Number of Oral Pills cycles distributed,TOTAL,547.0,530.0,523.0,455.0,445.0,434.0,473.0,438.0,445.0,381.0,375.0,364.0,5410.0
Serchhip,9.08,Number of Condom pieces distributed,TOTAL,1230.0,920.0,731.0,630.0,650.0,377.0,441.0,241.0,318.0,158.0,114.0,338.0,6148.0
Serchhip,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,14.0,10.0,6.0,9.0,0.0,1.0,0.0,0.0,2.0,5.0,0.0,5.0,52.0
Serchhip,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Serchhip,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,90.0,62.0,72.0,76.0,69.0,89.0,88.0,76.0,68.0,89.0,77.0,77.0,933.0
Serchhip,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,103.0,75.0,81.0,69.0,71.0,78.0,83.0,105.0,91.0,81.0,76.0,86.0,999.0
Serchhip,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,72.0,102.0,76.0,81.0,73.0,78.0,71.0,92.0,100.0,88.0,79.0,71.0,983.0
Serchhip,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,96.0,69.0,98.0,73.0,82.0,77.0,72.0,70.0,83.0,96.0,70.0,94.0,980.0
Serchhip,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,35.0,19.0,19.0,28.0,28.0,34.0,31.0,36.0,36.0,40.0,47.0,24.0,377.0
Serchhip,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,103.0,75.0,81.0,69.0,71.0,78.0,83.0,105.0,91.0,81.0,76.0,86.0,999.0
Serchhip,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,72.0,102.0,76.0,81.0,73.0,78.0,71.0,92.0,100.0,88.0,79.0,71.0,983.0
Serchhip,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,96.0,69.0,98.0,73.0,82.0,77.0,72.0,70.0,83.0,96.0,70.0,94.0,980.0
Serchhip,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,25.0,19.0,19.0,28.0,28.0,32.0,31.0,35.0,34.0,26.0,42.0,22.0,341.0
Serchhip,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,97.0,102.0,77.0,82.0,88.0,86.0,81.0,76.0,86.0,59.0,83.0,69.0,986.0
Serchhip,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,99.0,78.0,75.0,60.0,55.0,89.0,84.0,86.0,79.0,56.0,71.0,82.0,914.0
Serchhip,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,45.0,39.0,36.0,44.0,46.0,45.0,40.0,37.0,37.0,31.0,39.0,37.0,476.0
Serchhip,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,50.0,44.0,39.0,36.0,38.0,39.0,35.0,39.0,47.0,26.0,41.0,30.0,464.0
Serchhip,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,95.0,83.0,75.0,80.0,84.0,84.0,75.0,76.0,84.0,57.0,80.0,67.0,940.0
Serchhip,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,97.0,77.0,84.0,61.0,50.0,102.0,77.0,91.0,77.0,64.0,83.0,83.0,946.0
Serchhip,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,97.0,77.0,84.0,61.0,60.0,93.0,76.0,91.0,79.0,62.0,83.0,83.0,946.0
Serchhip,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,9.0,8.0,9.0,3.0,9.0,11.0,9.0,12.0,12.0,3.0,12.0,6.0,103.0
Serchhip,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,8.0,13.0,8.0,6.0,7.0,18.0,5.0,19.0,9.0,8.0,14.0,12.0,127.0
Serchhip,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,17.0,21.0,17.0,9.0,16.0,29.0,14.0,31.0,21.0,11.0,26.0,18.0,230.0
Serchhip,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,26.0,30.0,31.0,30.0,27.0,53.0,47.0,107.0,32.0,19.0,99.0,52.0,553.0
Serchhip,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,36.0,48.0,37.0,45.0,53.0,49.0,50.0,259.0,80.0,27.0,55.0,51.0,790.0
Serchhip,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,41.0,30.0,45.0,34.0,39.0,33.0,51.0,32.0,40.0,25.0,74.0,26.0,470.0
Serchhip,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Serchhip,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Serchhip,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,48.0,46.0,46.0,47.0,48.0,45.0,46.0,46.0,47.0,46.0,47.0,47.0,559.0
Serchhip,10.4.2,Number of Immunisation sessions held during the month,TOTAL,48.0,46.0,46.0,47.0,48.0,45.0,46.0,46.0,47.0,46.0,47.0,44.0,556.0
Serchhip,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,47.0,45.0,45.0,46.0,47.0,45.0,45.0,43.0,46.0,45.0,46.0,43.0,543.0
Serchhip,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,84.0,83.0,82.0,76.0,87.0,87.0,79.0,75.0,86.0,55.0,81.0,67.0,942.0
Serchhip,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,75.0,108.0,62.0,64.0,69.0,76.0,65.0,77.0,75.0,68.0,76.0,82.0,897.0
Serchhip,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,29.0,70.0,55.0,50.0,70.0,72.0,64.0,74.0,50.0,48.0,90.0,67.0,739.0
Serchhip,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,0.0,1.0,4.0,1.0,1.0,1.0,0.0,0.0,1.0,2.0,0.0,15.0
Serchhip,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,52.0,89.0,29.0,11.0,23.0,32.0,22.0,25.0,29.0,23.0,65.0,88.0,488.0
Serchhip,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Serchhip,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,7.0,14.0,12.0,22.0,24.0,17.0,16.0,14.0,10.0,10.0,18.0,8.0,172.0
Serchhip,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Serchhip,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Serchhip,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,28.0,42.0,40.0,38.0,39.0,39.0,42.0,44.0,43.0,41.0,42.0,43.0,-1.0
Serchhip,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Serchhip,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Serchhip,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Serchhip,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,12.0,11.0,15.0,24.0,17.0,17.0,7.0,4.0,14.0,22.0,21.0,12.0,176.0
Serchhip,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Serchhip,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Serchhip,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,,,,,,,,,,,,,
Serchhip,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,,,,,,,,,,,,,
Serchhip,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,,,,,,,,,,,,,
Serchhip,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,63.0,37.0,48.0,55.0,67.0,43.0,51.0,45.0,34.0,30.0,63.0,54.0,590.0
Serchhip,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,77.0,84.0,94.0,91.0,87.0,115.0,97.0,95.0,94.0,97.0,76.0,83.0,1090.0
Serchhip,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,50.0,39.0,26.0,46.0,57.0,35.0,33.0,31.0,38.0,21.0,44.0,66.0,486.0
Serchhip,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,145.0,140.0,135.0,131.0,137.0,165.0,143.0,143.0,136.0,128.0,164.0,125.0,1692.0
Serchhip,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,113.0,76.0,74.0,101.0,124.0,78.0,84.0,76.0,72.0,51.0,107.0,120.0,1076.0
Serchhip,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,222.0,224.0,229.0,222.0,224.0,280.0,240.0,238.0,230.0,225.0,240.0,208.0,2782.0
Serchhip,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,2.0,5.0,3.0,1.0,5.0,7.0,4.0,4.0,3.0,7.0,6.0,52.0
Serchhip,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,1.0,2.0,1.0,3.0,1.0,0.0,3.0,1.0,4.0,3.0,2.0,21.0
Serchhip,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5.0,3.0,7.0,4.0,4.0,6.0,7.0,7.0,5.0,7.0,10.0,8.0,73.0
Serchhip,14.11,In-Patient Head Count at midnight,TOTAL,371.0,449.0,480.0,562.0,2141.0,3593.0,3547.0,4032.0,3580.0,3254.0,4615.0,4365.0,30989.0
Serchhip,14.12.1,OPD attendance (All),TOTAL,3924.0,4623.0,5381.0,5630.0,5525.0,5543.0,5380.0,5334.0,4228.0,3107.0,5034.0,3989.0,57698.0
Serchhip,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,5.0,3.0,3.0,2.0,0.0,3.0,1.0,3.0,5.0,15.0,5.0,5.0,50.0
Serchhip,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,,,,,,,,,,,,,
Serchhip,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,156.0,179.0,211.0,212.0,361.0,261.0,227.0,262.0,37.0,81.0,208.0,151.0,2346.0
Serchhip,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,,,,,,,,,,,,,
Serchhip,14.14.a,Number of patients given AYUSH treatment,TOTAL,246.0,442.0,521.0,417.0,289.0,269.0,311.0,312.0,299.0,108.0,296.0,302.0,3812.0
Serchhip,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,260.0,337.0,494.0,487.0,405.0,482.0,379.0,407.0,368.0,114.0,359.0,279.0,4371.0
Serchhip,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,,,,,,,,,,,,,
Serchhip,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,203.0,250.0,275.0,219.0,263.0,363.0,270.0,362.0,186.0,336.0,343.0,197.0,3267.0
Serchhip,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,6.0,10.0,4.0,2.0,2.0,8.0,10.0,10.0,5.0,3.0,4.0,8.0,72.0
Serchhip,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,115.0,100.0,115.0,86.0,102.0,119.0,87.0,143.0,105.0,98.0,74.0,117.0,1261.0
Serchhip,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,1.0,0.0,1.0,2.0,4.0,0.0,0.0,0.0,1.0,2.0,13.0
Serchhip,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,57.0,36.0,52.0,34.0,50.0,27.0,34.0,59.0,33.0,21.0,35.0,35.0,473.0
Serchhip,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,4.0
Serchhip,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,78.0,90.0,86.0,86.0,105.0,103.0,72.0,139.0,92.0,62.0,154.0,182.0,1249.0
Serchhip,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,3.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,2.0,11.0
Serchhip,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,250.0,226.0,253.0,206.0,257.0,249.0,193.0,341.0,230.0,181.0,263.0,334.0,2983.0
Serchhip,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,4.0,1.0,1.0,2.0,2.0,6.0,1.0,1.0,0.0,3.0,4.0,28.0
Serchhip,15.2,Number of Widal tests conducted,Number tested,35.0,54.0,42.0,32.0,79.0,81.0,136.0,87.0,25.0,18.0,65.0,24.0,678.0
Serchhip,15.3.a,Number of VDRL tests conducted on males,Number tested,52.0,44.0,36.0,33.0,36.0,43.0,45.0,34.0,44.0,40.0,60.0,54.0,521.0
Serchhip,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,31.0,13.0,23.0,18.0,21.0,19.0,37.0,26.0,19.0,7.0,43.0,31.0,288.0
Serchhip,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,50.0,22.0,32.0,63.0,59.0,85.0,65.0,54.0,65.0,50.0,113.0,118.0,776.0
Serchhip,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,133.0,79.0,91.0,114.0,116.0,147.0,147.0,114.0,128.0,97.0,216.0,203.0,1585.0
Serchhip,15.4.1,Number of blood smears examined for Malaria,TOTAL,144.0,156.0,290.0,252.0,285.0,246.0,348.0,234.0,139.0,84.0,123.0,90.0,2391.0
Serchhip,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,0.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Serchhip,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,4.0,3.0,6.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Serchhip,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,227.0,216.0,205.0,193.0,30.0,15.0,0.0,62.0,59.0,34.0,230.0,175.0,1446.0
Serchhip,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,0.0,50.0,0.0,0.0,100.0,0.0,0.0,200.0,0.0,0.0,350.0
Serchhip,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,193.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,198.0
Serchhip,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,11.0,11.0,12.0,20.0,15.0,15.0,38.0,3.0,25.0,4.0,55.0,9.0,218.0
Serchhip,16.1.1,Stock position of DPT vaccines,5. Total Stock,216.0,205.0,193.0,30.0,15.0,0.0,62.0,59.0,34.0,230.0,175.0,161.0,1380.0
Serchhip,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,216.0,199.0,182.0,163.0,232.0,180.0,150.0,219.0,204.0,169.0,189.0,157.0,2260.0
Serchhip,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,100.0,0.0,0.0,100.0,0.0,0.0,50.0,0.0,0.0,250.0
Serchhip,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,17.0,17.0,19.0,31.0,52.0,30.0,31.0,15.0,35.0,30.0,32.0,44.0,353.0
Serchhip,16.1.1A,Stock Position of Pentavalent,5. Total Stock,199.0,182.0,163.0,232.0,180.0,150.0,219.0,204.0,169.0,189.0,157.0,113.0,2157.0
Serchhip,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,36.0,75.0,142.0,128.0,188.0,133.0,128.0,200.0,145.0,136.0,245.0,241.0,1797.0
Serchhip,16.1.2,Stock position of OPV vaccines,2. Stocks Received,100.0,100.0,0.0,100.0,0.0,0.0,100.0,0.0,0.0,200.0,0.0,0.0,600.0
Serchhip,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,61.0,33.0,14.0,40.0,55.0,5.0,28.0,55.0,9.0,91.0,4.0,27.0,422.0
Serchhip,16.1.2,Stock position of OPV vaccines,5. Total Stock,75.0,142.0,128.0,188.0,133.0,128.0,200.0,145.0,136.0,245.0,241.0,214.0,1975.0
Serchhip,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,291.0,169.0,248.0,227.0,320.0,265.0,210.0,266.0,238.0,179.0,219.0,215.0,2847.0
Serchhip,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,150.0,0.0,100.0,0.0,0.0,100.0,0.0,0.0,50.0,0.0,0.0,400.0
Serchhip,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.3,Stock position of TT vaccines,4. Stock Distributed,122.0,71.0,21.0,7.0,55.0,55.0,44.0,28.0,59.0,10.0,4.0,68.0,544.0
Serchhip,16.1.3,Stock position of TT vaccines,5. Total Stock,169.0,248.0,227.0,320.0,265.0,210.0,266.0,238.0,179.0,219.0,215.0,147.0,2703.0
Serchhip,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,146.0,125.0,208.0,143.0,239.0,237.0,182.0,278.0,275.0,219.0,180.0,178.0,2410.0
Serchhip,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,100.0,0.0,100.0,0.0,0.0,100.0,0.0,0.0,41.0,0.0,0.0,341.0
Serchhip,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,21.0
Serchhip,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,21.0,17.0,65.0,4.0,2.0,55.0,4.0,3.0,56.0,59.0,2.0,13.0,301.0
Serchhip,16.1.5,Stock position of BCG vaccines,5. Total Stock,125.0,208.0,143.0,239.0,237.0,182.0,278.0,275.0,219.0,180.0,178.0,165.0,2429.0
Serchhip,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,266.0,227.0,145.0,114.0,380.0,328.0,268.0,200.0,189.0,170.0,101.0,243.0,2631.0
Serchhip,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,0.0,324.0,0.0,0.0,100.0,0.0,0.0,0.0,150.0,0.0,574.0
Serchhip,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,52.0,0.0,0.0,0.0,0.0,0.0,52.0
Serchhip,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,39.0,82.0,31.0,58.0,52.0,60.0,116.0,11.0,19.0,69.0,8.0,70.0,615.0
Serchhip,16.1.6,Stock position of Measles vaccines,5. Total Stock,227.0,145.0,114.0,380.0,328.0,268.0,200.0,189.0,170.0,101.0,243.0,173.0,2538.0
Serchhip,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,246.0,240.0,240.0,230.0,230.0,230.0,229.0,219.0,219.0,218.0,208.0,208.0,2717.0
Serchhip,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,6.0,0.0,10.0,0.0,0.0,1.0,10.0,0.0,1.0,10.0,0.0,50.0,88.0
Serchhip,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,240.0,240.0,230.0,230.0,230.0,229.0,219.0,219.0,218.0,208.0,208.0,158.0,2629.0
Serchhip,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,2400.0
Serchhip,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,2400.0
Serchhip,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,384.0
Serchhip,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,32.0,384.0
Serchhip,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,604053.0,504543.0,482057.0,441721.0,401273.0,364945.0,328617.0,3127209.0
Serchhip,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,643795.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,643795.0
Serchhip,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,39742.0,99510.0,22486.0,40336.0,40448.0,36328.0,36328.0,0.0,315178.0
Serchhip,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,604053.0,504543.0,482057.0,441721.0,401273.0,364945.0,328617.0,328617.0,3455826.0
Serchhip,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,530.0,530.0,2930.0,2930.0,10630.0,10430.0,9930.0,37910.0
Serchhip,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,530.0,0.0,3000.0,0.0,8000.0,0.0,0.0,7000.0,18530.0
Serchhip,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,300.0,200.0,500.0,600.0,2200.0
Serchhip,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,530.0,530.0,2930.0,2930.0,10630.0,10430.0,9930.0,16330.0,54240.0
Serchhip,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4800.0
Serchhip,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4800.0
Serchhip,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,450.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,450.0
Serchhip,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,450.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,450.0
Serchhip,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,23300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23300.0
Serchhip,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,23300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23300.0
Serchhip,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,9250.0,8850.0,8750.0,8750.0,8750.0,8150.0,8150.0,8150.0,68800.0
Serchhip,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Serchhip,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,750.0,400.0,100.0,0.0,0.0,600.0,0.0,0.0,0.0,1850.0
Serchhip,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,9250.0,8850.0,8750.0,8750.0,8750.0,8150.0,8150.0,8150.0,8150.0,76950.0
Serchhip,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,10000.0,9800.0,9000.0,7400.0,7400.0,5600.0,5200.0,5200.0,59600.0
Serchhip,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,600.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10600.0
Serchhip,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,600.0,0.0,0.0,200.0,800.0,1600.0,0.0,1800.0,400.0,0.0,400.0,5800.0
Serchhip,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,10000.0,9800.0,9000.0,7400.0,7400.0,5600.0,5200.0,5200.0,4800.0,64400.0
Serchhip,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,500.0,500.0,490.0,490.0,1490.0,1000.0,1000.0,1000.0,1000.0,990.0,990.0,990.0,10440.0
Serchhip,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Serchhip,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Serchhip,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,10.0,0.0,0.0,490.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,510.0
Serchhip,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,500.0,490.0,490.0,1490.0,1000.0,1000.0,1000.0,1000.0,990.0,990.0,990.0,990.0,10930.0
Serchhip,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,1.0,,,,1.0
Serchhip,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Serchhip,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Serchhip,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Serchhip,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Serchhip,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Serchhip,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Serchhip,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,,,,,1.0,1.0,,,,,3.0
Serchhip,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,,,1.0
Serchhip,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,,,,,1.0,2.0,,,,,4.0
Serchhip,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Serchhip,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Serchhip,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,1.0,,,1.0
Serchhip,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,1.0,,,,,,,,1.0
Serchhip,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Serchhip,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,1.0,,,,,,,,1.0
Serchhip,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Serchhip,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Serchhip,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Serchhip,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Serchhip,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,,,,,,1.0
Serchhip,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,1.0,,,,,,2.0
Serchhip,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Serchhip,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Serchhip,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Serchhip,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,,,1.0,,,1.0,,,1.0,4.0
Serchhip,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,1.0,,,,,,,2.0
Serchhip,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,1.0,,2.0,,,1.0,,,1.0,6.0
Serchhip,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Serchhip,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Serchhip,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,1.0,1.0
Serchhip,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,1.0,2.0,,3.0
Serchhip,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Serchhip,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,1.0,2.0,,3.0
Serchhip,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,1.0,,,,,,,,,,2.0
Serchhip,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,1.0,2.0,1.0,1.0,,,2.0,1.0,2.0,2.0,13.0
Serchhip,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,1.0,2.0,2.0,1.0,1.0,,,2.0,1.0,2.0,2.0,15.0
Serchhip,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Serchhip,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Serchhip,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Serchhip,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,1.0,1.0,,,,,3.0
Serchhip,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Serchhip,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,2.0,,1.0,1.0,,,,,4.0
Serchhip,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Serchhip,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Serchhip,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Serchhip,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,3.0,1.0,,1.0,,,1.0,6.0
Serchhip,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,1.0,,2.0,,1.0,2.0,,,1.0,3.0,2.0,13.0
Serchhip,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,1.0,,2.0,,4.0,3.0,,1.0,1.0,3.0,3.0,19.0
Serchhip,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,1.0,,,,,1.0,2.0
Serchhip,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,1.0,,,1.0,1.0,1.0,,,3.0,,8.0
Serchhip,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,1.0,,,1.0,2.0,1.0,,,3.0,1.0,10.0
Serchhip,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Serchhip,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Serchhip,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Serchhip,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Serchhip,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Serchhip,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Serchhip,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Serchhip,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Serchhip,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Serchhip,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Serchhip,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Serchhip,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Serchhip,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Serchhip,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,1.0,,,1.0,,2.0
Serchhip,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,1.0,,,,,,2.0,,1.0,1.0,5.0
Serchhip,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Serchhip,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,1.0,,,,,1.0,2.0,,3.0,1.0,8.0
Serchhip,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,,1.0,1.0,1.0,2.0,,,,,,1.0,7.0
Serchhip,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Serchhip,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,,1.0,1.0,1.0,2.0,,,,,,1.0,7.0
Serchhip,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Serchhip,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Serchhip,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,1.0,,,,,1.0
Serchhip,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Serchhip,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,,3.0,,,,4.0,,,,,,9.0
Serchhip,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,2.0,,1.0,2.0,1.0,,,1.0,1.0,,8.0
Serchhip,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,,5.0,,1.0,2.0,5.0,,,1.0,1.0,,17.0
Serchhip,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Serchhip,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,1.0,1.0,4.0,1.0,4.0,7.0,3.0,1.0,7.0,8.0,6.0,45.0
Serchhip,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,6.0,6.0,6.0,11.0,6.0,3.0,7.0,7.0,5.0,3.0,9.0,7.0,76.0
Serchhip,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,8.0,7.0,7.0,15.0,8.0,7.0,14.0,10.0,6.0,10.0,17.0,13.0,122.0
Serchhip,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Serchhip,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,1.0,1.0,,,,2.0,,,2.0,,6.0
Serchhip,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,2.0,2.0,1.0,3.0,2.0,3.0,5.0,5.0,2.0,3.0,3.0,2.0,33.0
Serchhip,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2.0,2.0,2.0,4.0,2.0,3.0,5.0,7.0,2.0,4.0,5.0,2.0,40.0
